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Eine Theorie ist desto eindrucksvoller, je größer die Einfachheit ihrer Prämissen ist, je 
verschiedenartigere Dinge sie verknüpft und je weiter ihr Anwendungsbereich ist. 
 
(Albert Einstein) 
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With recent advances in molecular biology and the sequencing of the human genome, nucleic 
acids (DNAs and RNAs) are expected to assume a pivotal position as drugs in the treatment 
of genetic and acquired diseases. The minimalist approach towards a gene therapy application 
is the use of ‘naked’ DNA without any carrier. However, due to limited uptake, rapid 
degradation by nucleases and fast clearance from the plasma [1-3], carrier systems are 
required for efficient nucleic acid delivery. 
The carrier system has to overcome many obstacles: it has to transport the DNA to the proper 
cell type, mediate cell entry, avoid endo-lysosomal degradation, translocate the DNA to the 
nucleus and promote efficient gene expression (Figure 1). 
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Figure 1: Obstacles in gene delivery following in vitro administration. The carrier system, 
here a cationic polymer, should efficiently condense DNA into polyplexes, bind to the plasma 
membrane, be internalized by a target cell, avoid endo-lysosomal degradation and transport 
the DNA to the nucleus to be transcribed. 
Viral vectors have been engineering by evolution to wrapping DNA and embody many of the 
required characteristics for efficient gene transfer. The application of viruses as gene carriers 
has advanced to the stage of clinical trials for the treatment of cancer [4] and monogenetic 
hereditery diseases [5] as well as to treat vascular [6] and infectious diseases [7]. The 
cumulative number of clinical trials exceeded 1,000 by 2005 [8], however, progressed only 
moderately as several regulatory agencies put a temporary hold on new or ongoing trials [9], 
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due to severe safety risks based on the immunogenicity and oncogenic potential of the viral 
vectors [10,11]. 
In the light of these concerns, non-viral strategies have emerged as potential alternatives for 
nucleic acid-based therapeutics. Mechanical and physical methods such as the gene gun, 
electroporation, sonoporation or laser irradiation have been introduced [12], but their major 
disadvantage is that the target tissue must be surgically exposed for gene transfer. Cationic 
lipids have also been tested in various clinical trials, however, they lack adaquate efficacy, are 
toxic upon repeated use and bear a significant inflammatory toxicity in vivo [13,14]. 
Therefore, the attention has turned to a number of cationic polymers as carriers for nucleic 
acid delivery. Among several polymeric candidates, such as poly(L-lysine) (PLL), chitosan 
and poly(diethylaminoethyl methylacrylate) (pDEAEMA) that exhibit differences concerning 
their charge density, hydrophilicity and structure (for reviews see [15,16]), 
poly(ethylenimine) (PEI) has gained some prominence [17]. 
Although initially, polymer-mediated transfection efficacy had been relatively low compared 
to viral systems, significant progress has been made over the past decade regarding the carrier 
design, allowing transfection agents to perform multiple tasks, and the efficiency in cell lines 
cultured in vitro has steadily improved. The most potent polyplex formulations have reached 
efficiencies comparable to those of viral vectors, although far more particles are required per 
cell for successful transfection. However, the non-viral gene delivery systems still lack 
adequate efficiency in many primary cells both in vitro and in vivo. 
Improvement of the transfection efficiency is one of the most important research subjects for 
non-viral gene delivery systems. Therefore, investigations into intracellular mechanism of 
gene expression have attracted interest. 
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The ability of PEI to complex DNA into stable complexes, also termed polyplexes, via 
electrostatic interactions is a necessary prerequisite for efficient delivery into cells. The 
polyplex properties are not only dependent on the polymer characteristics, but also on other 
factors, such as the composition of the complexes, e.g. the ratio of nitrogens in polymer to 
phosphates in DNA (NP ratio) and the medium for polyplex building [18]. In the past, only 
limited attention has been given to the structure and composition of polyplexes. However, a 
recent study using fluorescence correlation spectroscopy (FCS) with two-photon-excitation 
showed that polyplexes contained on average about 3.5 plasmid DNAs and 30 PEI (25 kDa) 
molecules, while a high proportion of polymer (~86%) remained in its free, unbound form 
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[19]. The free polymer may play a significant part in cytotoxicity. Nevertheless, an excess of 
polycation is necessary, because the cationic surface charge of polyplexes mediates the 
interaction with the negatively charged cell membrane [20]. 
PEI exists as a branched polymer (BPEI), commercially available in a broad range of 
molecular weights (MWs), as well as in its linear form (LPEI). The transfection efficiency 
and cytotoxicity [21] of PEI-based transfection systems depends on the MW, the degree of 
branching, the cationic charge density and buffer capacity of the polymer [22-24]. High MW 
BPEI has been shown to have a superior transfection efficiency compared to BPEIs with 
lower MW [24], but unfortunately, the higher transfection efficiency was accompanied by a 
decrease in the cell viability. Therefore, among BPEIs, a MW of 25 kDa is commonly 
believed to be most suitable for gene transfer. Polyplexes containing LPEIs have recently 
been shown to have an improved transfection efficiency and cell viability compared to BPEI-
based transfection systems [25-28]. 
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Binding and uptake 
Early steps in transfection involve the binding of polyplexes to the cell surface and their 
internalization or uptake into the cell cytosol. Unmodified polyplexes interact non-
specifically with the negatively charged cell membrane due to their positive surface charge. 
Heparan sulfate proteoglycans have been suggested to play a major role in this interaction of 
lipopolyamine/DNA complexes [20]. This hypothesis could be verified and extended to apply 
to both PLL and PEI as well as some lipids [29,30]. Kopatz et al. also corroborated these 
findings with drug inhibition experiments analyzed with flow cytomerty and confocal laser 
scanning microscopy (CLSM) by demonstrating that heparan sulfate proteoglycans, 
presumably syndecans, play a major role in the cell entry of non-viral vectors [31]. Passive 
targeting with unmodified polyplexes is the simplest approach for polyplex binding to the cell 
membrane. 
Active targeting using receptor-mediated uptake of modified polyplexes may enhance their 
availability in specific cells. This strategy has been used to deliver nucleic acids to 
hepatocytes [32], tracheal epithelial [33] and dendritic cells [34] via carbohydrates. Tumor 
tissues have been targeted via the folate [35,36], integrin [37-39], or transferrin [40,41] 
receptors, and targeting to specific tissues has been accomplished with antibodies or their 
fragments [42,43]. 
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Recently, protein transduction domains (PTDs) have gained interest as sequences that may 
enhance cellular uptake of polyplexes and circumvent the endo-lysosomal pathway. For 
example, the HIV-1 TAT derived peptide is a small basic peptide that has successfully been 
shown to deliver a variety of cargos, from small particles [44,45] to proteins and peptides 
([46], for reviews see [47,48]) and nucleic acids [49] to the cytoplasm of cells. The 
‘transduction domain’ or region containing cell penetration properties appears to be confined 
to a small stretch of basic amino acids with the sequence RKKRRQRRR [50,51]. The 
mechanism by which the TAT peptide associates with and crosses the plasma membrane is 
currently a topic of heated discussion in the literature (for reviews see [52-54]). 
Endocytosis or endocytosis-like mechanisms have been proposed as main pathways for the 
internalization of polyplexes. Generally, endocytosis occurs by multiple mechanisms that fall 
into two broad categories, ‘phagocytosis’ (the uptake of large particles) and ‘pinocytosis’ (the 
uptake of fluid and solutes) (for reviews see [55,56]). Phagocytosis is typically restricted to 
specialized mammalian cells, whereas pinocytosis occurs in all cells by at least four basic 
mechanisms: macropinocytosis, clathrin-mediated endocytosis, caveolae-mediated 
endocytosis and clathrin- and caveolae-independent endocytosis. The exact nature of 
polyplex-containing endocytotic vesicles, the influence of serum, polymer type, polyplex size 
and cell type remains elusive. Various groups have tried to elucidate this pathway primarily 
using two different approaches: micoscopy analysis and endocytosis-interfering drugs. Using 
unmodified polyplexes consisting of fluorescently labeled jetPEITM (a LPEI type) and 
plasmid DNA, Kopatz et al. suggested the following mechanism: the electrostatic binding of 
DNA-containing cationic particles to syndecan heparan sulfate proteoglycans induces 
syndecan to cluster into rafts. Actin binding to the cytoplasmic tail of the syndecans then 
generates a cortical network that may pull the particle into a cell, like a kind of actin-filament-
mediated ‘phagocytosis’ [31]. They used HeLa cells as a model cell line, the uptake of 
polyplexes was investigated by flow cytometry and the interaction of polyplexes with the 
actin skeleton by CLSM. An alternative path for uptake was described for histidylated PLL 
(His-PLL) - polyplexes into HepG2 cells. Blocking various pathways followed by flow 
cytometry indicated that polyplexes were internalized via clathrin-dependent and -
independent pathways [57]. 
Binding and uptake seem to be a limiting step in differentiated primary cell culture using 
cationic lipids [58,59], it has yet to be demonstrated whether this is also true for cationic 
polymers. In contrast, the high endocytotic capacity of most cell lines favors the uptake of 
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polyplexes [33,60,61]. However, primary cells are more representative of the in vivo situation 
than transformed cell lines. 
Endosomolysis 
Polyplex-containing endosomes undergo a rapid maturation to late endosomes that are able to 
fuse with other late endosomes [62] and lysosomes [60]. DNase II is an acidic endonuclease 
active in lysosomes and may play a role in the destruction of DNA [63]. Therefore, the 
accumulation of polyplexes in lysosomes is not expected to be productive for transfection [3]. 
However, the chemical structure of the gene carrier plays a critical role for the endo-
lysosomal escape of polyplexes: using fluorescein-labeled plasmid DNA and Texas Red 
Dextran as an endosome marker, Itaka et al. observed with CLSM that BPEI - and LPEI - 
polyplexes rapidly escape from endosomes, in sharp contrast to PLL - polyplexes [61]. For 
the endo-lysosomal escape of PEI-containing polyplexes, Behr postultated the so called 
‘proton sponge hypothesis’ [64]: at physiolocical pH only 1 to 6 nitrogen atoms of PEI are 
protonated. Upon lowering the pH in endosomes, the proportion of protonated nitrogens 
increases and generates a charge gradient, which induces Cl- influx. The increase in Cl- 
concentration is followed by an influx of water, leading to endosomal swelling and rupture. 
The efficacy of the cationic PEI has been related to its extensive buffering capacity, 
provoking the swelling and disruption of endosomes. This hypothesis was directly supported 
by Sonawane et al. [65]. They compared the endosomal Cl- concentration and pH after uptake 
of complexes containing PLL, a non-buffering polyamine, PEI or polyamidoamine (PAM), 
two strongly buffering polyamines, by CLSM. The polymers were labeled with pH or Cl- 
sensitive fluorescent dyes. Substantially greater Cl- accumulation and swelling were found in 
PEI- and PAM-containing endosomes compared to PLL-containing endosomes. In a time 
course, the pH of endosomes containing PEI - or PAM - polyplexes decreased slowly from 
7.2 to ~5.9 over 60 minutes and then increased to 6.5 at 75 minutes. In contrast, the pH of 
PLL-containing endosomes decreased rapidly to 5.9, an increase was not observed. 
Another mechanism for endo-lysosomal escape was suggested by Bieber et al. [60]: in 
electron microscopy studies, endosomal membrane holes have been observed and were 
related to the direct interaction of high MW BPEI (800 kDa) with the endosomal membrane 
in a non-acidic environment. The authors suggested that low MW PEIs (25kDa) also induce 
minor membrane damages, but that those holes may be quickly resealed. In another study, the 
membrane damage was found to occur in a dose dependent manner [66]. 
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Furthermore, the endosomolytic activity seems also to depend on the particle size, suggesting 
that larger polyplexes entrapped in endosomes may facilitate endosomolysis compared to 
smaller particles [18,67]. In addition to direct membrane interaction, the release of polyplexes 
may also be attributed to the extension of the polymer network as a result of the increasing 
electrostatic repulsion of charged groups during acidification [68]. Moreover, the extent of 
osmotic swelling should also depend on the number of protons entering the vesicles, these 
may increase the swelling [69]. 
Regardless of the precise mechanism of escape, a large portion of DNA is trapped and 
eventually degraded in endo-lysosomes. The use of peptides that have fusogenic or endosome 
disrupting properties has been followed up to enhance cytoplasmic delivery. The benefit 
depends on the characteristics of the polymer: The transfection efficiency of PLL-based 
delivery systems, which were postulated to accumulate in the lysosomal compartment, was 
enhanced up to more than 1000-fold by endosomolytic compounds, while the 
supplementation of membrane-destabilising peptides such as INF, GALA or KALA to PEI - 
polyplexes that have their own potential to destabilize membranes has failed to significantly 
enhance transfection efficacy [42,70-73]. 
Several groups observed the pH environment of polymer and DNA during their trafficking 
through the cytosol. The pH microenvironment of polyplexes provides an indication of 
polyplex location, because the luminal pH decreases with the maturation of endocytotic 
vesicles from early endosomes (neutral pH to ~ pH 6), late endosomes (pH ~ 5-6) and 
lysosomes (pH ~ 4.5). Akinc et al. used a flow cytometry-based technique to measure the pH 
environment of the plasmid DNA, which was covalently double-labeled with fluorescein and 
Cy5. The ratio of fluorescence emission of fluorescein and Cy5 increased with the pH. 
Plasmid DNA complexed with PLL was trafficked to acidic lysosomes with a pH of 4.5; after 
condensation with BPEI and LPEI, plasmid DNA had a pH of 5.9 and 5.0, respectively, 
indicating that polyplexes were trafficked to less acidic organelles [74]. This would be 
consistent with Sonawane et al. [65], however, in one study the polymer was labeled and in 
the other one the DNA. Using a similar technique, but labeling either polymer or DNA in 
different experiments, Gonçalves et al. showed that polyplexes containing His-PLL 
dissociated, because His-PLL was found in a slightly acidic environment (pH 6.7) and 
plasmid DNA in an compartment with neutral pH (~7.4) [57]. Histidylated residues may 
improve the buffering capacity of PLL. This potential segregation was confirmed by double 
labeling the His-PLL - polyplexes and scoring the number of internalized and intact 
polyplexes, free DNA and polymer in CLSM pictures. A rapid segregation of plasmid DNA 
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from the polymer upon internalization was suggested [57]. Forrest et al. made observations 
not expected for PEI and PLL by measuring their pH environment with a similar method [75]. 
The data indicated that PEI does not prevent exposure of polyplexes to acidic environments in 
C2C12 and HepG2 cells, but were nevertheless accompanied by a rather efficient gene 
expression. On the contrary, avoiding pH < 6 as with PLL correlated with greatly reduced 
gene expression. They hypothized that their data were consistent with the proton sponge 
hypothesis, including swelling and rupture of the vesicles, but exposure to a highly acidic pH, 
perhaps within lysosomes, may be required for efficient PEI-mediated gene delivery. Some of 
the described results seem to be inconsistent, however, this may be due to the fact that in each 
study the fluorescence label was attached to different components of polyplexes, different 
methods for pH measurements were applied and different cell lines have been used. 
The above-mentioned study with His-PLL and earlier investigations indicate that a portion of 
polyplexes may dissociate, although the time point is still unclear. Whether polymer and 
DNA are then transported in separate vesicles or if the dissociation actually occurs after 
vesicular transport has concluded is unknown. Some double labeled PEI/DNA complexes 
were intact for 18 h and a higher proportion of free polymer was also detected [60]. Godbey 
et al. showed by CLSM that a certain amount of DNA separated in the cytoplasm, but most 
DNA/PEI polyplexes found their way to the nucleus together [76]. Our own investigations 
revealed similar results: intact polyplexes were available in the cytosol and nucleus six hours 
after transfection and a certain amount of plasmid DNA and LPEI was freely dispersed 
through the cells [77]. However, due to the resolution limit of a light microscope, it remains 
possible that the fluorescently labeled molecules are observed colocalized without being 
associated. Fluorescence resonance energy transfer (FRET) between a donor fluorophore on 
the DNA and an acceptor fluorophore on the carrier could be a better alternative to study the 
complexation. Itaka et al. made observations concerning the conformational change of 
plasmid DNA after condensation with polymer, which would lead to a change in the distance 
between two fluorescent molecules attached to plasmid DNA [78]. Plasmid DNA complexed 
with LPEI showed a remarkable decrease in FRET efficiency due to disintegration of the 
polyplexes, while a high FRET efficiency indicated stability of BPEI - polyplexes [61]. In the 
same study, AFM confirmed the tighter complexation of plasmid DNA by BPEI. The 
dissociation of polyplexes is a critical point. If the affinity between DNA and polymer is too 
low, a premature dissociation may occur; however a strong affinity may prevent intracellular 
release. The factors influencing the potential for and velocity of polyplex dissociation have 
not been elucidated so far. Most likely, the dissociation depends on the polymer 
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characteristics as well as polyplex size. Otherwise, it has not yet been shown whether free 
polymer or DNA detected inside cells is due to incomplete packing into polyplexes, i.e. 
uptake of free polymer, or really due to polyplex disintegration inside the cell. 
Nuclear entry 
One of the major steps limiting non-viral gene transfer is the entry of plasmid DNA from the 
cytoplasm into the nucleus. CLSM observations confirmed the nuclear transport of plasmid 
DNA complexed to either LPEI or BPEI, but only a small portion of DNA had been 
transported to the nucleus [61]. The translocation efficacy of plasmid DNA has been 
estimated to be 1 of 1000 plasmids [79]. Complexation of plasmid DNA to PEI improved the 
plasmid trafficking to the nucleus and increased the access of plasmid DNA to the nucleus by 
10-fold [80]. Three main reasons for the low transport rate into the nuclear compartment have 
been described so far. In comparison to a DNA fragment of 100 bp, which is fully mobile in 
cytoplasm with a diffusibility only 5 times slower than in water, the diffusion of larger DNA 
fragments (> 250 bp) in cytoplasm is remarkably slower, with little or no diffusion for DNAs 
larger than 2000 bp [81]. This is probably due to the actin skeleton restricting cytoplasmic 
transport of non-complexed DNA [82]. Furthermore, diffusion and nuclear uptake compete 
with degradation by cytosolic nucleases [1]. The half-life of DNA in the cytoplasm of HeLa 
and COS cells was estimated at 50 - 90 min when monitored by fluorescent in situ 
hybridzation (FISH) [1,83]. Regarding these two points, a possible role for endocytosis may 
be to transport DNA from the plasma membrane to the perinuclear region, thereby shortening 
the exposure time of plasmid DNA in cytoplasm. This would be in agreement with the results 
that DNA injected far from the nucleus resulting in less transgene expression than DNA 
microinjected near the nucleus [84]. Nonetheless, as the average velocity of actively 
transported PEI/DNA complexes was 0.2 µm/s as determined by real-time multiple particle 
tracking, an active gene carrier transport allows for perinuclear DNA accumulation within 
minutes [85]. Unfortunately, the most part of polyplexes is transported by diffusion or 
subdiffusion and, therefore, more perceptive to degradation. Third, the nucleus is surrounded 
by a double membrane, which contains highly regulated pores for transport. Typically, a 
mammalian cell nucleus posesses about 3,000 – 5,000 nuclear pore complexes (NPCs), which 
occupy about 10-25% of the nuclear surface. The pores of the nucleus, which can expand to 
26 nm, serve as size exclusion barriers (for a review see [86]). Studies with protein-coated 
gold particles confirm this upper limit for a non-deformable cargo [87]. Small molecules 
enter the nucleus via passive diffusion, while macromolecules larger than 40-50 kDa only 
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permeate through NPCs via highly regulated active processes mediated by nuclear 
localization signals (NLSs) [86]. The NLS is recognized by a heterodimer protein complex of 
importin-α and importin-β. In the classical case of NLS-containing proteins, importin-α 
directly interacts with the cargo-NLS, which in turn interacts with the importin-β molecule 
that docks the complex to the NPC. The translocation of the cargo through the nuclear pore is 
energy dependent (for reviews see [88,89]). 
After the disassembly of polyplexes, plasmid DNA may enter the nuclear compartment either 
by passive diffusion during mitosis when the nuclear envelope breaks down or active 
transport through the nuclear pore. The first hypothesis was supported by experiments that 
demonstrated a correlation between the stage of the cell cycle at the time of transfection and 
the final transgene expression [90,91]. To this end, cells were synchronized at various time 
points during the cell cycle. The transfection efficiency was much higher when cells were 
transfected at or near the M phase compared to tranfection in the G1 or early S phase. 
Brunner et al. showed that there are remarkable differences between various non-viral gene 
delivery systems. DNA electroporation and LPEI-containing polyplexes had very little cell 
cycle dependence in comparison to BPEI-based polyplexes or Lipofectamine-containing 
lipoplexes [90,91]. 
Into non-dividing, postmitotic cells such as neurons [92] or dendritic cells [93], the entry of 
plasmid DNA into the nucleus can only occur by active transport through the nuclear pores. 
As the translocation rate is much lower compared to cell lines, two general approaches are 
followed to enhance the nuclear import of plasmid DNA or polyplexes, respectively: either a 
sequence-specific nuclear import of plasmid DNA mediated by DNA nuclear targeting 
sequences (DTS) or the application of peptides carrying a NLS signal (Figure 2) [94]. 
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Figure 2: Approaches to increase the nuclear localization of transfected plasmids: Specific 
DTS incorporated in plasmid DNA allow for interaction with cytoplasmic transcription 
factors. As these transcription factors contain an NLS, they act as adaptors and home the 
plasmid DNA to the nucleus via the importin-mediated pathway. Other methods rely on the 
addition of NLS-peptides or NLS-containing proteins to the DNA by electrostatic, covalent or 
PNA clamps. By interaction with importin, the classical pathway is again followed (adapted 
from [94]). 
Various studies provided evidence that the nuclear entry of plasmid DNA is sequence specific 
by applying the 72-bp enhancer repeat from the SV40 genome to support nuclear import of an 
otherwise cytoplasmically localized plasmid [95-97]. It is suggested that such sequences bind 
to NLS-containing cytoplasmic proteins, such as transcription factors. These proteins then act 
as adaptors between the plasmid DNA and the importin-dependent nuclear import machinery 
[98]. As the 72-bp element of the SV40 enhancer additionally increased CMV promotor-
driven gene expression by as much as 20-fold in murine tibialis muscle in vivo, the SV40 
DTS has two functions incorporated in one element, namely the facilitation of nuclear import 
and transcriptional activity. However, it remains unclear how plasmid DNA, even though it is 
larger in diameter, can cross a nuclear pore. 
Coupling peptides containing the NLS to plasmid DNA or polymer is another approach 
towards enhancing nuclear uptake of cargo molecules. Coupling strategies have involved 
electrostatic interaction [99,100], PNA (peptide nucleic acid)-mediated hybridization 
[101,102] or covalent coupling to polymer or plasmid DNA [103-105]. Classical NLS 
peptides, such as the SV40 large T-antigen derived peptide [100,101,105], and non-classical 
NLS, such as the HIV-1 virus TAT derived peptide [106] and the M9 sequence from the 
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heterogeneous nuclear ribonucleoprotein [99,107], have been tested (for reviews see [108-
110]). Despite the promising concept there is a lack of consensus concerning the potency of 
NLS-peptides in nucleic acid delivery. Zanta et al. prepared a linear, double-stranded DNA 
fragment encoding luciferase, endcapped to enhance the resistance against nucleases and 
coupled to a NLS peptide [104]. Transfection efficacy was enhanced by 10- to 30- fold in 
non-dividing cells such as macrophages or murine neurons and 1,000- fold in fast dividing 
cells such as HeLa or 3T3 when DNA was complexed to Transfectam, BPEI 25 kDa or 
LPEI 22 kDa. However, in another study, linear DNA constructs containing a NLS 
complexed with cationic polymers failed to enhance gene expression [111]. It was also shown 
that a circular plasmid DNA covalently attached to NLS retained its transfection ability, but 
the reporter gene expression was not significantly increased [103,105,112]. Subramaniam et 
al. showed a 63-fold increase in the percentage of transfected cells in non-dividing confluent 
endothelial cells (83%) when plasmid was coupled to an M9-derived NLS and delivered via 
lipoplexes [99]. An up to 8- fold increase in the transfection efficiency was obtained when 
plasmid was coupled to an SV40-derived NLS and delivered into several cell lines via PEI-
based polyplexes [101]. Seymour et al. followed up another approach by linking the 
adenovirus hexonprotein covalently to the polymer, namely PEI 800 kDa, and complexed it to 
plasmid DNA. The hexon-mediated nuclear entry enabled substantially better transgene 
expression compared to classical NLS in HepG2 cells, however, results were only elevated 
10-fold compared to PEI/DNA complexes [113]. 
Concluding, success has been mixed so far, with some studies showing successful NLS-
mediated nuclear delivery of oligonucelotides or linearized plasmids [101,104], but less 
efficient transfer of intact plasmids [103]. This is, however, not a general rule as shown by 
[99]. Perhaps non-dividing cells may benefit more from nuclear targeting strategies compared 
to cell lines, because they cannot use the breakdown of the nuclear envelope during mitosis. 
Furthermore, the amount of NLS per plasmid DNA required for efficient nuclear import is 
controversial. Both the addition of an excess [101] or only one NLS linked to DNA [104] has 
been successful. 
Using the strategy of nuclear targeting, the specific targeting sequence should be accessible in 
polyplexes. However, it has been shown that compared to cationic lipids, PEI or PLL do not 
prevent gene expression when injected into the nucleus together with plasmid DNA [80]. 
Furthermore, it was also shown that DNA/PEI complexes can penetrate into the nucleus, 
suggesting that a complete dissociation may not be a necessary prerequisite for nuclear 
translocation [60,76]. 
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Non-viral, polymer-based nucleic acid delivery is increasingly acknowlegded to serve for 
both the development of novel therapeutic concepts and basic research. A functional design 
of polycationic carriers involves a material that enables efficient condensation of nucleic 
acids into polyplexes in terms of cellular uptake. Furthermore, the exposure of polyplexes to 
the acidic pH of the endo-lysosomal compartment requires an intrinsic ability of the polymer 
to facilitate endo-lysosomal release. Last, but not least, the DNA has to be transported to the 
nucleus to be transcribed. 
A successful delivery system allows for a high transfection efficiency and is assembled from 
non-toxic components. However, existing polymers fail at least one of these requirements. 
Therefore, the work presented in this thesis aimed at testing the hypothesis that biodegradable 
polymers are an intelligent alternative as effective polymer-based nucleic acid delivery 
systems with low cytotoxicity for in vitro use. On the way to accomplish the overall 
objective, it was necessary to meet the following specific aims: 
1. Investigation of low MW LPEI-based nucleic acid delivery systems 
The first aim strove to overcome the frequent restriction that high transfection efficiency is 
limited by the cytotoxicity of the non-viral carrier. Therefore, the potential of utilizing LPEIs 
with a MW ranging from 1.0 to 9.5 kDa was investigated. Furthermore, it was tested whether 
the unique property of PEI, namely the intrinsic endo-lysosmal escape capacity, is also 
evident for low MW LPEIs. Finally, it was investigated if, by reducing the MW, LPEIs retain 
their improved nuclear import characteristics (Chapter 2). 
In order to gain a more comprehensive insight into LPEI-mediated gene transfer, the uptake 
and stability of plasmid DNA during the transfection process were measured. As it is known 
that polyplexes are sensitive to changes in the ionic strength, the transfection efficiency of 
polyplexes generated in salt-free and -containing medium and in the presence or absence of 
serum was determined. The polycationic carrier should efficiently condense and protect the 
DNA extracellularly and release the DNA intracellularly. Therefore, the extra- and 
intracellular interaction of LPEIs with plasmid DNA was investigated by CLSM (Chapter 3). 
To measure the interaction of plasmid DNA and LPEI in a more precise distance range, 
Chapter 4 aimed at evaluating fluorescence resonance energy transfer (FRET) as a technique 
to determine the intracellular disintegration of double labeled LPEI - polyplexes. FRET was 
measured by different means, namely CLSM and flow cytometry, in living cells. 
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2. Investigation of biodegradable PEI-based nucleic acid delivery systems 
The intention of Chapter 5 was to identify suitable biodegradable, high MW polymers to 
further decrease the toxicity of the non-viral carrier. It was hypothesized that a bioreversible 
crosslinking of low MW LPEIs would raise the polymer’s efficacy, due to the higher MW 
and hence transfection efficiency, while the biodegradable linkages would undergo 
intracellular breakdown and hence not be toxic. In detail, various biodegradable PEIs 
originating from crosslinking LPEI with a MW of 2.4 kDa by bioreversible disulfide bonds 
were investigated concerning the transfection efficiency and cytotxicity. 
Furthermore, the capacity of biodegradable PEIs for gene transfer was evaluated in human 
primary cells in vitro (Chapter 6). Two different test systems were chosen, namely non-
dividing dendritic cells (DCs) and chondrocytes that have a limited mitogenic activity. As 
they are cheaper to maintain and more available than DCs, the HT-29 cell line was used as a 
model to test whether the uptake is a rate limiting step in the transfection of ‘hard-to-transfet’ 
cells using polymers. 
3. Investigation of the influence of variation in the PEI backbone 
Last, but not least, since it is postulated that the high cationic charge density of the PEI 
backbone is significantly responsible for efficient gene delivery, the impact of converting 
primary and secondary amines of PEI to tertiary ones on the transfection efficiency and 
cytotoxicity was investigated (Chapter 7). 
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Background 
Linear polyethylenimine (LPEI) with a molecular weight (MW) of 22 kDa has been described 
as having a superior ability to induce gene transfer compared to its branched form. However, 
the transfection efficiency of the polymer cannot be enhanced beyond a certain limit due to 
cytotoxicity. We explored the potential of utilizing LPEIs with MWs ranging from 1.0 to 9.5 
kDa to overcome this limitation. 
Methods 
Polyplexes of plasmid DNA encoding for enhanced green fluorescent protein (EGFP) and 
various LPEIs were compared concerning their transfection efficiency and cytotoxicity in 
CHO-K1 and HeLa cells by flow cytometry. The involvement of endolysosomes in LPEI – 
mediated gene transfer was investigated by applying the proton pump inhibitor bafilomycin 
A1 and the lysosomotropic agent sucrose. Confocal laser scanning microscopy was applied to 
assess the size and shape of polyplexes under cell culture conditions, to detect their 
endolysosomal localization and to observe their translocation to the nucleus. 
Results 
The transfection efficiency could be altered by varying the MW and the amount of the 
polymer available for polyplex formation. The highest transfection efficiency (about 44%), 
i.e. the fraction of EGFP positive cells, was obtained with LPEI 5.6 kDa, while the 
cytotoxicity remained low. The colocalization of polyplexes and endolysosomes was 
observed, and it appeared that the larger polyplexes escaped from the acidic organelles 
particularly quickly. For LPEI 5.0 and 9.0 kDa, the number of cells and nuclei that have taken 
up DNA after 6 hours was similar, as determined by flow cytometry. 
Conclusions 
Our study suggests that LPEIs with low MWs are promising candidates for non-viral gene 
delivery, because they are more efficient and substantially less toxic than their higher MW 
counterparts. 
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Gene therapy has the potential to treat inherited and acquired diseases for which there is little 
hope of developing conventional medications. Significant progress has been made since the 
inception of gene therapy in the 1960s [1], but many hurdles remain before gene therapeutics 
could be used routinely in clinics. So far, gene therapy clinical trials have predominantly been 
based on viruses as gene vectors, because they are quite efficient in delivering DNA and 
initiating gene expression. However, their broad use is limited by the risk of insertional 
oncogenesis [2,3]. 
In the light of these concerns, non-viral gene delivery systems are gaining attention, as they 
are considered to be safer alternatives. However, their application is hampered by a low 
transfection efficiency compared to viruses. One non-viral gene delivery strategy involves the 
use of polycationic polymers such as polyethylenimine (PEI) as a DNA complexing agent for 
in vitro and in vivo use [4-9]. PEI/DNA complexes (polyplexes) are taken up by a variety of 
cells via endocytosis, enter the endolysosomal compartment, and are finally released due to 
their buffer capacity via the so-called ´proton sponge mechanism´ [9,10]. Subsequent to their 
successful escape from intracellular vesicles, the translocation of polyplexes to the nucleus 
remains the major barrier. A number of branched PEI (BPEI) – based transfection systems 
with varying molecular weight (MW) have been described, which accomplish a relatively 
high transfection efficiency [11], but are generally afflicted with a high cytotoxicity [6,12]. 
The situation demands better materials with a high transfection efficiency and low 
cytotoxicity. 
Polyplexes containing linear PEI (LPEI) are larger (> 1000 nm) in salt-containing buffers 
compared to those prepared with its branched form (about 100 – 600 nm) [4,13,14], although 
the polyplex size not only depends on the polymer structure, but also on the MW and the NP 
ratio (indicates the ratio of nitrogens in polymer to phosphates in DNA). Larger particles 
sediment onto plated cells more quickly than smaller ones, which are limited to their 
Brownian molecular motion, and therefore result in an increase of particle uptake in vitro 
[7,15]. Furthermore, it has been suggested that large particles exhibit a higher intrinsic 
endolysosomal activity, which may enhance their escape from the acidic compartment [15]. 
Moreover, a particularly high gene expression was found with LPEI 22 kDa in non-dividing 
polarized cells [5], which implies that LPEI allows for a cell cycle independent gene transfer 
[16], and therefore may not be limited to fast-dividing cells. 
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Several studies revealed that polyplexes formed with LPEI 22 kDa reach a higher transfection 
efficiency than BPEI – polyplexes [17-20]. However, most studies have been confined to only 
a few commercially available LPEI derivatives, for example ExGen 500 with a MW of 22 
kDa. Moreover, even LPEI 22 kDa displays cytotoxic effects at a certain dose. In this study, 
we therefore explored the possibility and potential of utilizing LPEIs within the range of 1.0 
to 9.5 kDa as carriers for gene delivery. First, as it is known for BPEI that the transfection 
efficiency correlates with the MW of the polymer [11], we wanted to determine the size limit 
of LPEI that still allows for gene transfer. In particular, we intended to verify for LPEIs, that 
low MW substances are substantially less toxic than their high MW counterparts [14], but still 
retain their ability for gene transfer. We sought to overcome the restriction that high 
transfection efficiency is limited by the cytotoxicity of the non-viral carrier. Furthermore, we 
wanted to gain some insight into the mechanism of transfection using LPEI – polyplexes and, 
therefore, investigated their nuclear entry and the involvement of endolysosomes. 
#	#
All materials were purchased from Sigma-Aldrich Chemie GmbH (Germany) unless 
otherwise stated. 
Cell lines and cell culture 
CHO-K1 (ATCC No. CCL-61) and HeLa cells (ATCC No. CCL-2.1) were grown in 75 ml 
culture flasks in a 5% CO2 atmosphere at 37°C as adherent culture to 90% confluency before 
seeding. Culture medium for CHO-K1 cells consisted of Ham´s F-12 supplemented with 10% 
FBS (Biochrom AG, Germany). HeLa cells were maintained in Dulbecco´s Medium 
(Invitrogen, Germany) supplemented with 10% FBS, 1 mM sodium pyruvate and 2 mM L-
glutamine (both Invitrogen, Germany). 
Non-viral carriers 
Twelve LPEI derivates within the range of 1.0 to 9.5 kDa were synthesized by ring-opening 
polymerization of 2-ethyl-2-oxazoline and acidic hydrolysis of the corresponding poly(2-
ethyl-2-oxazoline) as previously described [13]. The amine bases of the LPEIs were 
precipitated, recrystallized in ethanol and the average MW was estimated by 1H-NMR 
spectroscopy. In the following, the notation of polymers was made without the unit kDa, for 
example LPEI 9.5 represents LPEI with a MW of 9.5 kDa. Polymer stock solutions were 
prepared with 150 mM NaCl, the pH of LPEI solutions was adjusted to 7 and then filtered 
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(0.2 µm filter, Corning GmbH, Germany). ExGen 500 was obtained from MBI Fermentas 
GmbH (Germany). When indicated, polymers were labeled with 6-TAMRA- succinimidyl 
ester (Molecular Probes, The Netherlands). Briefly, the amine bases of the corresponding 
LPEIs and 6-TAMRA- succinimidyl ester were dissolved in DMSO and stirred for 24 hours 
at room temperature in the dark. The labeled polymers were dissolved in diluted hydrochloric 
acid, precipitated with sodium hydroxide solution and then washed extensively. The labeling 
reaction was controlled by thin layer chromatography. 
Plasmid isolation and labeling 
Plasmid encoding enhanced green fluorescent protein (EGFP) (Clontech, Germany) was used 
as reporter gene in this study. Plasmid was isolated from E. coli by using a Qiagen Plasmid 
Maxi Kit (Qiagen, Germany) according to the supplier´s protocol. For confocal laser scanning 
microscopy (CLSM), in cases when only the plasmid DNA was stained, it was labeled with 
fluorescein using the FluoroULS Labeling Kit (MBI Fermantas GmbH, Germany) according 
to the manufacturer´s protocol. The labeled DNA was purified by ethanol precipitation. For 
uptake experiments by flow cytometry and other experiments by CLSM, plasmid DNA was 
stained with YOYO-1 (Molecular Probes, The Netherlands). The labeling reaction was 
carried out with a molar ratio of 1 dye molecule per 320 base pairs at room temperature in the 
dark. 
Preparation of plasmid DNA / polymer complexes - polyplexes 
Plasmid DNA / LPEI complexes were prepared at a NP ratio of 6, 12, 18, 24 and 30. 
Polyplexes were formed by mixing 2 µg DNA with the appropriate amount of polymer 
solution, while both components were diluted to 50 µl with 150 mM NaCl or 5% glucose, as 
indicated. The resulting LPEI - polyplexes were incubated for 20 minutes at room 
temperature before use. In the following, the notation of polyplexes was made without the 
unit kDa, for example LPEI 9.0 – polyplexes expresses that polyplexes were built with LPEI 
9.0. 
In vitro transfection and cytotoxicity experiments 
For gene transfer studies, CHO-K1 cells were grown in 24-well plates at an initial density of 
38,000 cells per well and HeLa cells at 40,000 cells per well. 18 hours after plating, the 
culture medium was removed, cells were washed with PBS (Invitrogen, Germany) and 900 µl 
serum-free medium was added (transfection medium). Thereafter, the prepared polyplexes 
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were added to the cells. After 4 hours, the medium was replaced with 1 ml of culture medium. 
When Bafilomycin A1, dissolved in ethanol (J.T. Baker, Holland), or sucrose were used, cells 
were pretreated for 15 min at 37°C, and the transfection was performed in the presence of the 
drug [21,22]. In experiments with sucrose, the transfection medium was replaced with culture 
medium containing the same concentration of sucrose to prevent osmotic lysis of the 
lysosomes and cells. 48 hours later, cells were prepared for flow cytometry analysis. Floating 
cells were collected and combined with adherent cells after trypsinization. The pooled cells 
were washed twice with PBS, resuspended in 500 µl PBS and propidium iodide was added at 
a concentration of 1 µg / ml to half of the samples. Measurements were taken on a 
FACSCalibur (Becton Dickinson, Germany) using CellQuest Pro software (Becton 
Dickinson, Germany) and WinMDI 2.8 (1993-2000 Joseph Trotter). EGFP positive cells 
were detected using a 530/30 nm band-pass filter, whereas the propidium iodide emission was 
measured with a 670 nm longpass filter. Logarithmic amplification of EGFP and propidium 
iodide emission in green and red fluorescence was obtained with 20,000 cells counted for 
each sample. In a density plot representing forward scatter against sideward scatter, whole 
cells were gated out (this process allows to distinguish between the cell population and cell 
fragments) and depicted in two-parameter dot plots of EGFP versus propidium iodide to 
analyse the measurements. The EGFP positive region, which corresponds to the transfection 
efficiency, was drawn starting above cell autofluorescence, where EGFP positive cells were < 
0.2%. The geometric mean fluorescence intensity was determined from the number of EGFP 
positive cells. Further, the number of propidium iodide negative cells was counted as a 
measure of cell viability [23]. 
Cellular and nuclear uptake of polyplexes 
YOYO-1 - labeled DNA was used to monitor polyplex delivery and LPEI 2.0, 5.0 and 9.0 
were applied for polyplex formation. As a negative control, mock transfected cells and cells 
transfected with unlabeled polyplexes were employed. 50,000 CHO-K1 cells per well were 
seeded in a 24-well plate and then treated as described in the previous section, but were 
detached after transfection for 6 hours with trypsin containing 20 mM sodium azide (Merck 
KGaA, Germany). Sodium azide depletes ATP and prevents further particle uptake [24], 
whereas trypsin cleaves surface bound proteins [25]. Briefly, the nuclei were isolated as 
follows: cells were incubated for 5 minutes in a buffer with low salt concentration containing 
10 mM Tris-HCl, 60 mM sodium chloride (Merck KGaA, Germany) and 1 mM EDTA. 
Thereafter, cells were treated with the same buffer additionally containing Phenyl
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Methylsulphonylfluoride, 1,4-Dithio-DL-threitol, protease inhibitors (Roche Diagnostics, 
Germany) and 0.5% Tergitol Type NP 40 (nuclei isolation buffer). Nuclei were pelleted at 
2,500 rpm, rinsed three times with nuclei isolation buffer without Tergitol Type NP 40, and 
then resuspended in PBS with 20 mM sodium azide. Whole cells were treated as described 
for in vitro transfection, but PBS was also supplemented with 20 mM sodium azide. The 
percentage of isolated nuclei was determined to be > 95% by propidium iodide incorporation 
measured by flow cytometry, and the absence of extracellular and nuclear associated 
polyplexes was confirmed by CLSM (data not shown). The percentage of cells and nuclei that 
had taken up polyplexes and their mean fluorescence intensity was determined by flow 
cytometry. The mean fluorescence intensity of cells and nuclei that have incorporated 
YOYO-1 - labeled DNA, cannot be regarded as absolute value for the number of polyplexes, 
because those are not homogeneous in size distribution, i.e. larger polyplexes display a higher 
fluorescence intensity than smaller ones. Furthermore, polyplexes may also show a different 
fluorescence intensity in various compartments of a cell or dissociate after uptake. Therefore, 
we used the mean fluorescence intensity only as an indirect measure or, rather, an indicator of 
the amount of the internalized polyplexes. 
Intracellular trafficking - confocal laser scanning microscopy (CLSM) 
A Zeiss Axiovert 200 M microscope coupled to a Zeiss LSM 510 scanning device (Carl Zeiss 
Co. Ltd., Germany) was used for CLSM experiments. The inverted microscope was equipped 
with a Plan – Apochromat 63x and Plan – Neofluar 100x objective. Cells were plated in 8 – 
well Lab-TekTM Chambered Coverglass (Nunc GmbH & Co. KG, Germany) at an initial 
density of 35,000 cells / chamber in a volume of 400 µl culture medium. For maintaining a 
pH of 7.4, 20 mM HEPES was supplied. After 18 hours, polyplexes were added and 
measurements were directly performed in each well at 37°C. The thickness of the optical 
sections was between 0.7 and 1.2 µm.  
For the investigation of the intracellular trafficking of polyplexes, LPEI 22, 9.0, 2.0 and 
fluorescein - labeled DNA were used. An argon laser with 488 nm was used to excite 
fluorescein. Images were taken using a band-pass filter of 505 – 530 nm in the singletrack 
mode at the indicated times after the addition of the polyplexes. Values for the approximate 
size of the various polyplexes were acquired by measuring the extent of a representative 
collective of intracellular polyplexes in confocal images. In cases, when double – labeled 
polyplexes were observed, YOYO-1 – labeled DNA was excited with 488 nm and 
fluorescence was detected using a 505 – 530 nm band-pass filter, whereas the TAMRA – 
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labeled LPEI was excited with 543 nm and recorded with a 560 nm lonpass filter. Images 
were taken in the multitracking modus. For the detection of polyplexes in acidic 
compartments of the cell, TAMRA – labeled LPEI 9.0 or 5.0 were applied. Polyplexes and 
quinacrine mustard at a concentration 10-6 M were added to the cells at the same point of 
time. An argon laser with 458 nm was used to excite the quinacrine mustard and the 
fluorescence was imaged using a band-pass filter of 475 – 525 nm. TAMRA – labeled LPEI 
was excited at 543 nm and the fluoresecence was recorded with a 560 nm longpass filter. 
Images were taken in the multitracking modus. 
Statistical analysis 
All measurements were collected (n = 3 to 6) and expressed as means ± standard deviation 
(SD). Single factor of variance (ANOVA) was used in conjunction with a multiple 
comparison test (Tukey test) to assess the statistical significance. 
"
LPEI - mediated gene transfer and cytotoxicity 
The transfection efficiency of polyplexes formed with LPEI 1.0 to 9.5 and plasmid DNA was 
evaluated in CHO-K1 cells (Figure 1). For polyplexes with LPEIs from 9.0 to 5.6 kDa, the 
transfection efficiency followed a certain profile: as the NP ratio was increased, the 
transfection efficiency first increased, plateaued and then decreased. Using LPEIs from 5.0 to 
1.0 kDa, the transfection efficiency could be increased with the amount of polymer. Such a 
plateau or drop was not observed for LPEI 9.5. With increasing NP ratio, the maximum in 
transfection efficiency shifted to polyplexes made with a LPEI derivative with lower MW. 
The maximum transfection efficiency of about 44% was obtained with LPEI 5.6 at NP 18. 
LPEI 1.0 seemed to be the limit for gene transfer, because LPEI 1.0 - polyplexes displayed a 
minimal transfection efficiency (Figure 1). The mean fluorescence intensity of EGFP positive 
cells can serve as average expression of EGFP per cell. After transfection with LPEIs with a 
MW from 9.5 to 5.6 kDa at NP 6 to 30, no statistically significant differences could be found 
in the mean fluorescence intensity. Using LPEIs with a MW from 5.0 to 1.0 kDa, the mean 
fluorescence intensity of EGFP positive cells was only significantly (p<0.05) higher at NP 30 
compared to NP 6 (data not shown). We confirmed our results by investigating the gene 
transfer ability of LPEI 9.0 - and 5.0 – polyplexes in HeLa cells (Figure 2). 
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Figure 1: Transfection efficiency of LPEIs with various MW [kDa] (as indicated in the 
legend) complexed with pEGFP-N1 as reporter gene in CHO-K1 cells determined by flow 
cytometry. Experiments were performed in duplicate; values represent the EGFP positive 
cells as means ± SD of one representative experiment (n=6). Transfection efficiencies of 
LPEI - polyplexes within each NP ratio are significantly different from LPEI ≤ 5.0 – 
polyplexes, denoted by , significantly different from LPEI ≤ 4.6 - polyplexes, denoted by , 
and significantly different from LPEI ≤ 3.5 – polyplexes, denoted by  (p < 0.01). 
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Figure 2: Transfection efficiency of LPEI 9.0 ( ) - or 5.0 ( ) - polyplexes with pEGFP-N1 
as reporter gene, tested in HeLa cells. Experiments were performed in duplicate; values 
represent the EGFP positive cells as means ± SD of one representative experiment (n=4). 
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The polymers showed the same trend in both cell lines. Polyplexes built in glucose resulted in 
a reduced efficacy compared to those prepared in sodium chloride, but a dependency of the 
transfection efficiency on the MW could also be observed: LPEI 9.0 – polyplexes reached 
higher values than LPEI 5.0 – polyplexes (Figure 3). 
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Figure 3: Transfection efficiency of LPEI 9.0 ( ) - or 5.0 ( ) - polyplexes with pEGFP-N1 
as reporter gene, polyplexes were formed in glucose. Experiments were performed in 
duplicate; values represent the EGFP positive cells as means ± SD of one representative 
experiment (n=4). 
The cell viability was evaluated by propidium iodide staining followed by flow cytometry 
analysis in the same experiment. Within a MW range of 4.6 to 9.5 kDa, the cell viability 
decreased with the MW of the polymer and the NP ratio in polyplexes (Figure 4). Using 
LPEIs with lower MW, the cell viability seemed to be unaffected compared to untreated cells. 
 
 
 
 
 
 
 
 
'  $
	"
 ) 
 
0
20
40
60
80
100
NP 6 NP 12 NP 18 NP 24 NP 30
Vi
ab
ili
ty
 
[%
]
9.5 9.0 6.0 5.6 5.0 4.6 3.9 3.5 3.0 2.4 2.0 1.0
Vi
ab
ili
ty
 
[%
]
 
Figure 4: Relative viability of CHO-K1 cells after treatment with LPEI - polyplexes at 
various NP ratios determined with propidium iodide staining followed by flow cytometry, 
whereby the MW [kDa] of LPEI in polyplexes is indicated in the legend. Experiments were 
performed in duplicate, values are means ± SD of one representative experiment (n=3). 
Relative viability of cells within each NP ratio is significantly different from treatment with 
LPEI ≤ 9.0 kDa in polyplexes, denoted by , significantly different from LPEI ≤ 6.0 kDa in 
polyplexes, denoted by , and significantly different from LPEI ≤ 5.0 kDa in polyplexes, 
denoted by  (p < 0.01). 
It was outstanding that within the same test system, LPEIs from 3.5 to 9.5 kDa obtained at 
certain NP ratios a higher transfection efficiency and cell viability compared to the 
commercially available LPEI 22 (ExGen 500) (Figure 5). 
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Figure 5: Transfection efficiency ( ) and viability ( ) of CHO-K1 cells after treatment with 
LPEI 22 – polyplexes as determined by flow cytometry. Values represent the EGFP positive 
or viable cells as means ± SD (n=4). 
Mechanistic insights into LPEI – mediated gene transfer 
Intracellular size and location of polyplexes 
To understand the transfection efficiency of LPEI - polyplexes, we studied the intracellular 
fate of polyplexes with fluorescein – labeled DNA by CLSM. For this purpose, we chose two 
LPEI derivatives near opposite ends of our molecular weight spectrum (LPEI 9.0 and 2.0), 
and used the commercially available LPEI 22 as a control. The size distribution of 
intracellular LPEI 9.0 - polyplexes at NP 6 was not homogenous. There were many small and 
some large irregular aggregates ranging from about 1 to 5 µm (Table 1). At a NP 24, the 
polyplexes were somewhat smaller with a size of about 1 to 3.5 µm. Polyplexes formed with 
LPEI 2.0 seemed to be smaller than those prepared with LPEI 9.0, appeared almost spherical 
in shape and fewer aggregates were visible. At NP 6, they ranged from about 0.5 to 1.5 µm, 
slightly increasing in size at NP 24. LPEI 22 – polyplexes were smaller than those prepared 
with LPEIs with lower MW within the first hour of incubation, ranging from about 0.2 to 1.5 
µm, but these polyplexes then grew to larger aggregates with sizes up to 5 µm. 
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Table 1: The approximate size [µm] of LPEI 9.0 -, 2.0 – and 22 - polyplexes at NP 6 and 24. 
The values were acquired from a representative collective of intracellular polyplexes in 
confocal images. 
 LPEI 9.0 – polyplexes LPEI 2.0 – polyplexes LPEI 22 - polyplexes 
NP 6 1.0 – 5.0 0.5 – 1.5 0.2 – 5.0 
NP 24 1.0 – 3.5 1.0 – 2.0 0.2 – 5.0 
 
After 2 hours of incubation, the number of internalized LPEI 2.0 – polyplexes reached a value 
of 1 to 2 at NP 6 and increased up to 4 at NP 24, whereas many more LPEI 22 – and 9.0 – 
polyplexes could be detected, irrespective of the NP ratio applied. LPEI 9.0 – polyplexes (NP 
6) appeared inside the cells in less than 30 minutes. Within the second hour, polyplexes could 
be observed in almost every cell (Figure 6 A). Longer incubation times increased the number 
of polyplexes in the perinuclear region. The number of intracellular LPEI – 9.0 polyplexes at 
NP 24 was higher compared to NP 6 within the same time of incubation (Figure 6 B). Using 
LPEI 2.0 (NP 6), polyplexes could be seen in only a few cells within the first hour, but these 
polyplexes moved towards the nucleus (Figure 6 C). The number of intracellular LPEI 2.0 - 
polyplexes slightly increased with increasing NP ratio (Figure 6 D). LPEI 22 – polyplexes at 
NP 6 sedimented rapidly and could be detected inside cells within 30 minutes (Figure 6 E). 
The cytosol seemed to be flooded by LPEI 22 – polyplexes at NP 24 within 1 hour (Figure 6 
F) and a slight contraction of the cells was observed. Polyplexes that have not been taken up 
by cells seemed to build larger aggregates in culture medium, irrespective of the MW and NP 
ratio (data not shown). 
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Figure 6: Intracellular distribution of fluorescein (A - F) - or YOYO-1 / TAMRA (G and H) - 
labeled polyplexes in CHO-K1 cells by CLSM. Times post transfection are as follows: A: 2h, 
LPEI 9.0 – polyplexes (NP 6) could be observed in nearly every cell; B: 2h, the number of 
intracellular polyplexes increased with increasing NP ratio (LPEI 9.0 – polyplexes, NP 24); 
C: 2h, LPEI 2.0 – polyplexes (NP 6) could be seen in only a few cells; D: 2h, the number of 
intracellular polyplexes only slightly increased with increasing NP ratio (LPEI 2.0 – 
polyplexes, NP 24); E: 2h, many LPEI 22 – polyplexes (NP 6) could be detected inside cells; 
D: 2h, cells seemed to be flooded by LPEI 22 – polyplexes (NP 24) and a slight contraction of 
cells was observed; G: 6h, double-labeled LPEI 9.0 – polyplexes at NP 24; H: double-labeled 
LPEI 5.0 – polyplexes at NP 24. DNA is represented by green dots and polymer by red dots. 
A colocalization of both would yield a mixture color of yellow. Intact polyplexes in nuclei are 
marked with a star, whereas disintegrated polyplexes and polymer or DNA only, are 
indicated with an arrow. Each bar indicates 20 µm (A – F) or 10 µm (G and H). 
Polyplexes were double-labeled to investigate whether they remain intact or disintegrate 
inside cells. DNA was labeled with YOYO-1 and depicted in green, whereas TAMRA – 
labeled LPEIs 9.0 or 5.0, Figure 6 G or H, respectively, were represented by red dots. The 
larger extracellular polyplexes and polyplex aggregates exhibited a mixture of colors 
representing polyplexes consisting of polymer and DNA. The smaller intracellular polyplexes 
could be divided into red, green and yellow dots, corresponding to polymer only, DNA only 
and intact polyplexes. Inside the nucleus, intact (star, Figure 6 G and H) or disintegrated 
polyplexes (arrow, Figure 6 G and H) could also be detected. 
Endosomolytic activity 
First, the endolysosomolytic activity of LPEI 9.0 -, 5.0 - and 2.0 – polyplexes was tested by 
supplementing sucrose at concentrations of 5 mM [21] during the transfection process. 
Sucrose is a lysosomotropic agent and therefore accumulates in the lysosomal matrix, 
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inducing an osmotic imbalance with water penetrating into the organelles causing their 
swelling [26]. No statistically significant differences were found in terms of transfection 
efficiency and cell viability with LPEI 9.0 and 5.0 at every NP ratio tested compared to 
transfection without sucrose (Figure 7 A and B, respectively; cell viability data not shown). 
Using LPEI 2.0 – polyplexes, a slight increase in transfection efficiency could be observed 
with sucrose at NP 6 and a significant (p < 0.05) increase at NP 24 (Figure 7 C). 
 
0
10
20
30
40
Tr
an
sf
ec
tio
n
 
Ef
fic
ie
n
cy
 
[%
]
NP 6 NP 24
A
 
0
10
20
30
40
NP 6 NP 18 NP 24
Tr
an
sf
ec
tio
n
 
Ef
fic
ie
n
cy
 
[%
] B
 
(continued on next page) 
'  $
	"
 )+ 
0
2
4
6
Tr
an
sf
ec
tio
n
 
Ef
fic
ie
n
cy
 
[%
]
NP 6 NP 24
C
 
Figure 7: The effect of the lysosomotropic agent sucrose at 5 mM ( ) on EGFP expression 
with LPEI 9.0 -, 5.0 – and 2.0 – polyplexes, respectively A, B and C, compared to transfection 
without sucrose ( ) determined by flow cytometry. Experiments were performed in duplicate, 
values are means ± SD of one representative experiment (n = 4). No statistically significant 
differences could be found with LPEI 9.0 and 5.0, while transfection efficiency with LPEI 2.0 
at NP 24 with and without sucrose was statistically significant different (p < 0.05), denoted 
by . 
The involvement of acid-mediated endosomal escape was also assessed with Bafilomycin A1. 
This substrate prevents endosomal acidification by inhibiting the vacuolar ATPase proton 
pump [22]. If lysosomes are involved in LPEI – mediated gene transfer, a decrease in gene 
expression would be expected due to a lower polyplex concentration available in the 
cytoplasm. Applying bafilomycin A1 dissolved in ethanol at a concentration of 50 nM, the 
decrease in transfection efficiency of either LPEI 9.0 -, 5.0 or 2.0 – polyplexes at NP 6 was 
statistically significant (p < 0.01) compared to transfection with supplementation of the 
solvent ethanol alone [27] (Figure 8). The transfection efficiency of LPEI 9.0 was about 55 
fold reduced upon the addition of bafilomycin, whereas the efficiency of LPEI 5.0 was 21 
fold and of LPEI 2.0 was only 5 fold reduced. 
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Figure 8: The effect of Bafilomycin A1, an inhibitor of vacuolar type H+-ATPase, on EGFP 
expression with LPEI 9.0 ( )-, 5.0 ( )- and 2.0 ( )– polyplexes at NP 6 in serum-containing 
transfection medium determined by flow cytometry. Experiments were performed in duplicate, 
values are means ± SD of one representative experiment (n = 3). The decrease in transfection 
efficiency of either LPEI 9.0 -, 5.0 - or 2.0 – polyplexes was statistically significant (p < 0.01) 
compared to transfection with supplementation of the solvent ethanol alone. 
Lysosomal localization 
CLSM was used to verify whether acidic vesicles and polyplexes ever colocalized. Recent 
studies used LysoTracker to investigate the involvment of lysosomes in the intracellular path 
of polyplexes [28,29]. However, it was shown that cationic amphiphilic drugs could displace 
this fluorescent dye from lysosomes [30]. Therefore, we chose the fluorescent dye quinacrine 
mustard as tag, as it is often used as an intracellular acidification marker [31] with pKa values 
of 7.8 and 9.72 [32]. LPEI 22 has an average pKa of 7.9 [33] and is less basic than quinacrine 
mustard. The acidic marker is likely not released from the lysosomes in presence of PEI. 
Acidic organelles, which were observed as turquoise patches, accumulated around the nucleus 
within 1.5 hours of exposure to the dye. A colocalization of acidic oranelles and polyplexes 
would yield a combination color of turquoise and red. The interaction of LPEI 9.0 - 
polyplexes with lysosomes was size and time dependent: after two hours, small polyplexes at 
NP 6 were observed trapped in acidic organelles (Figure 9 A, star); after 5 hours, these 
polyplexes were no longer associated with the acidic organelles (Figure 9 B, open arrow) or 
only partially colocalized (Figure 9 B, arrow). Large polyplexes at NP 6 were either only 
partially colocalized with acidic organelles (Figure 9 C; arrow) or completely unassociated 
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(Figure 9 C, open arrow) throughout the 6 hour observation period. At NP 24, similar results 
could be observed as for NP 6, despite the fact that fewer large polyplex - aggregates were 
present: Small polyplexes were associated with turquoise patches (Figure 9 D, star), and were 
released into the cytoplasm with further incubation time. Larger polyplexes were dispersed 
throughout the cytosol (Figure 9 D, open arrow). Using LPEI 5.0 – polyplexes, similar 
observations were made at NP 6. Most smaller polyplexes were combined with acidic 
organelles after 2 hours (Figure 9 E, star) and the larger ones only partially colocalized 
(Figure 9 E, arrow). With further incubation, most of the smaller polyplexes were no longer 
associated with acidic organelles (Figure 9 F, open arrow). At NP 24, already after 2 hours of 
incubation, many small polyplexes were dispersed in cytosol (Figure 9 G, open arrow). But 
we did not detect an increase of free polyplexes with further incubation (Figure 9 H). 
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Figure 9: Tracking of TAMRA -labeled (red) LPEI 9.0 (A – D) and 5.0 (E – H) - polyplexes in 
CHO-K1 cells with labeled acidic organelles (turquoise) by CLSM. A mixture of both colors 
indicates a close proximity and therefore an interaction. Times post transfection are as 
follows: A: 2h, smaller polyplexes at NP 6 were trapped in acidic organelles (star); B: 5h, 
these polyplexes were released (open arrow) or only partially colocalized (arrow); C: 3h, 
larger polyplexes at NP 6 only partially colocalized with acidic organelles (arrow) or no 
colocalization could be observed (open arrow); D: 3h: smaller polyplexes at NP 24 were 
combined with turquoise patches (star), and the larger polyplexes at NP 24 were present free 
in the cytosol (open arrow). E: 2h: most of the smaller polyplexes were combined with acidic 
organelles after 2 hours (star), the larger ones only partially colocalized (arrow). F: 5h: with 
further incubation many smaller polyplexes at NP 6 were no longer associated with acidic 
organelles (open arrow). G: 2h: in comparison to NP 6, many small polyplexes at NP 24 
were dispersed in cytosol (open arrow). H: 5h: an increase of free polyplexes with further 
incubation was not detected. Each bar indicates 10 µm. 
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Nuclear localization 
Recently, it was suggested that LPEI 22 - polyplexes have improved nuclear import 
characteristics compared to other gene delivery systems due to their cell cycle independent 
entry into the nucleus [16]. To verify this for LPEIs with low MW, CHO-K1 cells were 
incubated with LPEI 2.0 -, 5.0 - and 9.0 - polyplexes with YOYO-1 - labeled DNA. The 
number of cells that showed fluorescence due to intracellular YOYO-1 - labeled DNA 
increased with the NP ratio. No statistically significant differences in the number of cells and 
nuclei that have taken up polyplexes could be found after 6 hours for LPEI 5.0 and 9.0, 
whereas significantly fewer nuclei showed fluorescence due to intranuclear DNA compared 
to whole cells after transfection with LPEI 2.0 – polyplexes (Figure 10 A). 
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Figure 10: Uptake of polyplexes prepared with LPEI 2.0, 5.0 or 9.0 kDa and YOYO-1 – 
labeled DNA in whole cells ( ) or intact nuclei ( ) after 6 hours determined by flow 
cytometry. A: Fluorescent cells / nuclei indicates the percentage of cells / nuclei that show a 
fluorescence due to intracellular / intranuclear YOYO-1 – labeled DNA. Statistically 
significant differences between pairs are denoted by  (p < 0.01). B: The mean 
fluorescence intensity is represented from those cells or nuclei that have incorporated YOYO-
1 - labeled DNA. Statistically significant differences of pairs are denoted by  or  (p < 
0.05 or p < 0.01, respectively). Experiments were performed in duplicate, values are means ± 
SD of one representative experiment (n=3). 
The mean fluorescence intensity of cells that have incorporated DNA increased with the MW 
of LPEI and the NP ratio, whereas the mean fluorescence intensity of isolated nuclei seems to 
have reached a limit at the value 170. The mean fluorescence intensity of whole cells with 
incorporated polyplexes was significantly higher than of the nuclei alone, when cells were 
transfected with LPEI 5.0 – polyplexes at NP 18 (p<0.05) and 24 (p<0.01) or with LPEI 9.0 – 
polyplexes at NP 24 (p<0.01). Other polyplexes showed no statistically significant differences 
in the mean fluorescence intensity between whole cells and the nuclei (Figure 10 B). 
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A challenging demand in the field of non-viral gene therapy is to provide efficient delivery 
without significant toxicity. LPEI 22 has been described to have a superior ability to induce 
gene transfer compared to its branched form [17,20,34]. We explored the possibility and 
potential of utilizing LPEIs within the range of 1.0 to 9.5 kDa as carriers for gene delivery to 
verify our hypothesis that LPEIs with low MWs are substantially less toxic than their high 
MW counterparts, but still retain their ability for gene transfer. We sought to overcome the 
frequent restriction that high transfection efficiency is limited by the cytotoxicity of the non-
viral carrier. 
Experiments were performed with polyplexes at NP ratios from 6 to 30 in serum-free culture 
conditions. We found that LPEIs with MWs lower than 22 kDa are very efficient gene 
carriers. A maximal transfection efficiency of about 44% was obtained with LPEI 5.6 at NP 
18. We could also show that a MW greater than 1.0 kDa is necessary for gene expression. 
The values are not easy to compare with other studies carried out with LPEI 22, because these 
are confined to the gene expression of luciferase [4,5,33] and do not report a percentage of 
transfected cells. Compared to our own investigations with LPEI 22 in the same test system, 
we could reach even higher transfection efficiencies with certain low MW LPEI derivatives 
and NP ratios. To interpret the results, it is reasonable to divide the applied polyplexes into 
two groups: LPEI – polyplexes with a MW from 9.5 to 5.6 kDa and from 5.0 to 1.0 kDa. 
Regarding the group with the higher MW LPEIs in polyplexes, generally, when increasing the 
MW of the polymer and the NP ratio, the transfection efficiency increases to a certain point, 
while the cell viability decreases. Cell viability may be reduced drastically due to a large 
excess of polymer infiltrating the cells. Probably, the cells are then metabolically inactive and 
not able to express the delivered gene. This could be the reason why the transfection 
efficiency also decreases with decreasing cell viability. In the second group with lower MW 
LPEIs in polyplexes, it is surprising to see that the transfection efficiency can be enhanced 
with the NP ratio without affecting cell viability. LPEI 5.0 – polyplexes yield a transfection 
efficiency of about 40% with only a slight reduction in cell viability. The average expression 
of EGFP per cell seems to be nearly uneffected by the MW of LPEI and the NP ratio applied. 
Recently, it was shown that large complexes lead to a higher transfection efficiency than 
smaller ones [15]. To demonstrate that the high transfection efficiency is not only an effect of 
sedimentation due to polyplex size, but also depends on the MW of LPEI, we examined the 
efficiency of small polyplexes formed in glucose solutions. These particles have roughly the 
same size independent of the MW of the polymer (about 200 nm [13]) and differences in 
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transfection efficiency should be independent of polyplex size and depend on MW of the 
polymer (and other factors). The fact that small LPEI 9.0 – polyplexes result in a higher 
transfection efficiency than the corresponding LPEI – 5.0 polyplexes affirms that the MW of 
LPEI plays a major role in transfection process. Notably, such a high transfection efficiency 
accompanied by such a high cell viability has not yet been reported. These results were 
achieved by reducing the chain length of the polymer while still retaining its overall amount. 
As remarked before, polyplexes built in sodium chloride sediment onto the cells due to their 
size. Furthermore, polyplexes show a strong tendency towards aggregation after 
sedimentation onto the cells. Even though polyplexes built with various LPEIs have different 
sedimentation profiles due to varying size, and are therefore taken up by cells faster or 
slower, the uptake of polyplexes seems not to be a limiting step in the transfection process, 
because after 6 hours a large fraction of cells has taken up polyplexes irrespective of the MW 
and the NP ratio applied. 
The endolysosmolytic activity is due to the ability of PEI to increase the ionic strength in 
endosomes by capturing protons and chloride ions during endosomal acidification, which 
causes osmotic swelling and subsequent endosome disruption [10,35]. As demonstrated by 
the reduced efficacy in gene delivery of LPEI 2.0 -, 5.0 - and 9.0 – polyplexes in the presence 
of bafilomycin A1 [22], the ´proton sponge effect  ` is also applicable and necessary for the 
high transfection efficiency of these polymers. However, the suppression of gene expression 
after application of bafilomycin A1 declines with the MW of the polymer. This implies that 
these polyplexes may escape by another mechanism from lysosomes, such as direct 
membrane disruption [36], endosomal disruption by PEI swelling due to charge repulsion 
upon acidification, or may not escape from the acidic organelles. The results were confirmed 
in a complimentary experiment: sucrose, which is used as a lysosomotropic agent [21], 
produces no increase in transfection efficiency with LPEI 5.0 - and 9.0 – polyplexes. No 
increase in transfection efficiency results when sucrose is administered in conjunction with 
polyplexes with high intrinsic endosomolytic activity, as they can escape from 
endolysosomes without the addition of a lysosomotropic agent or rather because those 
polyplexes do not reach the lysosomes. However, a higher percentage of CHO-K1 cells 
express EGFP after the co-application of LPEI 2.0 – polyplexes and sucrose. This means that 
the buffer capacity and ability to escape from lysosomes depends on the MW of the polymer. 
The involvement of acidic organelles could also be demonstrated by CLSM. Particularly 
small polyplexes are found in acidic organelles, and most of them are released into the 
cytoplasm. Larger polyplexes are often only partially colocalized with acidic organelles, 
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because they either do not completely fit into the organelles or more likely, because they 
rapidly escape due to their higher buffer capacity [15]. In accordance with the literature, we 
could show that small complexes reach the lysosomal compartment, whereas big complexes 
either do not reach these organelles [37] or, in our opinion, probably escape from them 
rapidly. It could be that the smaller ones escape from lysosomes via the proton sponge 
mechanism, whereas the larger ones reach the cytoplasm via membrane damage [36] or other 
non-osmotic effects [15]. It is remarkable that many LPEI 5.0 – polyplexes at NP 24, a 
combination of MW and NP ratio that leads to a high transfection efficiency, can be detected 
freely dispersed in cytosol after only 2 hours. 
The largest hurdle to non-viral gene delivery is nuclear uptake. As shown by CLSM, some 
polyplexes reach the nuclei intact, some of these polyplexes may dissociate inside the nuclei 
or other polyplexes disintegrate in the cytosol and DNA or polymer reach the nucleus on their 
own. Therefore, to track the polyplexes, we preferentially used labeled DNA, as it is the 
component of the polyplexes that has to be transcribed in the nucleus. Regarding the CLSM 
pictures after 2 hours of incubation, it is not surprising to see that the nuclear membrane 
seems to be a barrier for polyplexes. But this difference in the amount of polyplexes in the 
cytosol and nucleus seems to equalize with further incubation. Comparing the number of cells 
and nuclei the have incorporated DNA, no differences could be found for LPEI 5.0 and 9.0. 
This means that every cell that has taken up polyplexes with labeled DNA exhibits DNA not 
only in the cytosol, but also in the nucleus. Using LPEI 2, a polymer that leads to very low 
transfection efficiency, significantly fewer nuclei have taken up polyplexes compared to 
whole cells. But this method and the determination of the mean fluorescence intensity do not 
provide information about the number of polyplexes that are located in whole cells and 
nuclei. The mean fluorescence intensity just gives an indication that the number of 
intracellular polyplexes increases with the MW and NP ratio and, because there seems to be a 
limit in the mean fluorescence intensity of nuclei, that only a certain amount of DNA can 
reach the nuclei. We suggest that larger polyplexes remain in the cytosol due to their size; 
only portions of the larger polyplexes reach the nucleus, while smaller polyplexes may enter 
the nucleus intact. The precise mechanism of entry of polyplexes into the cell nuclei is as yet 
unexplained. Endolysosomal vesicles may be a vehicle for the transport of small polyplexes 
to the nuclear membrane. However, the size of polyplexes, respectively the MW of LPEI, 
may play a major role in nuclear uptake. 
In summary, we first showed that we can control the transfection efficiency by the MW of the 
polymer and the NP ratio and that a certain chain length of LPEI is necessary for efficient 
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gene delivery. Moreover, we could prove our hypothesis that low MW LPEIs allow for a high 
transfection efficiency accompanied by a low cytotoxicity. In conclusion, our study suggests 
LPEIs with low MW as promising candidates for non-viral gene delivery, because they are 
very efficient and significantly less toxic than their higher MW counterparts. The 
endolysosomolytic activity and ability to cross the nuclear membrane are major prerequisites 
for the high transfection efficiency. 
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Background 
We recently debuted a variety of linear polyethylenimines (LPEIs) with relatively low 
molecular weights ranging from 1.0 to 9.5 kDa as polymeric carriers for nucleic acid delivery. 
The highest transfection efficiency (about 44%) was obtained with LPEI 5.6 kDa, while the 
cytotoxicity remained low. In order to explore conceptual aspects for further optimization of 
polymer-based gene delivery and to gain a more complete insight into LPEI-mediated gene 
transfer, the kinetics of the uptake as well as the intracellular stability and transport of 
plasmid DNA and LPEI - polyplexes were investigated in CHO-K1 cells. Furthermore, as the 
ionic strength of the polyplex formation medium and the presence of serum during the 
transfection process strongly influence the size of polyplexes, we evaluated their impact on 
the transfection efficacy and cytotoxicity. 
Methods 
The transfection efficiencies and cytotoxicities of a series of LPEI - polyplexes formed in 
media with varying ionic strengths were compared in CHO-K1 cells in the presence and 
absence of serum with flow cytometry. The uptake and stability of the LPEI - polyplexes 
were assessed by flow cytometry and confocal laser scanning microscopy, respectively. 
Furthermore, real-time PCR was used to determine the absolute amount of intact plasmid 
DNA after internalization of polyplexes.  
Results and Conclusions 
In summary, we did not determine a correlation between the uptake, stability of polyplexes or 
plasmid DNA and the transfection efficiency. Therefore, we conclude that these mechanisms 
only contribute to a negligible extent to the high efficacy of certain LPEIs. This means that 
we have a very robust system for transfection that is widely independent of external 
influences and suitable for routine transfection experiments. Furthermore, as the ionic 
strength and culture medium favor the superiority of certain polyplexes, a more detailed 
knowledge of the polyplex structure and composition and their influence on the transfection 
efficiency would be a further step towards the optimization of PEI-based delivery systems. 
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Technologies for gene delivery have advanced significantly over the past decade. However, 
no delivery system that is both safe and highly efficient has been introduced so far. Viral 
vectors are very efficient at transferring genes into mammalian cell, but are also accompanied 
by severe safety risks, namely immunogenicity and mutagenesis [1,2]. Therefore, interest in 
using polymers as gene carriers is growing as they may help to overcome the problems 
associated with viruses. Currently, in order to further enhance their efficacy and meet the 
requirements of idealized non-viral gene delivery systems, polymers are designed with tailor-
made structures and chemical properties. 
Due to its excellent efficacy, polyethylenimine (PEI) has gained some prominence compared 
to other non-viral gene delivery systems. It is capable of condensing DNA into polyplexes, 
allowing for cellular access and uptake of the nucleic acid. Once the polyplexes enter the 
endo-lysosomal compartment, PEI protects the DNA from degradation and guides it 
efficiently into the cytoplasm [3-6]. The final step in this process is the translocation of DNA 
to the nucleus for gene expression [7,8]. PEI exists as a branched polymer (BPEI), and in its 
linear form (LPEI), which has been shown to have a superior transfection efficiency and cell 
viability relative to BPEI-based transfection systems [9-12]. We have recently introduced a 
variety of LPEIs with molecular weights (MWs) ranging from 1.0 to 9.5 kDa [13]. The 
transfection efficiency of these LPEI - polyplexes can be altered by varying the MW and the 
amount of the polymer available for polyplex formation. The highest transfection efficiency 
(about 44%) was obtained with LPEI 5.6 kDa, while the cytotoxicity remained low. We 
proposed that the endo-lysosomolytic escape capacity and ability to cross the nuclear 
membrane are major prerequisites for the high transfection efficiency of LPEI - polyplexes. 
For a rational design and further optimization of the PEI-based delivery vectors, it would be 
desirable to elucidate the biophysical interactions of existing polyplexes with cells in detail. 
Besides the endo-lysosomal escape and nuclear entry, the uptake of polyplexes is also an 
important step in the transfection process. Unfortunately, it seems nearly impossible to contol 
the uptake of unmodified polyplexes in cell culture systems, usually a higher amount than 
necessary for gene expression is taken up by cells, which also contributes to a significant part 
to the high cytotoxicity of certain polyplexes. Furthermore, the impact of the intracellular 
stability of polyplexes and plasmid DNA on the transfection efficacy has been investigated 
only in few studies so far. 
(  /	

	$"
		
*)
Therefore, we chose three LPEI derivatives with MWs of 9.0, 5.0 and 2.0 kDa as carriers and 
addressed the uptake, intracellular stability and transport of plasmid DNA and polyplexes, in 
search of differences that could explain their varying transfection efficiencies. These three 
polymers were chosen because they have the same structure, but differed in their MW, 
transfection efficiency and cell viability: Polyplexes containing LPEI 9.0 kDa are capable of a 
high transfection efficiency, but are also quite cytotoxic. In contrast, the high efficacy of 
LPEI 5.0 kDa is accompanied by minimal cytotoxicity, while both the transfection efficiency 
and cytotoxicity of polyplexes formed with LPEI 2.0 kDa are very low [13]. Furthermore, as 
the ionic strength of the medium used during polyplex formation and the presence or absence 
of serum during the transfection process strongly influence the size of the polyplexes, we 
evaluated their influence on the transfection efficacy. 
With these investigations, we intended to determine the robustness of our LPEI-based gene 
delivery system and whether LPEI - polyplexes are candidates for routine transfection 
experiments. Furthermore, this study strove to gain a more complete insight into LPEI-
mediated gene transfer in order to compile a rational concept to further improve the efficacy 
of polymer-based nucleic acid delivery systems. 
#	#
All materials were purchased from Sigma-Aldrich Chemie GmbH (Germany) unless 
otherwise stated. 
Cell culture 
CHO-K1 cells (ATCC No. CCL-61) were grown in 75 ml culture flasks in a 5% CO2 
atmosphere at 37°C as adherent culture to 90% confluence before seeding. Culture medium 
consisted of Ham´s F-12 supplemented with 10% FBS (Biochrom AG, Germany). 
Non-viral carriers 
LPEI derivates with MWs of 9.0, 5.0 and 2.0 kDa were synthesized by ring-opening 
polymerization of 2-ethyl-2-oxazoline and acidic hydrolysis of the corresponding poly(2-
ethyl-2-oxazoline) as previously described [14]. In the following, the notation of polymers 
was made without the unit kDa, for example LPEI 9.0 represents LPEI with a MW of 9.0 
kDa. When indicated, polymers were labeled with 6-TAMRA-succinimidyl ester (Molecular 
Probes, The Netherlands) as described [13]. 
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Plasmid isolation and labeling 
Plasmid encoding enhanced green fluorescent protein (EGFP) (pEGFP-N1, Clontech, 
Germany) was used as reporter gene in this study. Plasmid was isolated from E. coli using a 
Qiagen Plasmid Maxi Kit (Qiagen, Germany) according to the supplier´s protocol. When 
indicated, plasmid DNA was stained with the intercalating dye YOYO-1 (Molecular Probes, 
The Netherlands). The labeling reaction was carried out with a molar ratio of 1 dye molecule 
per 320 base pairs at room temperature in the dark. 
Preparation of polyplexes 
Plasmid DNA/LPEI complexes were prepared at NP ratios (ratio of nitrogens in polymer to 
phosphates in DNA) of 6, 12, 18, 24 and 30. Polyplexes were formed by diluting a mixture of 
2 µg DNA and appropriate amount of polymer solution to 50 µl with 150 mM sodium 
chloride or 5% glucose. The resulting LPEI - polyplexes were incubated for 20 minutes at 
room temperature before use. The polyplexes are labeled such that LPEI 9.0 – polyplexes 
indicates that the plasmid DNA was complexed with LPEI 9.0. 
In vitro transfection and cytotoxicity experiments 
For gene transfer studies, CHO-K1 cells were grown in 24-well plates at an initial density of 
38,000 cells per well. 18 hours after plating, the culture medium was removed, cells were 
washed with PBS (Invitrogen, Germany) and 900 µl serum-free or -containing medium was 
added (transfection medium). Thereafter, the prepared polyplexes were added to the cells. 
After 4 hours, the medium was replaced with 1 ml of culture medium. 48 hours later, cells 
were prepared for flow cytometry analysis. Floating cells were collected and combined with 
adherent cells after trypsinization. The pooled cells were washed twice with PBS, 
resuspended in 500 µl PBS and propidium iodide was added at a concentration of 1 µg / ml to 
half of the samples. Measurements were taken on a FACSCalibur (Becton Dickinson, 
Germany) using CellQuest Pro software (Becton Dickinson, Germany) and WinMDI 2.8 
(1993-2000 Joseph Trotter). EGFP positive cells were detected using a 530/30 nm band-
pass filter, whereas the propidium iodide emission was measured with a 670 nm longpass 
filter. Logarithmic amplification of EGFP and propidium iodide emission in green and red 
fluorescence was obtained with 20,000 cells counted for each sample. In a density plot 
representing forward scatter against sideward scatter, whole cells were gated out and depicted 
in two-parameter dot plots of EGFP versus propidium iodide for data analysis. The EGFP 
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positive region corresponds to the transfection efficiency, while the fraction of propidium 
iodide negative cells was used as a measure of cell viability [15]. 
Cellular uptake of polyplexes 
YOYO-1 - labeled DNA was used to monitor the polyplex delivery for all three polymer 
MWs. 50,000 CHO-K1 cells per well were seeded in a 24-well plate and then treated as 
described in the previous section, but detached after transfection for 6 hours. Trypsin 
(Invitrogen, Germany) and PBS were supplemented with 20 mM sodium azide (Merck 
KGaA, Germany) to prevent further particle uptake and remove surface-bound polyplexes 
[13,16,17]. The percentage of cells that had internalized polyplexes was determined by the 
number of YOYO-1 positive cells by flow cytometry. YOYO-1 was excited with a 488 nm 
argon laser and detected with a 530/30 bandpass filter. The mean fluorescence intensity of 
those cells that had taken up polyplexes served an indirect measure of the number of 
internalized polyplexes [13]. 
Intracellular trafficking of polyplexes - confocal laser scanning microscopy 
(CLSM) 
A Zeiss Axiovert 200 M microscope coupled to a Zeiss LSM 510 scanning device (Carl Zeiss 
Co. Ltd., Germany) was used for CLSM experiments. The inverted microscope was equipped 
with a Plan – Apochromat 63x and Plan – Neofluar 100x objective. Cells were plated in an 8 
– well Lab-TekTM Chambered Coverglass (Nunc GmbH & Co. KG, Germany) at an initial 
density of 35,000 cells / chamber in a volume of 400 µl culture medium. To maintain a pH of 
7.4, 20 mM HEPES was supplemented to the medium. After 18 hours, polyplexes were added 
and imaging commenced immediately in each well at 37°C. The thickness of the optical 
sections was between 0.7 and 1.2 µm.  
For the estimation of intracellular disintegration of polyplexes, TAMRA-labeled LPEI 9.0 or 
5.0 and YOYO-1 - labeled DNA were used. YOYO-1 – labeled DNA was excited with a 488 
nm argon laser and fluorescence was detected using a 505 – 530 nm band-pass filter, whereas 
the TAMRA – labeled LPEI was excited at 543 nm and recorded with a 560 nm longpass 
filter. Images were taken in the multitracking modus. A lot of green, red, and yellow spots, 
i.e. free plasmid DNA, free polymer, and polyplexes, respectively, were scored for each 
condition from about 25 images. 
For the detection of polyplexes in endocytotic vesicles of the cell, polyplexes were marked 
with TAMRA-labeled LPEI 9.0 or 5.0 and YOYO-1 -labeled DNA, while FM4-64 was added 
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to highlight the vesicles. An argon laser with 488 nm was used to excite YOYO-1 and FM4-
64; the fluorescence was imaged using a 505 - 530 nm bandpass filterand a 650 nm longpass 
filter, respectively. TAMRA-labeled LPEI was excited at 543 nm and the fluoresecence was 
recorded with a 560 - 615 nm bandpass filter. Images were taken in the multitracking modus. 
Before each measurement, a sample with one label only was used to adjust the gain of the 
photomultiplier tubes to eliminate cross-talk. Images were then acquired with constant 
microscope settings. The intensity profile of the fluorescence emission was examined to 
identify a colocalization of LPEI and plasmid DNA with FM4-64 positive vesicles. 
Isolation of plasmid DNA from whole cells and quantification by real-time PCR 
After 6 hours of transfection and subsequent to washing with PBS, the intracellular plasmid 
DNA of attached cells was isolated according to the following procedure: Cells were 
resuspended in a buffer containing 50 mM Tris-HCl, 10 mM EDTA and 100 µg/ml Rnase A. 
Thereafter, the same volume of lysis solution (200 mM NaOH, 1% SDS) was added for 5 
minutes at room temperature. The reaction was stopped by neutralization with 3 M potassium 
acetate (pH 5.5). After 15 minutes at 4°C, the sample was centrifuged at 12,000 rpm for 25 
minutes. Plasmid DNA was precipitated from the supernatant, washed with 70% ethanol and 
resuspended in H2O. A portion of each sample was subjected to agarose gel electrophoresis. 
Real-time PCR was performed in a Light Cycler (Roche Applied Biosciences, Germany). The 
diluted template isolated from cells as described above was mixed with PCR master mix 
consisting of QuantiTectTM SYBR® Green PCR (Qiagen, Germany) and 10 pmol primer pairs 
(MWG Biotech GmbH, Germany). The forward primer (5´-ACG TAA ACG GCC ACA AGT 
TC-3´) and the reverse primer (5´- AAG TCG TGC TGC TTC ATG TG-3´) amplified a 187-
bp fragment of the pEGFP-N1 plasmid. The absolute amount of target nucleic acid was 
determined with pEGFP-N1 as an external standard. The amplification program consisted of 
1 cycle at 95°C for 15 min, followed by 45 cycles with a denaturing phase at 95°C for 15 s, 
an annealing phase of 20 s at 58°C, and an elongation phase at 72°C for 20 s. A melting curve 
analysis was performed in order to verify specifity and identify the PCR products. The protein 
content of the samples was determined with a Bradford assay [18]. 
In vitro transcription / translation assay 
The functionality of plasmid DNA complexed to LPEI was determined using the TNT®  quick 
coupled transcription/translation system (Promega, Germany). The kit’s control vector, SP6, 
was transformed into the E. coli strain JM109 (Promega, Germany). The transformed cells 
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were expanded in LB broth medium supplemented with ampicillin and plasmid DNA was 
isolated as described above. The in vitro transcription/translation reaction with LPEI - 
polyplexes or plasmid DNA was performed according to the supplier´s protocol. Luciferase 
expression was determined using the luciferase assay system (Promega, Germany); the 
luminescence was measured by photon counting (Lumat LB 9507, Berthold, Germany). 
Statistical analysis 
All measurements were collected (n = 3 to 6) and expressed as means ± standard deviation 
(SD). Single factor of variance (ANOVA) was used in conjunction with a multiple 
comparison test (Tukey test) to assess the statistical significance. 
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Transfection efficiency and cell viabilty 
The transfection efficiency of polyplexes formed with LPEI 9.0, 5.0 or 2.0 and plasmid DNA 
was evaluated in CHO-K1 cells (Figure 1). 
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Figure 1: Transfection efficiency of LPEI 9.0 ( ), 5.0 ( ) and 2.0 ( ) complexed with 
pEGFP-N1 as reporter gene in CHO-K1 cells as determined by flow cytometry. Polyplexes 
were formed in 150 mM sodium chloride and the 4 hour incubation period was carried out in 
serum-free culture conditions. Experiments were performed in duplicate; values represent the 
EGFP positive cells as means ± SD of one representative experiment (n=6). 
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As reported previously, the efficacy could be increased with the polymer MW and the amount 
of polymer available for polyplex formation to a certain point, while the NP ratio for the 
optimal gene expression decreased with the MW of LPEI in polyplexes [13]. 
When introducing LPEIs with low MW, the transfection efficiency was examined for 
polyplexes formed in 150 mM sodium chloride solution and cells were kept in serum-free 
culture conditions during the 4 hour incubation period with polyplexes (Figure 1). By forming 
the polyplexes in salt-free medium (5% glucose instead of 150 mM sodium chloride) or using 
serum-containing transfection medium, the efficacy of certain polyplexes could be strongly 
influenced. Figure 2 shows that at certain NP ratios LPEI 9.0 - polyplexes formed in glucose 
and incubated in serum-free transfection medium were superior to other conditions tested. 
The transfection efficiency was maximized at a value of 52.38 ± 6.01% at NP 12, while the 
higher efficacy was also accompanied by a higher cell viability (Figure 3). 
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Figure 2: Transfection efficiency of LPEI 9.0 complexed with pEGFP-N1 as reporter gene in 
CHO-K1 cells as determined by flow cytometry. Polyplexes were formed in 150 mM sodium 
chloride or 5% glucose and the 4 hour incubation period was carried out in serum-free (150 
mM sodium chloride:
 
 or 5% glucose:
 
, respectively) and –containing culture conditions 
(150 mM sodium chloride:
 
 or 5% glucose:
 
, respectively). Experiments were performed 
in duplicate; values represent the EGFP positive cells as means ± SD of one representative 
experiment (n=6). Transfection efficiency is at the same NP ratio significantly lower 
compared to transfection efficiency of polyplexes formed in glucose and incubated in serum-
free transfection medium as denoted by  (p < 0.01) or by  (p < 0.05). 
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When transfecting cells with LPEI 9.0 - polyplexes that were built in glucose in serum-
containing medium, much higher NP ratios were necessary to yield the efficiencies possible 
under other conditions (Figure 2), although the cell viability was not affected by the NP ratio 
under these conditions (Figure 3). 
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Figure 3: Relative viability of CHO-K1 cells after treatment with LPEI 9.0 - polyplexes at 
various NP ratios. Polyplexes were formed in 150 mM sodium chloride or 5% glucose and 
the 4 hour incubation period was carried out in serum-free (150 mM sodium chloride:
 
 or 
5% glucose:
 
, respectively) and –containing culture conditions (150 mM sodium chloride:
 
 or 5% glucose:
 
, respectively). Experiments were performed in duplicate, values are 
means ± SD of one representative experiment (n=3). 
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Using LPEI 5.0 in polyplexes, the transfection efficiency was higher in serum-free culture 
conditions irrespective of the medium used for polyplex formation (Figure 4). The effect of 
glucose - polyplexes on the transfection efficiency as achieved with LPEI 9.0 could not be 
observed. Similar tendencies as for LPEI 5.0 were obtained for LPEI 2.0, but the overall 
efficacy was much lower (data not shown). 
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Figure 4: Transfection efficiency of LPEI 5.0 complexed with pEGFP-N1 as reporter gene in 
CHO-K1 cells as determined by flow cytometry. Polyplexes were built in 150 mM sodium 
chloride or 5% glucose and the 4 hour incubation period was carried out in serum-free (150 
mM sodium chloride:
 
 or 5% glucose:
 
, respectively) and –containing culture conditions 
(150 mM sodium chloride:
 
 or 5% glucose:
 
, respectively). Experiments were performed 
in duplicate; values represent the EGFP positive cells as means ± SD of one representative 
experiment (n=6). 
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Uptake of polyplexes 
The uptake of complexes of LPEI 9.0, 5.0 and 2.0 and YOYO-1-labeled DNA in 150 mM 
sodium chloride was evaluated by measuring the cell-associated fluorescence after incubation 
in serum-free transfection medium (Figure 5). The number of fluorescent cells upon 
internalization of polyplexes increased with the NP ratio. No statistically significant 
differences were found between LPEIs at the same NP ratio, which implies that the number of 
cells that have taken up polyplexes is independent of the MW of LPEI. 
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Figure 5: Uptake of polyplexes built in 150 mM sodium chloride with LPEIs of different MW 
as indicated in the legend. Fluorescent cells express the percentage of CHO-K1 cells that 
show a fluorescence due to intracellular YOYO-1 – labeled DNA. Statistically significant 
differences between the NP ratios of a certain polymer are denoted by  (p < 0.05). 
Experiments were performed in duplicate, values are means ± SD of one representative 
experiment (n=3). 
The mean fluorescence intensity from those cells that have taken up polyplexes also increased 
with the NP ratio (Figure 6). No difference could be measured between LPEI 5.0 and 9.0 at 
the same NP ratio, but both polymers entailed a statistically significant higher mean 
fluorescence intensity compared to LPEI 2.0. 
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Figure 6: The mean fluorescence intensity is represented from those cells that have 
incorporated YOYO-1 - labeled DNA complexed with LPEI as indicated in the legend. 
Statistically significant differences between the NP ratios of a certain polymer or a certain 
NP ratio of various polymers are denoted by  (p < 0.01). Experiments were performed in 
duplicate, values are means ± SD of one representative experiment (n=3). 
When fabricating the polyplexes in glucose solution or incubating in serum-containing culture 
conditions, the results were not statistically significantly different (data not shown). 
Intracellular polyplex stability and transport 
Polyplexes were double-labeled to investigate by CLSM whether they remained intact or 
disintegrated inside cells. DNA was labeled with YOYO-1 and depicted in green, whereas 
TAMRA-labeled LPEIs 9.0 or 5.0 (Figure 7 or 8, respectively; LPEI 2.0 was not tested) were 
represented by red dots. Polyplexes that were not internalized aggregated during the 
incubation time to large clusters. Over 95% of these extracellular polyplexes exhibited a 
mixture of colors representing polyplexes consisting of polymer and DNA and indicating that 
polyplexes were not dissociating. The smaller intracellular polyplexes could be divided into 
red, green and yellow dots, corresponding to polymer only, DNA only and intact polyplexes, 
indicating that at least a portion of the polyplexes dissociated. Polyplexes were considered to 
be intact even if the visual overlap of green and red was minimal. 
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Figure 7: Double labeled LPEI 9.0 – polyplexes at NP 6 or 24 built in 150 mM sodium 
chloride (NaCl) or 5% glucose (Glc) solution, DNA is depicted in green, the polymer is 
represented by red dots and intact polyplexes by yellow dots. The 4 hour incubation period 
was carried out in serum-free (SF) culture medium. The confocal images were recorded after 
6 hours internalization, representative images shown correspond to the superposition of 
phase-contrast image and the merge of green and red fluorescence images. Each bar 
indicates 10 µm. 
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Figure 8: Double labeled LPEI 5.0 – polyplexes at NP 6 or 24 built in 150 mM sodium 
chloride (NaCl) or 5% glucose (Glc) solution, DNA is depicted in green, the polymer is 
represented by red dots and intact polyplexes by yellow dots. The 4 hour incubation period 
was carried out in serum-free (SF) culture medium. The confocal images were recorded after 
6 hours internalization, representative images shown correspond to the superposition of 
phase-contrast image and the merge of green and red fluorescence images. Each bar 
indicates 10 µm. 
No visual differences in the proportion of intact to dissociated polyplexes could be 
determined when changing the polymer, the medium used for polyplex fabrication or the NP 
ratio. To support the images with data, a certain number of green, red and yellow spots were 
scored and expressed as relative number of all spots (Figure 9). 
(  /	

	$"
		
+*
0.0
0.2
0.4
0.6
0.8
DNA only Polymer only Intact Polyplexes
R
e
la
tiv
e 
N
u
m
be
r
R
e
la
tiv
e 
N
u
m
be
r
 
0.0
0.2
0.4
0.6
0.8
DNA only Polymer only Intact Polyplexes
R
el
at
iv
e 
N
u
m
be
r
R
el
at
iv
e 
N
u
m
be
r
 
Figure 9: Estimation of dissociation of LPEI 9.0 – polyplexes (left) and LPEI 5.0 – polyplexes 
(right). Polyplexes were either built in 150 mM sodium chloride or 5% glucose at NP 6 (  or 
) and 24 (  or , respectively). Green, red, and yellow spots, i.e. free plasmid DNA, free 
polymer, and polyplexes, respectively, were scored for each condition from about 25 images. 
Statistically significant pairs of one polyplex formation medium are denoted by  (p<0.01). 
No striking differences could be found between LPEI 9.0 or 5.0 in polyplexes. Free DNA 
slightly decreased with an increase in the NP ratio, at the same time the amount of free 
polymer increased, but only significantly when polyplexes were built in sodium chloride. The 
most prominent point to mention was the slightly higher amount of free LPEI 5.0 compared 
to LPEI 9.0. To estimate the amount of intact intracellular polyplexes the assumption was 
made that free DNA and polymer arise from polyplex dissociation in a proportion 1:1 (which 
is not completely correct, because it is not known if DNA and polymer participate in polyplex 
formation in this proportion). A calculated amount of about 60-70% polyplexes were still 
intact after 6 hours; they were detected both in the cytosol and the nucleus [13]. In serum-
containing-culture conditions the images were similar (data not shown). 
CLSM images indicate that a portion of intracellular polyplexes disintegrate. However, it 
remains ambigous whether polymer and DNA are then transported in separate endo-
lysosomal vesicles or the dissociation may occur after endo-lysosomal release in the cytosol. 
Furthermore, some polyplexes were still intact even after they have reached the nuclear 
compartment. To elucidate the intracellular transport of plasmid DNA and LPEI, endocytotic 
vesicles were additionally labeled with the fluorescent dye FM4-64. Spots in confocal images 
were depicted in ochre, green and red indicating the vesicles, plasmid DNA and LPEI, 
respectively (Figure 10). After an incubation time of 2 hours (Figure 10, left), two different 
patterns were visible: on the one hand a merging of the three colors suggesting a localization 
of intact polyplexes in endocytotic vesicles (arrow) and on the other hand a merging of the 
three colors coexisting with a red color representing polyplexes in endocytotic vesicles from 
which the polymer may be escaping (stars). After 5 hours (Figure 10, right), the number of 
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vesicles with polyplexes as content decreased, while the number of vesicles from which the 
polymer appeared to escape and the plasmid DNA to remain (star) seemed to increase. 
Additionally, free polymer could be detected in the cytosol (open arrowhead), and plasmid 
DNA that was still colocalized with the FM4-64 labeled vesicles (triangle). 
 
 
Figure 10: Intracellular localization of polyplexes with regard to endocytotic vesicles that 
were labeled with the fluorescent dye FM4-64 and depicted in ochre. The plasmid DNA was 
labeled with YOYO-1, LPEI 5.0 with TAMRA and depicted in green and red, respectively. 
CLSM images were taken after 2 (left) and 5 (right) hours. The intensity profile of the 
fluorescence emission was examined to identify a colocalization. The arrow indicates a 
colocalization of plasmid DNA and LPEI with the vesicles, the star denotes vesicles from 
which the polymer appeared to escape and the plasmid DNA to remain, polymer freely 
dispersed in the cytosol is denoted by an open arrowhead, while plasmid DNA that remained 
in the vesicles is denoted by triangles. Each bar indicates 10 µm. 
Intracellular plasmid DNA stability 
The intracellular stability of plasmid DNA was examined by electrophoresis of cellular 
extracts. Intact plasmid DNA could be detected when cells were transfected in the presence or 
absence of serum with LPEI 9.0 -, 5.0 - and 2.0 - polyplexes built in 150 mM sodium chloride 
or 5% glucose (Figure 11). The extracted material showed the relaxed and supercoiled 
plasmid forms, indicating that the nucleic acid has not been intracellularly processed. No 
short DNA fragments were visible in the gel, which implies that plasmid DNA that has been 
degraded must have been completely degraded or the amount of any linear remnants was 
below the detection limit. Plasmid DNA that did not migrate in the gel (plasmid DNA that 
remained in the pockets) was complexed with cellular components that have not been 
released by the cellular extraction procedure. 
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Figure 11: Agarose gel electrophoresis of plasmid DNA isolated from CHO-K1 cells upon 6 
hours of transfection with LPEI 9.0, 5.0 and 2.0 at NP 6 or 24. Polyplexes were formed in 
150 mM sodium chloride or 5% glucose and the 4 hour incubation period was carried out in 
serum free- or -containing culture conditions. The relaxed (top) and supercoiled (bottom) 
form of plasmid DNA were visible. Plasmid DNA that did not migrate was still complexed 
with cellular components and hence remained in the pockets.  
Any differences in the intensity of the bands in the gel that arise due to complexation with a 
certain LPEI type, the NP ratio or the culture conditions could not be quantified. Furthermore, 
the images represent only the absolute amount of isolated DNA, but the toxicity, especially of 
LPEI 9.0, also has to be taken into account. Therefore, the isolated plasmid DNA was 
quantified by real-time PCR and normalized to the total protein (Figure 12). 
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Figure 12: Amount of plasmid DNA / protein isolated after 6 hours of transfection with LPEI 
9.0, 5.0 or 2.0 as carriers. Polyplexes were built in 150 mM sodium chloride or 5% glucose 
and the 4 hour incubation period was carried out in serum-free (150 mM sodium chloride:
 
 
or 5% glucose:
 
, respectively) and –containing culture conditions (150 mM sodium 
chloride:
 
 or 5% glucose:
 
, respectively). The absolute amount of target nucleic acid was 
determined with pEGFP-N1 as an external standard in a Light Cycler, while the protein 
content was determined with a Bradford assay. 
The results could be divided in two groups with different patterns: Applying LPEI 9.0 - and 
5.0 - polyplexes, the amount of intact plasmid DNA increased with the NP ratio when 
polyplexes were built in 150 mM sodium chloride, but decreased when polyplexes were built 
in 5% glucose. For LPEI 2.0 - polyplexes, the results were reversed. When LPEI 9.0 at NP 24 
(sodium chloride, serum-free) and LPEI 2.0 at NP 24 (glucose, serum-free and -containing) 
were used as carriers, the amount of intact plasmid DNA was much higher compared to other 
conditions tested. Based on the amount of DNA used in the transfection process, only about 
1/6 to 1/3 could be detected intracellularly and intact after 6 hours. The majority of the 
plasmid DNA used in the experiments was either not internalized or was intracellularly 
degraded. 
Plasmid DNA accessibility for transcription 
In CLSM pictures, DNA that was still complexed by LPEI was detected in the nucleus. 
Earlier studies revealed that transcription is not impaired when BPEI 25 kDa is closely 
attached to the template DNA [4]. To test this for our LPEI derivatives, we used the cell free 
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assay TNT® quick coupled transcription/translation system to determine the functionality of 
plasmid DNA complexed to LPEIs of various MW (Figure 13). The luciferase expression was 
reduced by nearly three-fold when plasmid DNA was complexed to LPEI 2.0 compared to 
plasmid DNA alone. A further decrease could be measured when using LPEI with higher 
MW, but there was no correlation between the MW of the polymer and the luciferase 
expression. Nevertheless, intracellular polyplexes are not as closely compacted as the 
polyplexes tested in this assay. After having been in contact with culture medium or cells, the 
polyplexes dissociate at least in part and hence, the accessibility of plasmid DNA for enzymes 
of the transcription machinery may be higher. 
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Figure 13: The functionality of plasmid DNA complexed to LPEI 9.0, 5.0 and 2.0 was 
accessed by the cell free assay TNT® quick coupled transcription/translation system. Plasmid 
DNA alone was used as a control. The luciferase expression as relative light units was 
determined using the luciferase assay system. 
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In order for non-viral gene delivery systems to become real substitutes for viral carriers, their 
transfection efficiency must be improved. We introduced a variety of LPEIs that achieve a 
relatively high transfection efficiency (about 44%) without significant toxicity in vitro [13]. 
In our opinion, LPEI - polyplexes provide a good basis for the further optimization of 
polymer-based nucleic acid delivery systems. Therefore, in order to better understand the 
transfection mechanism, we strove to elucidate the interaction of LPEI – polyplexes with their 
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environment in detail. We suggested that the endo-lysosomal escape capacity and nuclear 
entry are major prerequisites for the high transfection efficiency of certain LPEIs. In this 
study, we investigated the possible correlation of the uptake, intracellular stability of plasmid 
DNA or polyplexes and the transfection efficiency when using LPEI 9.0, 5.0 or 2.0 in 
polyplexes. Furthermore, the influence of the ionic strength of the polyplex formation 
medium and the presence of serum during the transfection process was evaluated. 
Especially LPEI 9.0 - polyplexes positively influenced the transfection efficiency and cell 
viability when polyplexes were formed in salt-free medium and the transfection process was 
carried out in the absence of serum, the transfection efficiency yielded a value of about 53%. 
It is known that the ionic strength of the medium for polyplex formation greatly influences 
the size of the complexes [19]. Generating LPEI - polyplexes in 150 mM sodium chloride or 
5% glucose entails either very large (> 1 µm) or small (about 200 - 300 nm) polyplexes, 
respectively [14]. However, as our confocal images show, once in contact with the culture 
medium (serum-free or –containing) the glucose-polyplexes also tended to grow and the 
differences in the size seemed to equalize. Therefore, we conclude that the MW of LPEI and 
the medium for polyplex formation only minorly influence the size of LPEI - polyplexes in 
culture medium and that the fabrication procedure is a very robust method for building LPEI - 
polyplexes. Furthermore, it is reported that PEI/DNA polyplexes interact with various plasma 
proteins during incubation [5,20,21]. This may be also true for LPEI – polyplexes and after 
having been in contact with cells in serum-free culture medium, LPEI 9.0 – polyplexes built 
in glucose may have structural advantages for a high transfection efficacy. As the knowledge 
of the structure of polyplexes is still fragmentary, more interest should be focused on their 
formation and composition. 
Changing the culture conditions or the medium for polyplex formation did not significantly 
influence the uptake of polyplexes. However, LPEI 5.0 and 9.0 increased the number of 
polyplexes in cells compared to the lower MW LPEI. As it is known that only one of 1000 
uncomplexed plasmid DNA copies is efficiently translocated from the cytoplasm to the 
nucleus [22], it it clear that an excess of polyplexes is needed in the cytosol for efficient gene 
delivery. But this amount has not been determined yet, and therefore, it is difficult conclude 
whether the higher amount of plasmid DNA taken up after complexation with LPEI 9.0 or 5.0 
has a benefit, and hence is one of the reasons for the higher efficacy compared to LPEI 2.0. 
On the other hand, plasmid DNA stability after application of LPEI 2.0 - polyplexes was 
similar or even higher than the to higher MW derivatives and therefore, the lower amount of 
polyplexes taken up may not impair the transfection efficiency considerably. 
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At least a portion of polyplexes was separated after uptake, but some intact polyplexes were 
also detected in the nucleus. LPEI may probably escape earlier from the endocytotic vesicles 
compared to plasmid DNA, while plasmid DNA may be transported further towards the 
nucleus in the endocytotic vesicles. This dissociation is an important point when considering 
that the transcriptional / translational activity of plasmid DNA is strongly reduced by a close 
interaction of polyplexes as simulated by the TNT® assay. The better accessibility of plasmid 
DNA in LPEI 2.0 - polyplexes may be due to a poor compaction of plasmid DNA by low 
MW polymers [23], which is also supported by the slightly larger size of LPEI 2.0 - 
polyplexes compared to LPEI 5.0 or 9.0 in cell free conditions [14]. The differences in 
polyplex disintegration between LPEI 9.0 and 5.0 were only marginal, other than the fact that 
a higher amount of free LPEI 5.0 was detected in the cytosol. The higher proportion of free 
polymer in cytosol could result from a better endo-lysosomal escape capacity of LPEI 5.0. 
The examination of the plasmid DNA stability after a transfection incubation of 6 hours 
revealed that LPEIs are able to protect plasmid DNA to a large extent from the degradation 
by nucleases. It was surprising that the complexation with LPEI 2.0, a LPEI derivative that is 
only capable of a very low gene transfer efficiency, resulted in an enhanced stability of 
plasmid DNA under certain conditions. The fabrication method, respectively the ionic 
strength, did not impair the stability of plasmid DNA with regards to the transfection 
efficiency. Considering that there is likely an excess of polyplexes inside the CHO-K1 cells, 
DNases may be saturated by plasmid DNA and hence, further plasmid DNA degradation may 
be prevented. 
In summary, our LPEI-based nucleic acid delivery system is very robust and excellent for 
routine transfection experiments. The high transfection efficiency of certain LPEI - 
polyplexes probably arises from a balance of endo-lysosomal escape capacity, nuclear 
transport and cytotoxicity [13]. In contrast, the cellular uptake of polyplexes built with 
various LPEIs, their intracellular disintegration and the stability of plasmid DNA do not 
influence the transfection efficiency considerably. As the structure of polyplexes significantly 
influences the transfection efficiency and cytotoxicity, a more detailed insight into polyplex 
assembling would be helpful for a further optimization of PEI-based delivery systems. 
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The investigation of intracellular mechanisms of non-viral nucleic acid delivery systems has 
attracted great impetus for the improvement of their efficacy. Especially the intracellular 
release of the nucleic acid from the non-viral carrier system may be a relevant criterion for 
the high transfection efficiency of certain polymers. Therefore, we evaluated fluorescence 
resonance energy transfer (FRET) in combination with confocal laser scanning microscopy or 
flow cytometry as tool to determine the intracellular disintegration of polyplexes built with 
plasmid DNA and linear polyethylenimine in living CHO-K1 cells. In microscopy, which 
allowed for an observation of polyplexes within single cells, sensitized emission 
measurement and acceptor photobleaching have been tested towards quantitative FRET 
analysis. In contrast, the whole cell population was analyzed by the flow cytometry-based 
method. We suggest that FRET is a useful tool in order to evaluate the intracellular 
disintegration of polyplexes built with various polymers. 
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In order for non-viral nucleic acid delivery systems to become a real alternative to viral 
vectors, the transfection efficiency must be substantially increased. Due to its relatively high 
efficiency, polyethylenimine (PEI), available in both branched (BPEI) and linear (LPEI) 
forms, has gained some prominence compared to other non-viral gene delivery systems. PEI 
is capable of condensing DNA into polyplexes, allowing for the cellular uptake of DNA. 
Once the polyplexes enter the endo-lysosomal compartment, PEI guides the minimally 
degraded DNA into the cytoplasm and finally to the nucleus to be transcribed [1-4]. To 
further optimize the transfection efficiency of PEI-based delivery systems, it would be useful 
to investigate the interactions of polyplexes with cells and the intracellular mechanisms 
involved in the transfection process. 
Some of the unique properties of PEI include its efficient condensation and protection of 
DNA extracellularly and its capability to release the DNA, even if only partially, 
intracellularly. For the investigation of the interaction of plasmid DNA and polymer, both 
components of polyplexes have been labeled with fluorescent dyes and observed by confocal 
laser scanning microscopy (CLSM) [5,31] (see also Chapter 3). However, investigations are 
often hampered by the limited spatial resolution of conventional widefield fluoresence 
microscopy. The application of a fluorescence resonance energy transfer (FRET) -based 
technique would allow for more precise distance measurements in the range of 1-10 nm. 
So far, only two studies have utilized a FRET-based approach for the determination of the 
complexation state of intracellular polyplexes: Itaka et al. made observations concerning the 
condensation of double labeled plasmid DNA in intracellular polyplexes [6]. The 
conformational change of plasmid DNA after condensation with polymer, which would lead 
to a change in the distance between two fluorescent molecules attached to plasmid DNA, was 
detected. For analyzing FRET the fluorescence intensity ratio of the fluorescent dyes was 
calculated at each pixel and an image in grey scale was created to express the ratios. A 
decrease in the FRET efficiency of plasmid DNA in LPEI - polyplexes due to disintegration 
was observed after intracellular uptake, while plasmid DNA retained high FRET efficiency in 
BPEI - polyplexes indicating that the DNA was kept in a condensed state. However, the 
selection of the filter set in this measurement enables a cross-talk of the selected dyes that is 
not considered during the calculation of the ratio images. Nevertheless, the method can be 
applied in the described case, because the molar ratio of the two fluorescent dyes is constant. 
Similarly, Kong et al. observed the decondensation of BPEI - polyplexes within cells, when 
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plasmid DNA and BPEI were separately labeled with Alexa Fluor 488 and rhodamine, 
respectively [7]. The degree of energy transfer within the polyplexes was evaluated by the 
ratio between the average intensity of Alexa Fluor 488 and rhodamine emission at a given 
location. Unfortunately, a possible cross-talk and varying concentrations of fluorescent dyes 
in polyplexes were not considered. In conclusion, while both experimental designs are 
interesting, neither approach was state-of-the-art for the determination of a FRET efficiency. 
Therefore, we evaluated whether various methods for the investigation of FRET described in 
literature are applicable to determine the stability of intracellular LPEI - polyplexes. To this 
end, each component of the polyplexes, i.e. polymer and plasmid DNA, was labeled with a 
fluorescent dye and FRET was measured using both microscopy and flow cytometry. 
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FRET is a process by which a fluorophore (the donor) in an excited state transfers its energy 
to a neighboring molecule (the acceptor) by non-radiative dipole-dipole interaction [8-11]. 
One of the most important factors influencing the efficiency of energy transfer is the distance 
between the donor and acceptor dye molecules (Figure 1). Energy transfer within the 1-10 nm 
distance range correlates well with the macromolecular dimension [12] and is, therefore, 
capable of resolving distances much shorter than the inherent diffraction limit of conventional 
microscopy. 
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Figure 1: FRET is the non-radiative transfer of photon energy from an excited fluorophore 
(the donor) to another fluorophore (the acceptor) when both are located within close 
proximity (1-10 nm) (adapted from [13]). 
When FRET occurs, there is a net gain in the energy of emission by the acceptor at the 
expense of the fluorescence emitted from the donor (donor quenching); this process is called 
sensitized emission (Figure 2). 
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Figure 2: Fluorescence excitation and emission spectra of a FRET donor - acceptor pair. The 
spectra from left to right represent: donor excitation (solid line), donor emission (dashed 
line), acceptor excitation (solid line) and acceptor emission (dashed line). Sensitized emission 
requires the excitation of the donor and then the detection of the acceptor emission. Upon 
FRET the donor emission decreases (), while the acceptor emission increases (). The gray 
region indicates the overlap of the donor emission spectrum and the absorption spectrum of 
the acceptor 
For FRET to occur efficiently: 
1. The donor must have a high quantum yield. 
2. The emission spectrum of the donor must overlap with the absorption spectrum of the 
acceptor (Figure 2). 
3. The donor and acceptor molecules must be in close proximity (typically 1-10 nm). 
4. The absorption and emission moments and their separation vector must be 
appropriately aligned. 
 
According to the theory of Förster the transfer efficiency (E) is defined as the probability of 
decay of the excited donor molecules due to energy transfer as compared to the total number 
of decay events, and is given by (for reviews, see [14,15]): 
(1) 
D FT
T
    
  
kkk
k
E
++
=  , 
where kT is of the rate constant of the transfer process, kF is the rate constant of fluorescence 
emission of the donor, and kD is the sum of the rate constants of all other de-excitation 
processes of the donor. 
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The rate of energy transfer (kT) can also be expressed by: 
 
(2) 26 4F T   const   κ−−= RnJkk  , 
 
where R is the distance between the donor and acceptor molecules, and 2 is an orientation 
factor describing the relative orientation of the donor’s emission dipole and the acceptor’s 
absorption dipole in space. The overlap integral J represents the degree of overlap between 
the donor fluorescence spectrum and the donor absorption spectrum, n is the refractive index 
of the medium. 
Furthermore, E depends on the inverse sixth power of the distance between the donor and the 
acceptor, and hence quickly decreases with an increase of R: 
(3) 6
0
6
6
  
  
−−
−
+
=
RR
RE  , 
where R0 is the characteristic separation distance of each dye pair, defined as the distance at 
which the probability of energy transfer is 50%. 
From equations (1), (2) and (3) the rate kT of energy transfer is also defined by:  
(4) 
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, 
where  is the donor lifetime in the absence of the acceptor. As the fluorescence lifetime of a 
fluorophore is the characteristic time that a molecule exists in the excited state prior to 
returning to the ground state, time-resolved FRET measurements can be used to perform 
experiments with greater accuracy. 
As with any proper fluorescence measurement, to be quantitative FRET methods have to 
account for ‘bleed-through’ in excitation, when the donor is excited by the excitation 
wavelength of the acceptor, and ‘cross-talk’ in emission detection, when the emission of a 
donor also contributes to the signal measured in a setup for acceptor detection, and vice versa. 
FRET associated with cells can be measured by different means, the two most common 
methods being microscopy and flow cytometry. While a whole cell population can be 
analyzed by flow cytometry, the distribution of FRET events within a single cell can be 
elucidated using fluorescence microscopy. In microscopy, two main approaches have been 
established towards quantitative FRET analysis: sensitized emission measurement and 
acceptor photobleaching.  
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Sensitized emission in microscopy 
Sensitized emission is the most common approach towards quantitative FRET. It requires the 
excitation of the donor and the detection of light emitted by either the donor and/or the 
acceptor in the presence of the other fluorophore. When FRET occurs, the intensity of donor 
emission is decreased and that of the acceptor emission is increased. Various methods have 
been applied to measure FRET from changes in donor and acceptor emission [16-19]. In the 
following, three different methods for the quantitative determination of sensitized emission in 
CLSM reported in literature are described [17-19] (the measurements are performed with a 
softwaretool from Carl Zeiss Co. Ltd., Germany [13]). For each measurement at least three 
samples are required; the donor (d) and acceptor (a) controls and the experimental sample (f). 
Furthermore, a combination of three filter sets for the detection of the donor fluorescence (D), 
the acceptor fluorescence due to direct excitation (A) or due to FRET (F) is used for the 
measurement of each sample. 
The calculation of three different FRET values for sensitized emision is possible, (i) Fc 
(FRET corrected), (ii) Fn (FRET net) and (iii) NF (normalized FRET). In the following 
equations, the uppercase letter denotes the filter set and the lowercase letter indicates which 
fluorophores are present in the specimen (as described above in brackets), for example Fd 
indicates that the donor is labeled (d) and the donor fluorophore is excited and the emission is 
detected in the acceptor channel (F). 
(i) The method according to Youvan et al. (calculation of Fc) simply determines a FRET 
intensity image corrected by the cross-talk and background intensity, but is not normalized for 
the concentration of the donor and acceptor [19]. This means that the FRET values are 
proportional to the donor and acceptor concentration and that high Fc numbers occur when 
high concentration of donor and acceptor are present: 
 
(5) 	




⋅	




⋅= Af   -     -   
Aa
FaDf
Dd
FdFfFc . 
 
Fd/Dd is a measure for the ratio of donor signal detected in the donor channel and emission 
crosstalk of donor signal detected in the FRET channel. Fa/Aa is a measure for the ratio of the 
acceptor signal detected in the acceptor channel and excitation crosstalk of acceptor signal 
detected in the FRET channel. The terms Df and Af correlate with the donor and acceptor 
concentration, respectively. Thus, the FRET value Ff can be corrected by the direct 
contribution of the donor and acceptor, their cross-talk and concentration, namely Donor corr 
and Acceptor corr, to get Fc according to Youvan et al.: 
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(6) [ ] [ ]corrAcceptorcorrDonorFfFc   -   -   = . 
 
(ii) According to Gordon et al. (Fn) the image resulting from calculation of Fc should be 
additionally normalized to the donor and acceptor signals [17]. This method may be of special 
interest when structures with low intensities are investigated. However, it also 
overcompensates for concentration, resulting in FRET values that are inversely proportional 
to the concentration: 
 
(7) [ ] [ ]
FaFdG
corrAcceptorcorrDonorFfFn
    
  -   - 
  
⋅⋅
= . 
 
(iii) In the analysis described by Xia et al. (NF), the corrected FRET image is divided by the 
square root of the product of donor and acceptor [18]. Hence, the FRET efficiency should be 
constant and independent of the local concentration of donor and acceptor. 
 
(8) [ ] [ ]
FaFdG
corrAcceptorcorrDonorFfNF
    
  -   - 
  
⋅⋅
= . 
Acceptor photobleaching in microscopy 
Another approach to detect FRET by microscopy is acceptor photobleaching [16,20-24]. The 
donor is excited and its emission is detected before and after acceptor photobleaching. After 
the acceptor is bleached or chemically destroyed, the donor signal increases since no energy 
transfer to the acceptor is possible. Such an increase in fluorescence following bleaching is 
particularly diagnostic of FRET, because fluorescence normally decreases following a bleach. 
An advantage of acceptor photobleaching is that corrections are not necessary because an 
increase in donor fluorescence cannot be related to acceptor bleed-through. 
For the measurement, a FRET positive and negative control and the spectral references are 
required. In a time series with about 2 to 5 pre bleach images, the acceptor should be bleached 
to about 20% and imaging should continue after bleaching. The FRET efficiency E is 
calculated from photobleaching kinetics of the donor in the presence and absence of the 
acceptor in pixels or regions of interest (ROIs) using the following equation [24]: 
(9) 
max 
min max  - 
  
Donor
DonorDonor 
F
FF
E = . 
Linear regression of the fluorescence intensity of the donor FDonor versus acceptor FAcceptor 
allows for the determination of
 
FDonor max, while FDonor min is obtained as average value of the 
fluorescence intensity of the donor from a time series of about 2-10 pre bleach images. 
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FRET measurements in flow cytometry 
Flow cytometry enables the statistical analysis of the distribution of FRET events in a cell 
population. In addition to the controls needed for microscopy, an additional sample of 
unlabeled cells is required to account for the cell autofluorescence [15,25,26]. 
In the following equations it is assumed that the donor fluorescence is excited with a 488 nm 
laser line and detected at 530 nm and a laser emitting light of 635 nm is used to excite the 
acceptor which is recorded at 670 nm. Sensitized acceptor emission is detected with excitation 
at 488 nm and emission at 670 nm. 
The simplest approach to measure energy transfer would be to determine the decrease in the 
fluorescence of the donor in the presence of the acceptor. Donor quenching (ET) can be 
calculated from mean fluorescence intensity of flow cytometry measurements according to 
[32]: 
(10) ( ) ( )( )530,488 
530,488     530,488 
  
0,1
1,10,1
F
FF
ET
−
=  , 
where Fd,a (x,y) represents the mean fluorescence intensity obtained in the absence (d=0) or 
presence (d=1) of a donor, in the absence (a=0) or presence (a=1) of an acceptor after 
excitation at x nm and detection at y nm. 
The acceptor sensitized emission is expressed by the energy transfer parameter (ETp): 
 
(11) 
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The factors a and b are used to correct by the direct contribution of donor and acceptor in 
samples with donor or acceptor labeled only, respectively: 
 
(12) ( )( )670,488 
530,488 
  
0,1
0,1
F
F
a =   and 
 
(13) ( )( )670,488 
670,635 
  
1,0
1,0
F
F
b =  . 
 
These calculations provide a single mean FRET efficiency for the whole cell population. 
However, sensitized emission can also be applied to calculate the distribution of the transfer 
efficiency on a cell-by-cell basis. Szollossi and co-workers reported the technical details and 
computer-based methods for calculation of the FRET efficiency in various papers [15,25,27-
29]: 
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Briefly, a correction factor , which represents the correction due to the different detectability 
of the donor and acceptor fluoresence, is determined by the following formula: 
 
(14) ( )( ) 488 Acceptor,Acceptor 0,1
488 Donor,Donor 1,0
    488,530  
     488,670 
  
ε
ε
α
⋅⋅
⋅⋅
=
rF
rF
. 
 
The numerical value of  is determined from the fluorescence intensities of cells saturated 
with either donor or acceptor label. Furthermore, the molar extinction coefficients  and the 
conjungate-to-dye ratio r are required. 
The sensitized emission has to be corrected for the direct contribution of the donor. The S1 
correction factor is determined from cells labeled with donor only and calculated using the 
following formula: 
 
(15) ( )( )488,530 
 488,670 
  
1,0
1,0
1 F
F
S = . 
The sensitized emission has also to be corrected by the contribution of the acceptor which 
may suboptimally be excited at 488 nm. The correction factor S2 is determined from cells with 
acceptor labeled only: 
 
(16) ( )( )635,670 
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F
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Furthermore, the acceptor emission is corrected for the direct contribution of the donor which 
may suboptimally be excited by 635 nm. The S3 correction factor is determined from cells 
labeled with donor only and is calculated as follows: 
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Thereafter, an intermediate value A is calculated using the following formula: 
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The FRET efficiency E can be finally obtained by the following formula: 
 
(19) 
A
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+
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Plasmid DNA labeling 
When indicated, plasmid DNA (pEGFP-N1, Clontech) was either covalently labeled with 
Alexa Fluor 488 according to the manufacturer´s protocol (ULYSIS Nucleic acid labeling kit, 
Molecular Probes, The Netherlands) or stained with the intercalating dye YOYO-1 
(Molecular Probes, The Netherlands). The labeling reaction with YOYO-1 was carried out 
with a molar ratio of 1 dye molecule per 320 base pairs at room temperature in the dark. 
Non-viral carriers 
LPEI with a MW of 5.0 kDa was synthesized as previously described [30]. When indicated, 
the polymer was labeled with 6-TAMRA-succinimidyl ester or Alexa Fluor 633 (both 
Molecular Probes, The Netherlands) as described [31]. In the following, the notation of LPEI 
was made without the unit kDa. 
Preparation of polyplexes 
Plasmid DNA / LPEI complexes were prepared at NP ratios (ratio of nitrogens in polymer to 
phosphates in DNA) of 6, 18 or 30 in 150 mM sodium chloride as described [31]. In the 
following, the notation of polyplexes was made without the unit kDa; LPEI 5.0 – polyplexes 
indicates that polyplexes were built with LPEI 5.0. 
CLSM experiments 
A Zeiss Axiovert 200 M microscope coupled to a Zeiss LSM 510 scanning device (Carl Zeiss 
Co. Ltd., Germany) was used for CLSM experiments. The inverted microscope was equipped 
with a Plan - Apochromat 63x objective. CHO-K1 cells were plated in 8 - well Lab-TekTM 
Chambered Coverglass (Nunc GmbH & Co. KG, Germany) at an initial density of 35,000 
cells / chamber in a volume of 400 µl culture medium. 20 mM HEPES was added to the 
medium to maintain a pH of 7.4. After 18 hours, polyplexes were added and measurements 
were directly performed in each well at 37°C. The thickness of the optical sections was 
between 0.7 and 1.2 µm. 
Sensitized emission 
FRET values for sensitized emission were calculated with the FRET Macro software tool 
from Carl Zeiss Co. Ltd. (Germany). The specimens used to acquire the raw data were: CHO-
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K1 cells incubated with polyplexes at NP 6 with donor labeled only (DNA in polyplexes 
labeled with YOYO-1), acceptor labeled only (LPEI 5.0 in polyplexes labeled with TAMRA) 
and the FRET specimen (double labeled polyplexes). The donor YOYO-1 was excited with a 
488 nm argon laser and detected with a 505-530 nm bandpass filter, while TAMRA was 
detected with a 560 –615 nm bandpass filter after excitation with 543 nm. Each specimen was 
acquired in a multitrack configuration with 3 tracks: donor excitation/donor emission 
detection (donor track), acceptor excitation/acceptor emission detection (acceptor track) and 
donor excitation/acceptor emission detection (FRET track). The quantitative FRET analysis 
was performed according to the suppliers´ instruction. For the determination of the location of 
polyplexes a transmitted light image was also recorded. 
Acceptor photobleaching 
The acceptor photobleaching method was applied for polyplexes at NP 6 consisting of 
TAMRA-labeled LPEI 5.0 and Alexa Fluor 488-labeled DNA incubated with CHO-K1 cells. 
As controls, polyplexes with only the donor labeled were used. Images were taken in the 
multitracking modus with the configuration of filters for the donor and acceptor tracks 
without the FRET track as described above. Bleaching was conducted by scanning a region of 
interest 12 times using the 543 nm argon laser line at 100% intensity. Each time the whole 
cells were bleached to avoid unwanted fluorescence recovery after photobleaching (FRAP) 
effects. Before and after this bleach, Alexa Fluor 488 and TAMRA images were recorded to 
assess changes in donor and acceptor fluorescence. Any increase in Alexa Fluor 488 
fluorescence caused by bleaching of the TAMRA acceptor could be masked by bleaching of 
Alexa Fluor 488 related simply to the imaging process itself. Hence, to ensure that bleaching 
due to imaging was minimal, the level of bleaching in each experiment was monitored by 
collecting Alexa Fluor 488/TAMRA image pairs before and after the bleach. 
Flow cytometry 
CHO-K1 cells were grown in 24-well plates at an initial density of 38,000 cells per well. 18 
hours after plating, the prepared polyplexes were added to the cells. After 6 hours of 
transfection with polyplexes with donor labeled only (DNA in polyplexes labeled with 
YOYO-1), acceptor labeled only (LPEI 5.0 in polyplexes labeled with Alexa Fluor 633) and 
double labeled polyplexes, cells were prepared for flow cytometry analysis as described 
previously [31]. Untreated cells were used to determine the autofluorescence of cells. 
Measurements were taken on a FACSCalibur (Becton Dickinson, Germany) using CellQuest 
Pro software (Becton Dickinson, Germany) and WinMDI 2.8 (1993-2000 Joseph Trotter). 
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YOYO-1 was excited using a 488 nm argon laser and detected with a 530 ± 30 nm bandpass 
filter, while Alexa Fluor 633 was excited with 635 nm and detected with a 661 ± 8 nm 
bandpass filter. Sensitized acceptor emission was detected with excitation at 488 nm and 
emission at > 670 nm. 
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Previous observations of double-labeled LPEI - polyplexes by CLSM indicated that 
polyplexes remained intact extracellularly, but once entered the cell at least a part dissociated 
or seemed to form loose aggregates ([31], Chapter 3). However, the evaluation of interaction 
of LPEI and plasmid DNA in confocal images is very time consuming and may be limited by 
the spatial resolution in microscopy. Therefore, FRET was introduced as tool to investigate 
the interaction of plasmid DNA and LPEI in polyplexes. 
Sensitized emission in microscopy 
For measurement of the sensitized emission of double-labeled LPEI 5.0 - polyplexes at NP 6 
in CHO-K1 cells, three samples, the donor and acceptor control and the FRET sample, were 
analyzed. To evaluate the location of polyplexes within the cells, the calculated FRET ratio 
images were directly compared to an image showing both the donor and acceptor channels as 
well as the transmitted light channel (Figure 3 A). In this image, extracellular polyplexes were 
characterized by an overlay of green and red, respectively plasmid DNA and LPEI, indicating 
a close interaction between polymer and plasmid DNA. Some of the intracellular polyplexes 
seemed to disintegrate. Figures 3 B to D show the corresponding calculated FRET ratio 
images according to Youvan (Figure 3 B), Gordon (Figure 3 C) and Xia (Figure 3 D). The 
colored pixels indicate a FRET efficiency from 0 (dark blue) to 100% (white). For a direct 
comparison with Figure 3 A, the ratio image D according to Xia et al. was chosen because it 
is independent of the concentration of the fluorescent dyes, which is most appropriate for 
LPEI - polyplexes. Figure 3 B does not take the concentration of the two fluorophores into 
account and Figure 3 C overcompensates for the concentration. 
Comparing Figures 3 A and D, extracellular polyplex aggregates were represented by colored 
pixels with FRET efficiencies of about 30 to 90%. The values for the FRET efficiency varied 
within polyplexes, indicating that the extent of interaction between polymer and plasmid 
DNA in extracellular polyplexes was not equally distributed. It was less time consuming to 
detect FRET events in intracellular polyplexes in the ratio images compared to Figure 3 A 
because it was not necessary to zoom into the images for a careful evaluation of each 
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polyplex. Polyplexes that seemed to disintegrate consisted of green, red and yellow areas, 
representing plasmid DNA, polymer and an overlay of both. In times when an overlay of red 
and green was detected in Figure 3 A, a corresponding FRET efficiency ranging from 40 to 
90% was also visible in Figure 3 D, but not in areas where only a green or red fluorescence 
was detected. The results were reasonable and indicated that intracellular polyplexes 
disintegrated, but the contact between polymer and DNA was still very close in certain areas. 
 4
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Figure 3: Sensitized emission measurements of LPEI 5.0 - polyplexes at NP 6 in CHO-K1 
cells by CLSM. A: Observing double labeled LPEI - polyplexes in the multitracking mode, 
DNA is represented by green dots and polymer by red dots. A colocalization of both would 
yield a mixture color of yellow. To evaluate the location of polyplexes with regard to the cells 
a transmitted light image was also recorded. The bar indicates 20 µm. Figures B to D show 
the corresponding calculated FRET ratio images according to Youvan (B), Gordon (C) and 
Xia (D). The colored pixels were calculated according to [13] and indicate a FRET efficiency 
from 0 (dark blue) to 100% (white) as indicated by the sidebars. 
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Acceptor photobleaching in microscopy 
Double-labeled LPEI 5.0 - polyplexes at NP 6 were used to evaluate the acceptor photobleach 
method. According to this procedure, if FRET occurs, photobleaching of the acceptor 
(TAMRA) should yield a significant increase in the fluorescence of the donor (Alexa Fluor 
488). To minimize the effect of photobleaching due to imaging, images of Alexa Fluor 488 
were collected at low laser intensity. The intensity of a certain number of Alexa Fluor 488 - 
labeled polyplexes remained nearly constant during a time series of 15 images, but sometimes 
also varied (about 5%) during imaging, most likely due to polyplex movements during 
imaging (data not shown). As a negative control, acceptor photobleaching of cells transfected 
with polyplexes stained with Alexa Fluor 488 alone was conducted, while larger extracellular 
polyplex aggregates and smaller intracellular polpylexes were evaluated. In these samples, 
FRET should be impossible, because the acceptor fluorophore TAMRA is absent. The 
fluorescence intensity decreased during imaging and bleaching, especially in smaller 
polyplexes (Figure 4 A, lower curve). This decrease in fluorescence intensity could be due to 
an unwanted bleaching of the donor or, as discussed above, due to movements of the 
polyplexes, the cells or even stage drift during the imaging process. Immediately after 
bleaching, the fluorescence intensity of larger polyplexes (Figure 4 A, upper curve) and 
smaller polyplexes (Figure 4 A, lower curve) seemed to remain constant. 
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Figure 4: Acceptor photobleaching of LPEI 5.0 - polyplexes at NP 6 in CHO-K1 cells. A: As 
negative control cells transfected with polyplexes that were labeled with Alexa Fluor 488 
alone were used. The fluorescence intensity of larger polyplexes (upper curve) and smaller 
polyplexes (lower curve) was quantified by averaging the fluorescence within one ROI of a 
certain number of polyplexes. Some bleaching due to imaging occurred at all time points 
except the one immediately after the bleach where constancy was detected. B: As positive 
control extracellular double labeled polyplexes were used. After bleaching the acceptor 
TAMRA (lower curve) the fluorescence of the donor Alexa Fluor 488 (upper curve) increased 
substantially. 
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As the simplest approach to evaluate whether our acceptor photobleaching protocol was 
feasible, the FRET efficiencies from 10 bleached extracellular polyplexes was measured and 
calculated as positive control. Figure 4 B shows an example of such a polyplex, after 
bleaching the acceptor (lower curve) the fluorescence of the donor (upper curve) substantially 
increased, the calculated FRET efficiency was 62.03%. This effect was reproducible for a set 
of 10 different polyplexes. The acceptor fluorophor TAMRA was not very effectively 
bleached by the applied method, but additional bleaching iterations lead to a decrease in the 
intensity of Alexa Fluor 488 in the negative control. 
To test the intracellular polyplexes, the whole cell was bleached to avoid FRAP effects, but 
the intensity was calculated from a defined region containing intracellular green and red spots, 
respectively polyplexes. In the example shown in Figure 5, the FRET efficiency of an area 
containing about eight intracellular polyplexes that seemed to dissociate was calculated, it had 
a value of 30.5%. 
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Figure 5: Acceptor photobleach of eight intracellular double labeled LPEI 5.0 - polyplexes 
that appeared to dissociate as shown by the fluorescence intensity of Alexa Fluor 488 (upper 
curve) and TAMRA (lower curve) during imaging. After bleaching the acceptor the 
fluorescence of the donor slightly increased. 
This pattern was reproducible for intracellular polyplexes of about 10 cells. The FRET 
efficienies were not as high as for the positive control, indicating the interaction between 
polymer and plasmid DNA was not as close as in extracellular polyplexes. 
However, the results were not accurate because some polyplexes, especially the smaller ones, 
disappeared due to drift of the stage or polyplex and cell movements (in and out of the z-
stack) during the imaging and bleaching process. The acceptor photobleaching can only be 
applied given the fact that the time between pre- and post-bleaching is not too long to allow 
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for movements of or in the sample. In the samples shown, the pre and post bleach images and 
the bleaching itself took about 5 minutes and sample movement was visible in sequentially 
recorded images (data not shown). However, also image sets recorded with framewise 
multitracking may show a delay between the same pixel position for different channels. These 
problems are more pronounced in living cells compared to fixed samples. However, in our 
opinion, fixed samples do not reflect the situation as well as living samples, because the fixing 
agents alter the structure of polyplexes (data not shown). The choice of fluorescent dyes that 
are more readily bleached than TAMRA may help to solve the problem, but only in part. 
Flow cytometry 
For the evaluation of interaction between polymer and plasmid DNA in intracellular 
polyplexes, donor quenching of double labeled LPEI 5.0 - polyplexes (with YOYO-1 and 
Alexa Fluor 633) was determined (Figure 6). Donor quenching arises due to sensitized 
emission, but also depends on competition effects. The latter can be neglected because of a 
minimal bleed-through in excitation of the used FRET pair YOYO-1 and Alexa Fluor 633. 
The donor quenching increased with increasing NP ratio indicating an enhanced stability of 
polyplexes with increasing NP ratio. The enhanced stability of polyplexes may be due to more 
LPEI available for polyplex formation. 
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Figure 6: Donor quenching of double labeled LPEI 5.0 - polyplexes at NP 6, 18 and 30 after 
6 hours of transfection as determined by flow cytometry. Statistically significant differences 
between NP ratios are denoted by  (α < 0.01). 
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The FRET efficiency E on a cell-by-cell basis could not be calculated because the conjungate-
to-dye ratio r (of polymer and plasmid DNA) were unknown. However, as it is most likely 
that the proportion of polymer to DNA is not constant in different polyplexes, donor 
quenching as average value for the whole cell population meets the situation better than a cell-
by-cell evaluation. 
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In this study, FRET was evaluated as tool to determine the intracellular disintegration of 
double labeled LPEI - polyplexes in CHO-K1 cells. In microscopy, two approaches have been 
considered for quantitative FRET analysis: sensitized emission measurement and acceptor 
photobleaching. Applying the acceptor photobleach method, the results were not accurate 
because of movements of or in the sample during the imaging process. Therefore, we would 
not recommend acceptor photobleaching for this application. Sensitized emission 
measurement using the method according to Xia et al. [18] worked quite well for the 
determination of interaction between LPEI and plasmid DNA. Generally, we would advise 
caution for the investigation of interaction of polymer and plasmid DNA in living samples by 
FRET because of movement during the imaging process, but working with fixed cells is not 
an alternative because fixation agents may alter the structure of polyplexes. Furthermore, 
FRET occuring between two fluorescent molecules in LPEI - polyplexes was also 
successfully measured by flow cytometry. The advantage of the flow cytometry-based method 
is the analysis of a whole cell population. 
With the established methods it is now possible to evaluate the intracellular stability of 
polyplexes built with various polymers at different NP ratios. We suggest that FRET is a 
useful tool in order to gain a deeper insight into LPEI-mediated gene transfer. 
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Although polyethylenimine (PEI) is one of the most successful non-viral gene delivery 
systems, its cytotoxicity is still a severe problem. We hypothesized that biodegradable PEIs 
crosslinked with disulfide bonds would maintain the efficient gene transfer, but with low 
cytotoxicity. Our results proved this hypothesis; the most effective biodegradable PEI was 
capable of 27-fold greater gene delivery than the non-degradable linear starting material. 
Furthermore, the maximal transfection efficiency achieved in CHO-K1 cells was with a value 
of about 73% much higher than the linear PEI (LPEI) derivative of similar molecular weight. 
Moreover, the efficacy was nearly 3-fold higher than that of branched PEI (BPEI) 25 kDa and 
LPEI 22 kDa, which have become benchmarks for newly synthesized polymers. It was 
remarkable that the cytotoxicity at NP ratios with the highest transfection efficiency was 
negligible compared to BPEI 25 kDa and LPEI 22 kDa. Biodegradable PEI-mediated gene 
delivery was dependent on intracellular reduction and could be modulated by manipulation of 
the number of stabilizing bonds. Confocal laser scanning microscopy revealed a longer 
colocalization of biodegradable PEI - polyplexes with acidic organelles compared to LPEI, 
which may be a prerequisite for its efficient gene delivery. In conclusion, biodegradable PEIs 
allow for a very high transfection efficiency accompanied by minimal cytotoxicity in vitro 
and are, therefore, a real alternative to existing polymer-based nucleic acid delivery systems. 
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Despite early excitement and continued progress, there is a long way to go before non-viral 
gene delivery systems become a real substitute for viral vectors. One of the most successful 
and widely studied polymers for gene delivery reported to date is polyethylenimine (PEI). 
Due to their relatively high efficiency, branched PEI (BPEI) 25 kDa and linear PEI (LPEI) 22 
kDa (ExGen®) have become benchmarks for other polymers, especially newly synthesized 
ones. PEI-based gene delivery systems work very well in many cells lines in vitro, but still 
present disappointing results in many primary cells in vitro and in vivo [1-3]. The toxicity 
increases with the degree of polymerization of the carrier molecule, but appears also to 
depend on the degree of branching. For example, by increasing the molecular weight (MW) 
of BPEIs, the transfection efficiency increases but is also accompanied by a high cytotoxicity 
[1,4]. This is not exactly true for LPEIs, the transfection efficiency also increases with the 
MW, but is to a certain point decoupled from cytotoxicity [5]. LPEIs have therefore been 
reported to be superior to BPEIs [6-9]. 
The acute toxicity of polycationic carriers is associated with their ability to bind non-
specifically to negatively charged DNA and other biological materials. Furthermore, because 
the therapeutic application of transfection reagents requires a repeated use, the long-term fate 
of the polymeric carrier has to be considered in an organism. Therefore, high MW polymers 
that have superior properties to complex DNA and a stabilizing effect on polyplexes 
(DNA/polymer complexes) [10-14], but which can be easily degraded by the host, might help 
to overcome this obstacle. A popular strategy to reduce the toxicity of polyplexes is to use 
low MW polycations that are less cytolytic and have only a low transfecting ability [5], and 
crosslink them with agents that can be cleaved or activated by the intracellular environment. 
Such bioreversible linkages comprise esters [15-18], amides [18], orthoesters [19], imines 
[12,20] and disulfides [10,11,13,21-25]. 
Surprisingly, gene delivery using biodegradable polycations has with a few exceptions had 
only limited success so far [17,21,25]. The low efficiency of some biodegradable polycations 
may be due to their short half-life under physiological conditions and hence, reduced 
extracellular stability of polyplexes. Therefore, not only the biodegradability of the polymer, 
but also the stability of polyplexes in the extracellular environment are necessary 
prerequisites for efficient gene delivery. Bioreversible disulfide linkers are best suited to 
fulfill these demands, because they can take advantage of the high redox potential difference 
between the oxidazing extracellular space and the reducing intracellular environment (for 
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review see [26]), and therefore, they most likely allow for the release of the contained nucleic 
acid not until the arrival within the target cell [13,24]. 
Therefore, we crosslinked a LPEI derivative with a MW of 2.1 kDa with bioreversible 
disulfide bonds. LPEI 2.1 kDa was chosen because its polyplexes showed a minimal 
transfection efficiency and no cytotoxicty in a cell culture model [5]. We hypothesized that 
crosslinking would lead to a transfection efficiency comparable to a LPEI derivative of 
similar MW, but cytotoxicity as low as for LPEI 2.1 kDa. 
#	#
Materials were purchased from Sigma-Aldrich Chemie GmbH (Germany) unless otherwise 
stated. 
Cell lines and cell culture 
Chinese hamster ovarian cells (CHO-K1; ATCC No. CCL-61) were grown in culture medium 
consisting of Ham´s F-12 supplemented with 10% FBS (Biochrom AG, Germany). The 
human cervical carcinoma cell line HeLa (ATCC No. CCL-2) was maintained in Dulbecco´s 
Medium (Invitrogen, Germany) supplemented with 10% FBS, 1 mM sodium pyruvate and 2 
mM L-glutamine (both Invitrogen, Germany). The monkey kidney cell line COS-7 (ATCC 
No. CRL-1651) and murine kidney As.4.1 cells (ATCC No. CRL-2193) were maintained in 
DMEM (Invitrogen, Germany) with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium 
bicarbonate and 4.5 g/l glucose supplemented with 10% FBS. All cells were incubated at 
37°C in a 5% CO2 humidified environment. 
Non-viral carriers 
Biodegradable PEIs were obtained by crosslinking LPEI with a MW of 2.1 kDa with 
Lomant´s reagent. The four resulting polymers had a different degree of branching and a 
slightly increasing MW with increasing linker/polymer proportion. The notation of the 
polymers was made as follows: LRx-LPEI, where x indicates the percentage of linker 
compared to the polymer starting material.  
The notation of LPEIs was made without the unit kDa, for example LPEI 2.1 represents LPEI 
with a MW of 2.1 kDa (it should be annotated that LPEI 2.1 is the same polymer as LPEI 2.4 
in [5], the indication of MW slightly differs because the lower one was determined by gel 
permeation chromatography and the higher one was estimated by 1H-NMR spectroscopy). 
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Polymer stock solutions for LR-LPEIs, LPEIs and BPEI were prepared with 150 mM NaCl, 
the pH of LPEI solutions was adjusted to 7 and then filtered (0.2 µm filter, Corning GmbH, 
Germany). ExGen 500 was obtained from MBI Fermentas GmbH (Germany). 
Plasmid isolation and labeling 
Plasmid encoding enhanced green fluorescent protein (EGFP) (Clontech, Germany) was used 
as reporter gene in this study. Plasmid was isolated from E. coli by using a Qiagen Plasmid 
Maxi Kit (Qiagen GmbH, Germany) according to the supplier´s protocol. When indicated, 
plasmid DNA was either covalently labeled with Alexa Fluor 546 according to the 
manufacturer´s protocol (ULYSIS Nucleic Acid Labeling Kit, Molecular Probes, The 
Netherlands) or stained with the intercalating dye YOYO-1 (Molecular Probes, The 
Netherlands). The labeling reaction with YOYO-1 was carried out with a molar ratio of 1 dye 
molecule per 320 base pairs at room temperature in the dark. 
Preparation of polyplexes 
Plasmid DNA/LR-LPEI or LPEI complexes were prepared at a NP ratio (nitrogens in 
polymer to phosphates in DNA) of 6, 12, 18, 24 and 30. Polyplexes were formed by mixing 2 
µg DNA with the appropriate amount of polymer solution, while both components were 
diluted to 50 µl with 150 mM NaCl or 5% glucose. The resulting polyplexes were incubated 
for 20 minutes at room temperature before use. The notation of polyplexes was made as 
follows: LR1-LPEI - polyplexes expresses that polyplexes were built with LR1-LPEI. When 
indicated, polyplexes were incubated with dithiothreitol (DTT) at a concentration of 1 mM 
prior to transfection to confirm that the reduction of disulfides occurs intracellularly. 
In vitro transfection and cytotoxicity experiments 
For gene transfer studies, cells were grown in 24-well plates at an initial density of 38,000 – 
42,000 cells per well, depending on the cell line. 18 hours after plating, the culture medium 
was removed, cells were washed with PBS (Invitrogen, Germany) and 900 µl serum-free or -
containing medium was added (transfection medium). Thereafter, the prepared polyplexes 
were added to the cells. After 4-6 hours, the medium was replaced with 1 ml of culture 
medium. Analysis of transfection efficiency and cell viability was performed by flow 
cytometry 24 hours later as described previously [5,27]. Briefly, measurements were taken on 
a FACSCalibur (Becton Dickinson, Germany) using CellQuest Pro software (Becton 
Dickinson, Germany) and WinMDI 2.8 (1993-2000 Joseph Trotter). EGFP positive cells 
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were detected using a 530/30 nm band-pass filter, whereas the propidium iodide emission was 
measured with a 670 nm longpass filter. In a density plot representing forward scatter against 
sideward scatter, whole cells were gated out and depicted in two-parameter dot plots of EGFP 
versus propidium iodide to analyse the measurements. The EGFP positive region 
corresponded to the transfection efficiency and the geometric mean fluorescence intensity 
was determined from the number of EGFP positive cells. Further, the number of propidium 
iodide negative cells was counted as a measure of cell viability. 
Glutathione monoethyl ester (GSH MEE) was dissolved in serum-free medium and added to 
the cells 1 hour prior to transfection at concentrations of 1 or 5 mM. The amount of 
intracellular NAD(P)H of CHO-K1 cells after addition of duroquinone at concentrations of 50 
or 100 µM was determined fluorometrically (excitation 340 nm and 460 nm emission) and 
expressed as fluorescence intensity [28,29]. The evaluation of the transfection efficiency and 
mean fluorescence intensity of the EGFP positive cells after addition of GSH MEE and 
duroquinone was performed at the indicated times by flow cytometry as described above. 
Intracellular trafficking of polyplexes - confocal laser scanning microscopy 
(CLSM) 
A Zeiss Axiovert 200 M microscope coupled to a Zeiss LSM 510 scanning device (Carl Zeiss 
Co. Ltd., Germany) was used for CLSM experiments. The inverted microscope was equipped 
with a Plan - Apochromat 63x and Plan - Neofluar 100x objective. Cells were plated in 8 – 
well Lab-TekTM Chambered Coverglass (Nunc GmbH & Co. KG, Germany) at an initial 
density of 35,000 cells / chamber in a volume of 400 µl culture medium. For maintaining a 
pH of 7.4, 20 mM HEPES (Invitrogen, Germany) was supplied. After 18 hours, polyplexes 
were added and measurements were directly performed in each well at 37°C. The thickness of 
the optical sections was between 0.7 and 1.2 µm. 
For the investigation of the intracellular trafficking of polyplexes, LR-LPEI and YOYO-1 - 
labeled DNA were used. YOYO-1 was excited with a 488 nm argon laser, images were taken 
using a band-pass filter of 505 – 530 nm in the singletrack mode at the indicated times after 
the addition of the polyplexes. For the detection of polyplexes in acidic compartments of the 
cell, Alexa Fluor 546 - labeled plasmid DNA was applied. Polyplexes and quinacrine mustard 
at a concentration 10-6 M were added to the cells at the same point of time. Quinacrine 
mustard was excited at 458 nm and the fluorescence was imaged using a band-pass filter of 
475 - 525 nm. Alexa Fluor - labeled DNA was excited at 543 nm and the fluoresecence was 
recorded with a 560 nm longpass filter. Images were taken in the multitracking modus. 
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Statistical analysis 
All measurements were collected (n = 3 to 6) and expressed as means ± standard deviation 
(SD). Single factor of variance (ANOVA) was used in conjunction with a multiple 
comparison test (Tukey test) to assess the statistical significance. 
"
LR-LPEI - mediated gene transfer and cytotoxicity 
The transfection efficiency of polyplexes formed with LR-LPEI (crosslinked with 1 to 4% 
linker) and plasmid DNA was evaluated in CHO-K1 cells and compared with LPEI 2.1, the 
starting material (Figure 1). As reported previously, the transfection efficiency of LPEI 2.1 - 
polyplexes was negligible and increased only slightly with increasing NP ratio [5]. A 
crosslinking of LPEI 2.1 with a linker/polymer proportion of 2% and higher statistically 
significantly increased the transfection efficiency. LR4-LPEI - polyplexes at NP 12 with a 
transfection efficiency of 73,60 ± 5,96% transfected 27 times more cells than the LPEI 2.1 - 
polyplexes. The NP ratio for the optimal gene expression decreased with the degree of 
branching of LR-LPEI. Furthermore, LR3-LPEI was also compared with LPEI 5.0 that had a 
different structure, but similar MW (Figure 1). It was remarkable that LR3-LPEI exceeded the 
non-degradable LPEI 5.0 - polyplexes at NP 18 nearly two fold. 
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Figure 1: Transfection efficiency of LR-LPEI, crosslinked with 1% ( ), 2% ( ), 3% ( ) and 
4% ( ) linker compared to LPEI 2.1 ( ) complexed with pEGFP-N1 as reporter gene at 
various NP ratios in CHO-K1 cells as determined by flow cytometry. Experiments were 
performed in duplicate; values represent the EGFP positive cells as means ± SD of one 
representative experiment (n=6). Transfection efficiency of polyplexes built with LR-LPEI, 
crosslinked with 2 to 4% linker, was statistically significant higher (p<0.01, LR2-LPEI at NP 
6 with p<0.05) compared to LPEI 2.1 and LR1-LPEI at each NP ratio tested. Further, LR3-
LPEI was compared to LPEI 5.0 ( ) that has similar MW but different structure. Statistically 
significant differences between LPEI 5.0 and LR3-LPEI are denoted by  (p<0.05) and  
(p<0.01). 
The cell viability was evaluated by propidium iodide staining followed by flow cytometry 
analysis in the same experiment [27]. Using LPEI 2.1, LR1-LPEI and LR2-LPEI in 
polyplexes, the cell viability seemed to be unaffected compared to untreated cells at every NP 
ratio tested (Figure 2). When cells were transfected with LR3-LPEI or LR4-LPEI, the cell 
viability slightly decreased at NP 30 or NP 24 and 30, respectively. The cell viability after 
transfection with LPEI 5.0 resembled that of LR3-LPEI. 
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Figure 2: Relative viability of CHO-K1 cells after treatment with LR-LPEI, crosslinked with 
1% ( ), 2% ( ), 3% ( ) and 4% ( ) linker, compared to LPEI 2.1 ( ) and LPEI 5.0 ( ) in 
polyplexes at various NP ratios determined with propidium iodide staining followed by flow 
cytometry. Experiments were performed in duplicate, values are means ± SD of one 
representative experiment (n=3). Cell viability statistically significant decreased compared to 
the treatment with same polyplexes at lower NP ratios, as indicated by  (p<0.05) or by 
 
(p<0.01). 
Effect of serum and ionic strength of polyplex building medium on LR-LPEI-
mediated gene transfer 
It is known that the ionic strength of the formation medium affects the size and structure of 
PEI-based polyplexes and consequently their transfection efficiency [30]. Hence, we tested 
whether LR-LPEI - polyplexes built in 150 mM sodium chloride or 5% glucose could be used 
in the presence of 10% serum. For LR3-LPEI - polyplexes built in 150 mM sodium chloride, 
the number of EGFP positive cells was statistically significantly higher from NP 6 to 18 in 
serum-free culture condition, similar at NP 24 and finally statistically significant lower at NP 
30 compared to transfection in serum-containing culture conditions (Figure 3). The efficacy 
of polyplexes formed in 5% glucose in serum-free transfection medium was statistically 
significantly higher compared to all other conditions tested. However, at the same time the 
cell viability also slightly decreased from about 91% at NP 6 to about 80% at NP 30 (data not 
shown). 
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Figure 3: Transfection efficiency of LR3-LPEI, when polyplexes were built in 150 mM sodium 
chloride and the 4 hour incubation period was carried out in the absence or presence of 
serum (  or , respectively) or when polyplexes were built in 5% glucose (  or , 
respectively). Values represent the EGFP positive cells as means ± SD of one representative 
experiment (n=6). Statistically significantly different pairs are denoted by 
 
(p<0.01). 
Transfection efficiencies of glucose-polyplexes in serum-free culture conditions were at every 
NP ratio statistically significant higher compared to other conditions (p<0.01). 
The influencing effect of the ionic strength and culture conditions on the transfection 
efficiency was also observed for LR-LPEIs with another degree of branching (data not 
shown). However, the differences between the various conditions tested were not as 
remarkable and, furthermore, glucose-polyplexes were not superior to sodium chloride-
polyplexes. 
Response of LR-LPEI-mediated gene transfer to changes in the 
reducing/oxidizing environment of polyplexes and cells 
After the treatment of polyplexes with DTT, the transfection efficiency of LR4-LPEI - 
polyplexes decreased significantly from about 75% to 60% (Figure 4). The preincubation of 
LPEI 5.0 - polyplexes that contained no cleavable disulfide bonds resulted only in a marginal 
decrease in the number of EGFP positive cells. Higher concentrations of DTT did further 
reduce the number of EGFP positive cells after transfection with LR4-LPEI, but did 
negatively influence the efficacy of LPEI 5.0 - polyplexes (data not shown). 
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Figure 4: Transfection efficiency of LPEI 5.0 ( ) - and LR4-LPEI ( ) - polyplexes at NP 18 
incubated with 1 mM DTT prior to transfection compared to control conditions. Values 
represent the EGFP positive cells determined 24 hours post transfection by flow cytometry as 
means ± SD of one representative experiment (n=3). Statistically significant differences 
between DTT treated polyplexes and controls are denoterd by  (p<0.05). 
Next, we evaluated whether changes in the intracellular NAD(P)H concentration would affect 
transfection. An hour before transfection, each culture was treated with duroquinone, a 
chemical that oxidizes NAD(P)H via a diaphorase reaction thereby lowering cellular 
NAD(P)H levels [28,31], which were monitored fluorometrically. As shown in Figure 5 A, 
the fluorescence intensity of CHO-K1 cells corresponding to the cellular level of NAD(P)H 
immediately decreased after the addition of duroquinone and remained low for at least 5 
hours (data not shown). After 18 hours, the fluorescence intensity of duroquinone treated cells 
increased again to values comparable to the control, indicating that the cells may have a 
mechanism to adjust their NAD(P)H levels (data not shown). When transfecting cells with 
low NAD(P)H levels with LPEI 5.0 - polyplexes, the efficacy was not affected at either 
duroquinone concentration (Figure 5 B). Using LR4-LPEI - polyplexes, however, the number 
of transfected cells after 6 hours was significantly lower, but was similar to the control after 
24 hours. The mean fluorescence intensity of EGFP positive cells after 6 hours of transfection 
was influenced by the addition of duroquinone using both forms of PEI in polyplexes, but for 
the linear form a higher concentration of duroquinone was necessary to induce a statistically 
significant decrease (Figure 5 C). After 24 hours, the mean fluorescence intensity of EGFP 
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positive cells was again similar to the controls using both linear and biodegradable PEI in 
polyplexes. 
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Figure 5: Effect of intracellular NAD(P)H on the transfection efficiency (B) and mean 
fluorescence intensity of EGFP positive cells (C). Duroquinone at a concentration of 50 or 
100 µM was added to the cells one hour prior to transfection with LPEI 5.0 - polyplexes and 
LR4-LPEI - polyplexes at NP 12. A: Changes in the fluorescence intensity of CHO-K1 cells 
corresponding to the intracellular concentration of NAD(P)H after the addition of 
duroquinone at concentrations of 50 ( ) or 100 ( ) µM. The fluorescence intensity of CHO-
K1 cells resuspended in PBS buffer after trypsinization was measured fluorimetrically (340 
nm excitation and 460 nm emission). B: Values represent the EGFP positive cells as means ± 
SD of one representative experiment (n=3) as determined by flow cytometry 6 hours (LPEI 
5.0 
 
and LR4-LPEI ) and 18 hours (LPEI 5.0 
 
or LR4-LPEI ; respectively) post 
transfection. C: Values represent the mean fluorescence intensity of EGFP positive cells as 
determined by flow cytometry 6 and 18 hours post transfection. Statistically significant 
differences compared to untreated cells are denoted by  (p<0.05) or by 
 
(p<0.01). 
Enhancing the intracellular reducing conditions with glutathione (GSH) might effect the 
activation and hence, the efficiency of polyplexes. GSH MEE was used for this purpose, 
because it is effectively transported into various types of cells and converted intracellularly 
into GSH [32]. But boosting the intracellular GSH using GSH MEE did not further enhance 
the transfection efficiency of polyplexes independent of the degree of branching and hence, 
amount of cleavable disulfide bonds in polyplexes (Figure 6). Even higher concentrations of 
GSH MEE (5 mM) did not influence the number of EGFP positive cells (data not shown). 
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Figure 6: Influence of glutathione monoethylester (GSH MEE) at a concentration of 1 mM on 
the transfection efficiency of LR-LPEI, crosslinked with 1% ( ), 2% ( ), 3% ( ) and 4% 
( ) linker, complexed with plasmid DNA at NP 18 compared to controls after 24 hours. 
Values represent the EGFP positive cells as means ± SD of one representative experiment 
(n=4). Statistically significant pairs are denoted by  (p<0.05). 
Evaluation of LR-LPEI - mediated gene transfer in various cell lines 
The next step was to evaluate the polyplexes formed with crosslinked LPEI in a number of 
cell lines (Figure 7). Regarding CHO-K1, COS-7 and HeLa cells, the optimal NP ratio for the 
transfection was different, but the maximum value was in the same range. The cell viability 
was as favorable in the other cell lines as it was in the CHO-K1 cells, with the exception of 
5% more dead cells in COS-7 at NP 18 to 30 (data not shown). The performance of LR3-
LPEI - polyplexes in As4.1 cells was much lower, but the cell viability was not affected by 
the transfection process (data not shown). 
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Figure 7: Transfection efficiency of LR3-LPEI complexed with pEGFP-N1 in As4.1 ( ), 
CHO-K1 ( ), COS-7( ) and HeLa ( ) cells at various NP ratios as determined by flow 
cytometry. Values represent the EGFP positive cells as means ± SD of one representative 
experiment (n=4). 
Uptake and lysosomal localization of LR-LPEI - polyplexes 
The uptake of LR-LPEI - polyplexes into CHO-K1 cells and their shape was evaluated by 
CLSM during incubation over 8 hours (Figure 8 A) using plasmid DNA in polyplexes labeled 
with YOYO-1. The first polyplexes were detected inside CHO-K1 cells after one hour (data 
not shown). With further incubation, polyplexes were dispersed over the cytosol and in some 
cells polyplexes could be detected in the nucleus. The larger green dots in Figure 8 A were 
polyplex aggregates that were not taken up by cells. Intracellular polyplexes were more round 
compared to extracellular polyplexes. It was remarkable that cells showed a strong green 
fluorescence due to EGFP production only after five hours (data not shown, but see also 
Figure 5). 
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Figure 8: Observation of LR3-LPEI - polyplexes at NP 18 in CHO K1 cells five hours post 
transfection by CLSM. A: Uptake of polyplexes when plasmid DNA was labeled with YOYO-1 
(green). Intracellular polyplexes were dispersed over the cytosol. B: Tracking Alexa 546-
labeled DNA (red) and acidic vesicles (turquoise). A mixture of both colors indicates a close 
proximity. Most polyplexes were colocalized with acidic vesicles, some examples are 
indicated by an arrow. Pictures are an overlay of transmitted light and fluorescence images. 
Each bar indicates 10 µm. 
CLSM was also used to verify whether acidic vesicles and polyplexes ever colocalized 
(Figure 8 B). A merge of acidic organelles and polyplexes would yield a combination color of 
turquoise and red. Most of the polyplexes taken up by CHO-K1 cells were colocalized with 
the acidic organelles through the whole observation time (Figure 8 A, arrow). The larger red 
dots were again polyplex aggregates that were not taken up by cells. 
Comparison with BPEI 25 kDa and LPEI 22 kDa 
Finally, the biodegradable PEIs were compared to BPEI 25 kDa and LPEI 22 kDa, the gold 
standards in the field of polymer-based nucleic acid delivery. The most effective polymer in 
the series of biodegradable PEIs, LR4-LPEI, far exceeded the efficacy of BPEI 25 kDa and 
LPEI 22 kDa (Figure 9). It was outstanding that, in contrast to BPEI and LPEI (data not 
shown), the high transfection efficiency was not associated with a reduction in cell viability. 
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Figure 9: Transfection efficiency of BPEI 25 kDa ( ), LPEI 22 kDa ( ) and LR4-LPEI ( ) 
complexed with pEGFP-N1 as reporter gene at NP 6 to 18 in CHO-K1 cells as determined by 
flow cytometry. Values represent the EGFP positive cells as means ± SD of one 
representative experiment (n=4 or 6). 
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In this study we proved our hypothesis that a bioreversible crosslinking of low MW LPEIs 
would raise the polymer´s efficacy due to the higher MW and hence transfection efficiency, 
while the biodegradable linkages would undergo intracellular breakdown and therefore not be 
toxic. LR4-LPEI exhibited a gene transfer activity greater than either BPEI 25 kDa or LPEI 
22 kDa, some of the most effective polymers for gene transfection reported to date. 
Moreover, the cell viability was nearly unaffected after the transfection process. Furthermore, 
it is remarkable that many EGFP positive cells could be detected already after 6 hours of 
incubation with polyplexes. However, the mean fluorecence intensity of these EGFP positve 
cells was much lower compared to 24 hours, indicating that the translation had just begun. 
The early transcription/translation of EGFP has not been observed for LPEI – polyplexes. It is 
unclear why certain LR-LPEIs are more effective than the non-degradable form of similar 
MW. Perhaps the polymer degradation may facilate the unpacking and hence, easier 
transcription [33]. 
Disulfides were designed to exploit the differences in the degradation potential at different 
locations within and upon cells providing a clear opportunity to design vectors that are stable 
in the plasma but unstable within the endo-lysosomal compartment or cytoplasm. The 
concentration of extracellular GSH (estimated 1–2 µM) is usually 100 to 1000 times less than 
intracellular GSH and hence favors the maintenance of disulfide bonds. The majority of GSH 
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in cells is usually found in the cytosol; estimated GSH levels in the cells are 1–11 mM. Some 
organelles, however, such as the nucleus, appear to have their own GSH pools [26,34]. A 
simulated activation of polyplexes with DTT in the extracellular space decreased the 
transfection efficiency, which implies that the integrity of polyplexes is necessary for 
effective delivery. The decrease may be ascribed to the formation of shorter polymer chains 
that show a reduced gene transfer ability [5]. Higher concentrations of DTT for preincubation 
further decreased LR-LPEI-mediated gene transfer, but also influenced the efficiency of LPEI 
- polyplexes. This may be due to the fact that the structure and hence the transfection 
efficiency of polyplexes is responding to changes in the ionic strength during the formation 
and content of the culture medium. Pretreatment of CHO-K1 cells with GSH MEE to increase 
the cellular GSH pool [35] did not improve the gene expression of LR-LPEI - polyplexes. 
The level of GSH in CHO-K1 cells appears to be sufficient to activate the carriers at the 
tested NP ratios irrespective of the proportion of the disulfide linker. Furthermore, NAD(P)H 
also participates in the intracellular activation of LR-LPEI - polyplexes. Lower intracellular 
NAD(P)H levels reduced not only the number of EGFP positive cells, but also the amount of 
EGFP. Therefore, from literature and our results we conclude, that the polyplexes may at least 
partially undergo a GSH- and NAD(P)H-dependent reduction inside the cell [25,29,36]. It is 
not completely clear in which compartment of the cell the disulfide cleavage occurs, but most 
likely within the endolysomal compartment or in the cytoplasm. A cleavage in the early 
endosome probably plays a minor role because it is thought to be devoid of reducing activity 
[37-39]. It is also possible that the disulfide bonds are broken in the lysosomes, because a 
prolonged colocalization of plasmid DNA with acidic vesicles was observed. 
By generating polyplexes in salt-free (5% glucose) or -containing (150 mM sodium chloride) 
medium and transfecting in serum-free or -containing culture conditions, we could show that 
the transfection ability of some of the LR-LPEI - polyplexes used for gene transfer is strongly 
influenced by these conditions. Wagner et al. hypothesized that this effect may be due to 
different polyplex stability and growth [30]. When examining the CLSMs pictures, it is clear 
that polyplex size has to be controlled and optimized. Therefore, in future studies the focus 
should not only be based on novel polymers, but also on techniques for polyplex building and 
understanding the polyplex structure - transfection ability relationship. 
Concluding, we identified biodegradable PEI-based polyplexes that are superior to other 
polymer-based non-viral gene delivery systems reported so far. Our study proved the 
hypothesis that polyplexes with very high gene tranfer percentages, that are decoupled from 
cytotoxicity, could be produced using biodegradable PEIs. The efficacy of the most effective
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LR-LPEI was nearly 3-fold higher than branched BPEI 25 kDa or LPEI 22 kDa, while the 
cytotoxicity of the biodegradable PEI - polyplexes was negligible. LR-LPEI-mediated gene 
delivery was dependent on intracellular reduction and could be modulated by manipulation of 
the number of stabilizing bonds. Moreover, the functionality of LR-LPEI could be 
demonstrated in various cell lines. 
Therefore, we suggest that LR-LPEIs are a real substitute for existing polymer- and PEI-
based nucleic acid delivery systems. The next step will be to test the capacity of 
biodegradable LR-LPEIs to transfect primary cells in vitro. 
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The need for safe and efficient nucleic acid delivery methods remains a critical obstacle to the 
routine clinical implementation of human gene therapy. Although virus-based delivery 
systems are the most efficient gene delivery systems currently available, polymeric carriers 
have several advantages that make them a promising alternative. Unfortunately, none of the 
existing polymer systems is generally acceptable for human gene therapy, primarily due to 
lack of efficiency. Among various cationic polymers polyethylenimines (PEIs) have emerged 
as the most efficient non-viral carriers for gene transfer into many cells. Although PEI-based 
gene delivery systems work very well in many cells in vitro, their gene expression is still too 
low for in vivo application. 
Recently, we have introduced a variety of biodegradable PEIs that have successfully been 
applied for the transfection of various cell lines in vitro (see Chapter 5). Their efficacy was 
nearly by 3-fold higher than that of branched PEI (BPEI) 25 kDa and linear PEI (LPEI) 22 
kDa, which have become benchmarks for newly synthesized polymers. The next step was to 
evaluate their gene transfer ability in human primary cells in vitro. Primary cells should be 
more representative of the in vivo situation than transformed cell lines and would better 
predict limitations to gene transfer in vivo. We chose two different test systems, namely 
denritic cells (DCs) and chondrocytes. In contrast to cell lines that are permanently dividing, 
DCs are terminally differentiated and non-dividing (for reviews, see [1,2]), while human 
chondrocytes still have the ability for proliferation [3], but their mitogenic activity is limited. 
Furthermore, both cell types are interesting candidates concerning a therapeutic application as 
described below. 
The polymer-based carrier system has to navigate multiple obstacles to perform nucleic acid 
delivery. After condensing the DNA into polyplexes allowing for cellular uptake, the polymer 
should guide the nucleic acid safely through the endo-lysosomal compartment, and finally to 
the nucleus to be transcribed [4-7]. In cell lines, the endo-lysosomal escape and translocation 
to the nucleus seem to be a limiting step, but not the uptake of polyplexes [5,8,9]. In contrast, 
it was described that using cationic lipids as carrier systems, the uptake of plasmid DNA into 
differentiated primary cells severly restricts gene transfer [10,11]. Therefore, a second subject 
of this study was to test whether this is also true for polymers. We used the colon carcinoma 
cell line HT-29 as a model for ‘hard-to-transfect’ cells and measured the amount of 
internalized plasmid DNA. 
*  	
	

('
Dendritic cells 
DCs are unique antigen-presenting cells (APCs) with the competence to induce a primary 
immune response by transferring information from the outside world to the adaptive immune 
response (for reviews, see [2,12,13]). They originate from the bone marrow and their 
precursors home via the bloodstream to almost all organs, where they can be found in an 
immature state with high endocytotic and phagocytic capacity. This has lead to considerable 
interest in the application of DCs and DNA vaccines as tools for immunotherapy in the field 
of cancer and infectious diseases [2,14-17]. However, the development of effective DC-based 
vaccines requires their genetic manipulation. 
The situation is rather complicated (for reviews, see [2,13]), but in short, DCs respond to 
DNA vaccines in two ways: by inducing both cellular and humoral immune responses. The 
cell-mediated immune response to DNA vaccines results from the uptake of plasmid DNA 
into DCs in vitro or in vivo, where the expression of the target antigen gene occurs. 
Fragments of the resulting proteins bind to class I MHC molecules. The presentation of these 
MHC-bound peptides on the cell surface stimulates CD8 T cells which are cytotoxic and have 
the machinery to destroy the infected cell. The humoral-mediated response occurs if the 
synthesized proteins are released and engulfed by APCs. In this case, the proteins are 
degraded in the class II pathway and presented to helper T cells. These secrete lymphokines 
that aid B cells to produce antibodies. A cross-priming and hence class I presentation of 
exogenous antigens is also possible. 
DCs can be generated in sufficient numbers from circulating precursors, such as peripheral 
blood monocytotic cells (PBMCs) and CD34+ stem cells, in the presence of cytokine 
cocktails [17]. Of particular interest are the more abundant CD14+ PBMCs, which 
differentiate on culture in the presence of granulocyte-macrophage colony stimulating factor 
(GM-CSF) and interleukin-4 (IL-4) to immature DCs (iDCs), defined in part by their high 
antigen uptake. Further induction by inflammatory stimuli (for example bacterial DNA, 
lipopolysaccharide, double-stranded DNA) or transfection results in the expression of DC 
maturation markers. The mature DCs (mDCs) are more potent T cell stimulators than iDCs, 
but have reduced phagocytic and endocytic activities [1,2,13]. 
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Figure 1: Generation of human DCs from peripheral blood CD14+ mononuclear cells 
(PBMCs) when cultured in the presence of GM-CSF and IL-4. Immature DC (iDCs) can be 
further induced by inflammatory stimuli or transfection to mature DCs (mDCs). Human DC 
are characterized by the surface expression. The DC phenotype varies with different stages of 
maturation and differentiation. CD1a is preferentially expressed on human iDC. Antibodies 
to CD83 react with mDCs, which also express high levels of costimulatory molecules such as 
CD80 or CD86 and adhesion molecules including MHC I. 
Chondrocytes 
Chondrocytes populate the articular cartilage at low density. Certain concepts for repairing 
articular cartilage lesions employ a cell-based therapy (for review, see [18]), in which the 
initial healing response is, in part, mediated and dependent on signalling polypeptides. A 
major challenge is an appropriate delivery system for these therapeutic agents, because 
experiments in vitro and in vivo require relatively large, often repeated doses (for review, see 
[19]). Genetically engineered chondrocytes may be used as factories for the sustained protein 
production (for review, see [20]). 
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Materials were purchased from Sigma-Aldrich Chemie GmbH (Germany) unless otherwise 
stated. 
DC preparation and cell culture 
DCs were generated as desribed with slight modifications [21,22]. Briefly, PBMCs were 
isolated from buffy coat preparation of healthy donors by Ficoll density centrifugation 
(density of 1.077 g/cm3) in Leucosep® Separation Falcon tubes (Greiner Bio-One GmbH, 
Germany). CD14+ monocytes were enriched by magnetic cell sorting using the MACS system 
and MACS CD14 MicroBeads (both Milteny Biotec, Germany) according to the 
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manufacturer´s protocol. Monocytes were cultured for 6 days in RPMI 1640 medium 
containing 10% FBS, 2 mM glutamine (all Biochrom GmbH, Germany), non-essential amino 
acids, pyruvate, β-mercaptoethanol, penicillin/streptomycin (all Invitrogen, Germany). GM-
CSF (Leucomax®) and IL-4 (Sigma, Germany) were added to the culture medium at 
concentrations of 500 U/ml. At days 3 and 5 culture medium was refreshed and at day 5 cells 
were transfected with polyplexes as desribed below. 
Human chondrocytes in passage 2 were a kind gift from the HNO clinic (University of 
Regensburg). They were maintained in DMEM  (4.5 g/l glucose) supplemented with 1% 
HEPES, 1% non-essential amino acids, 1% penicillin/streptomycin (all Invitrogen GmbH, 
Germany), 0.1 % proline, 0.1% ascorbic acid and 10% FBS (Biochrom AG, Germany). 
Chinese hamster ovarian cells (CHO-K1; ATCC No. CCL-61) were grown in culture medium 
consisting of Ham´s F-12 supplemented with 10% FBS (Biochrom AG, Germany). HT-29 
cells (ATCC No. HTB-38) were grown in McCoy´s modified 5A medium supplemented with 
10% FBS. All cells were incubated at 37°C in a 5% CO2 humidified environment. 
Non-viral carriers 
Biodegradable PEIs were obtained by crosslinking LPEI with a MW of 2.1 kDa [23] with 
Lomant´s reagent. The four resulting polymers had a different degree of branching and a 
slightly increasing MW with increasing linker/polymer proportion. Polymers are denoted as 
follows: LRx-LPEI, where x indicates the percentage of linker compared to the polymer 
starting material. Polymer stock solutions for LR-LPEIs were prepared with 150 mM NaCl, 
the pH of LPEI solutions was adjusted to 7 and then filtered (0.2 µm filter, Corning GmbH, 
Germany). ExGen 500 was obtained from MBI Fermentas GmbH (Germany). 
Plasmid isolation and labeling 
Plasmid encoding enhanced green fluorescent protein (EGFP) (Clontech, Germany) was used 
as reporter gene in this study. Plasmid was isolated from E. coli by using a Qiagen Plasmid 
Maxi Kit (Qiagen GmbH, Germany) according to the supplier´s protocol. 
When indicated, plasmid DNA was either covalently labeled with Alexa Fluor 546 according 
to the manufacturer´s protocol (ULYSIS Nucleic Acid Labeling Kit, Molecular Probes, The 
Netherlands) or stained with the intercalating dye YOYO-1 (Molecular Probes, The 
Netherlands). The labeling reaction with YOYO-1 was carried out with a molar ratio of 1 dye 
molecule per 320 base pairs at room temperature in the dark. 
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Preparation of polyplexes 
Polyplexes were prepared at NP ratio (nitrogens in polymer to phosphates in DNA) of 6, 12, 
18 and 24. Unless otherwise stated, polyplexes were formed by mixing 2 µg DNA with the 
appropriate amount of polymer solution and diluting to 50 µl with 150 mM NaCl. The 
resulting polyplexes were incubated for 20 minutes at room temperature before use. The 
notation of polyplexes was made as follows: LR1-LPEI - polyplexes indicates that polyplexes 
were formed with LR1-LPEI.  
Transfection experiments 
For gene transfer studies, cells were grown in 24-well plates at an initial density of 38,000 – 
100,000 cells per well, depending on each cell type. The prepared polyplexes were added to 
cells in 900 µl serum-free or -containing medium. After 4-6 hours, the medium was replaced 
with 1 ml of culture medium. Analysis of transfection efficiency and cell viability was 
performed by flow cytometry 24 hours later as described previously [24,25]. Briefly, 
measurements were taken on a FACSCalibur (Becton Dickinson, Germany) using CellQuest 
Pro software (Becton Dickinson, Germany) and WinMDI 2.8 (1993-2000 Joseph Trotter). 
EGFP positive cells were detected using a 530/30 nm band-pass filter, whereas the propidium 
iodide emission was measured with a 670 nm longpass filter. In a density plot representing 
forward scatter against sideward scatter, whole cells were gated out and depicted in two-
parameter dot plots of EGFP versus propidium iodide to analyse the measurements. The 
EGFP positive region corresponded to the transfection efficiency. Further, the number of 
propidium iodide negative cells was counted as a measure of cell viability. 
Intracellular trafficking of polyplexes - confocal laser scanning microscopy 
(CLSM) 
A Zeiss Axiovert 200 M microscope coupled to a Zeiss LSM 510 scanning device (Carl Zeiss 
Co. Ltd., Germany) was used for CLSM experiments. The inverted microscope was equipped 
with a Plan - Apochromat 63x objective. Cells were plated in 8 – well Lab-TekTM Chambered 
Coverglass (Nunc GmbH & Co. KG, Germany) at an initial density of 35,000 cells / chamber 
in a volume of 400 µl culture medium. For maintaining a pH of 7.4, 20 mM HEPES 
(Invitrogen, Germany) was supplied. After 18 hours, polyplexes were added and 
measurements were directly performed in each well at 37°C. The thickness of the optical 
sections was between 0.7 and 1.2 µm. 
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For the investigation of the intracellular trafficking of polyplexes, YOYO-1 was excited with 
a 488 nm argon laser and images were taken using a band-pass filter of 505 – 530 nm at the 
indicated times after the addition of the polyplexes. Alexa Fluor 546 - labeled plasmid DNA 
was excited at 543 nm and the fluoresecence was recorded with a 560 nm longpass filter. 
Isolation of plasmid DNA from whole cells and determination by real-time PCR 
After 6 hours of transfection with LR-LPEI - polyplexes and subsequent to washing with 
CellScrub buffer (PEQLAB Biotechnologie GmbH, Germany), intracellular plasmid DNA of 
attached CHO-K1 or HT-29 cells (same initial cell density) was isolated according to the 
following procedure: Cells were resuspended in a buffer containing 50 mM Tris-HCl, 10 mM 
EDTA and 100 µg/ml Rnase A. Thereafter, the same volume of lysis solution (200 mM 
NaOH, 1% SDS) was added for 5 minutes at room temperature. The reaction was stopped by 
neutralization with 3 M potassium acetate, pH 5.5. After centrifugation at 12,000 rpm, 
plasmid DNA in the supernatant was precipitated, washed with 70% ethanol and resuspended 
in H20. The solutions of three samples were pooled for real-time PCR. 
Real-time PCR was performed in a Light Cycler (Roche Applied Biosciences, Germany). The 
diluted templates were mixed with PCR master mix consisting of QuantiTectTM SYBR® 
Green PCR (Qiagen, Germany) and 10 pmol of each primer pair. The forward primer (5´-
ACG TAA ACG GCC ACA AGT TC-3´) and the reverse primer (5´- AAG TCG TGC TGC 
TTC ATG TG-3´) amplified a 187-bp fragment of the pEGFP-N1 plasmid. The absolute 
amount of target nucleic acid was determined with pEGFP-N1 as external standard. The 
amplification program consisted of 1 cycle at 95°C for 15 min, followed by 45 cycles with a 
denaturing phase at 95°C for 15 s, an annealing phase of 20 s at 58°C, and an elongation 
phase at 72°C for 20 s. A melting curve analysis was performed in order to verify specifity 
and identify the PCR products. 
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Transfection of DCs and chondrocytes 
After 5 days of cultivation in the presence of GM-CSF and IL-4, the proportion of iDCs in the 
whole cell population was determined to be 94% by flow cytometry after staining with 
fluorescein-conjugated anti-CD1a antibody. Furthermore, 24 hours after transfection, over 
90% of cells exhibited the surface markers CD80 and CD86, which is indicative of a 
successful maturation to mDCs (data not shown). 
Because of limitations in the cell source, only few conditions were tested in this experimental 
setup. Using LR3-LPEI for complex formation the number of EGFP positive cells increased 
with the amount of plasmid DNA in polyplexes to a maximum of 2.65% and the cell viability 
was similar compared to untreated cells. The efficacy of LPEI 22 kDa (ExGen®) resembled 
LR3-LPEI, but the linear polymer was by three-fold more toxic as compared to the 
biodegradable form of PEI. 
The cytotoxicity appears to depend to a large extent on the donor of PBMCs, because the 
transfection efficiency of LR3-LPEI (2 µg plasmid DNA) was reproducible in three 
independent experiments, but the cytotoxicity only twice. In the third experiment the toxicity 
increased up to about 30% (data not shown). 
Table 1: Transfection efficiency of LR3-LPEI or ExGen® complexed with pEGFP-N1 at NP 
18 in DCs. Values represent the EGFP positive or dead cells as means ± SD (n=2). 
Polyplex type Transfection Efficiency [%] Toxicity [%] 
LR3-LPEI (1 µg plasmid DNA) 0.45 ± 0.21 6.37 ± 0.76 
LR3-LPEI (2 µg plasmid DNA) 0.64 ± 0.32 8.63 ± 0.53 
LR3-LPEI (3 µg plasmid DNA) 2.65 ± 0.10 13.56 ± 0.45 
ExGen® (2 µg plamid DNA) 2.32 ± 0.23 28.92 ± 2.01 
Untreated Cells 0.10 ± 0.05 12.73 ± 1.89 
 
To get a better insight into the transfection process, polyplexes were fluorescently labeled and 
observed by CLSM during incubation with DCs. During maturation, DCs lost their 
charcteristic spiky arms, assumed a spherical shape and formed large colonies (Figure 2A). 
This process was nearly completed after three hours of transfection as observed by 
microscopy (data not shown). LR3-LPEI - polyplexes appeared to be associated with the 
surface of some round DCs, but not internalized. Presumably, the passage to the center of the 
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colonies was obstructed to the polyplexes. Examining the cells by 3D confocal z-image 
stacks, this observation could not be confirmed for certain, because it was difficult to 
distinguish the cell exterior from interior in transmitted light images (Figure 2 B). 
 
A
 
B
 
Figure 2: A: Incubation of DCs with LR3-LPEI - polyplexes at NP 18 labeled with Alexa 
Fluor 546 (indicated by red dots). The bar indicates 20 µm. B: The cells were examined by 
3D confocal z-image stacks to evaluate the location of polyplexes with regard to the cells. 
Pictures are an overlay of transmitted light and fluorescence images. 
Transfection of chondrocytes 
Human chondrocytes were more susceptible to PEI-based transfection, but the overall 
efficacy was lower than in the cell lines tested in Chapter 5. The transfection efficiency could 
again be modulated by the NP ratio and the degree of branching of the polymer. The 
maximum transfection efficiency of about 9% was obtained with LR4-LPEI at NP 12 (Figure 
3). The cell viability did not dip below 90% at any NP ratio tested (data not shown). 
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Figure 3: Transfection efficiency of LR3-LPEI ( ) and LR4-LPEI ( ) complexed with 
pEGFP-N1 at various NP ratios in human chondrocytes of passage 3. Values represent the 
EGFP positive cells as means ± SD (n=4). 
Transfection and uptake of polyplexes in HT-29 cells 
To test whether the uptake may be a limiting step in the transfection process as it is reported 
for certain lipids such as DMRIE-DOPE or LipofectACE® [10,11], HT-29 cells were chosen 
as a model because of ease of maintainance and better availability compared to DCs. The 
transfection efficiency seemed to increase with the degree of branching of PEI and was 
similar as obtained in DCs (Table 2). Furthermore, the shape of HT-29 cells is similar to that 
of to mDCs and at high densities they preferentially grew in colonies (images not shown). 
Table 2: Transfection efficiency and cytotoxicity of various LR-LPEIs, crosslinked with 1 to 
4% linker, complexed with pEGFP-N1 at NP 18 in HT-29 cells. Values represent the EGFP 
positive or viable cells compared to untreated cells as means ± SD of one representative 
experiment (n=4). 
LR-LPEI type Transfection Efficiency [%] Toxicity [%] 
LR1-LPEI 0.23 ± 0.08 10.31 ± 0.33 
LR2-LPEI 0.48 ± 0.11 12.51 ± 0.52 
LR3-LPEI 1.54 ± 0.15 16.88 ± 1.29 
LR4-LPEI 3.66 ± 0.52 19.41 ± 1.13 
Untreated Cells 0.09 ± 0.03 10.06 ± 0.88 
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To study the uptake in HT-29 cells, polyplexes were labeled with YOYO-1 and observed by 
CLSM during incubation. In CHO-K1 cells, which were used as positive control, polyplexes 
were dispersed over the cytosol of cells after 5 hours of incubation (Figure 4 A). The larger 
green dots were polyplex aggregates that were not taken up by cells. In contrast, the 
polyplexes seemed only losely attached to HT-29 cells as shown for DCs (Figure 4 B). 
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Figure 4: Uptake of LR3-LPEI - polyplexes at NP 18 labeled with YOYO-1 in CHO-K1 (A) 
and HT-29 (B) cells five hours post transfection as examined by CLSM five hours after 
transfection. Pictures are an overlay of transmitted light and fluorescence images. Each bar 
indicates 10 µm. 
To document the CLSM images with data, plasmid DNA taken up by the cells was isolated 
after 6 hours and quantified by real-time PCR. As carrier molecules for plasmid DNA transfer 
into cells, various LR-LPEIs, crosslinked with 1 to 4% linker, were used at NP 18. 
Irrespective of the polymer tested, the amount of plasmid DNA isolated from CHO-K1 cells 
was a multiple higher compared to HT-29 cells (Figure 5). 
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Figure 5: Plasmid DNA isolated after 6 hours of transfection from an aliquot of CHO-K1 ( ) 
or HT-29 ( ) cells with various LR-LPEI - polyplexes (as indicated in the legend) at NP 18. 
The absolute amount of target nucleic acid after 6 hours of transfection was determined with 
pEGFP-N1 as external standard in a Light Cycler. 
To test the effectivity of plasmid DNA in HT-29 cells compared to CHO-K1 cells as positive 
control, the ratio of plasmid DNA taken up or the transfection efficiency, respectively, 
between CHO-K1 and HT-29 cells was calculated. The ratio of plasmid DNA taken up 
(CHO-K1/HT-29) varied with the polymer used for transfection (Table 3). The ratio first 
increased with the degree of branching of LR-LPEI, but then decreased with LR4-LPEI as 
carrier molecule below the ratio of LR1-LPEI. The ratio of transfection efficiency (CHO-
K1/HT-29) depended also on the LR-LPEI type and was much higher than the ratio of the 
uptake (Table 3). 
Table 3: The ratio of plasmid DNA taken up (column 2) and transfection efficiency (column 
3) between CHO-K1 and HT-29 cells after transfection with various LR-LPEIs at NP 18. 
LR-LPEI type 
Plasmid DNA taken up 
(CHO-K1 / HT-29) 
Transfection efficiency 
(CHO-K1 / HT-29) 
LR1-LPEI 8.5 ~ 22 
LR2-LPEI 14.9 ~ 80 
LR3-LPEI 21.8 ~ 41 
LR4-LPEI 4.4 ~ 19 
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Substantial effort has been devoted towards the development of efficient polymers for nucleic 
acid delivery. Non-viral carriers are typically safer but much less efficient than viruses. In 
addition, many polymers still exhibit significant cytotoxicity in various cells. Biodegradable 
PEIs (Chapter 5) were the first delivery systems that enabled a remarkably high transfection 
efficiency simultaneously with a high cell viability. This study aimed at testing the 
functionality of biodegradable PEI - polyplexes in human primary cells, namely DCs and 
chondrocytes. 
The transfection efficiency of biodegradable PEI-based polyplexes seemed to depend on the 
mitogenic activity of cells, because the number of EGFP positive cells decreased in the 
following order: permanently dividing cell lines (Chapter 5) > human chondrocytes > human 
DCs. This implies that biodegradable PEIs have improved nuclear import characteristics 
compared to other polymer-based delivery systems, because they are capable of transfecting 
non-dividing cells, but nevertheless the breakdown of the nuclear envelope favors gene 
transfer. 
Various attemps have been undertaken in order to transfect DCs with polymer- and lipid-
based gene delivery systems or even by electroporation, however, only with limited success. 
The amount of transfected monocyte-derived DCs did not exceed 1-5%, and was also 
accompanied by a high cytotoxicity [26,27]. Therefore, biodegradable PEI-based polyplexes 
are a good basis for further optimization because they are accompanied by a very low 
cytotoxicity. A first step towards this direction would be to enhance the cellular uptake of 
polyplexes. For example, the attachment of mannose to PEI-based polyplexes and taking 
advantage of receptor-mediated endocytosis slightly improved the transfection efficiency in 
DCs [28,29]. Furthermore, the strategy of using immunolipoplexes containing anti-CD71 or 
anti-CD205 monoclonal antibodies has been shown to be more effective compared to 
unmodified lipoplexes: up to 10% mDCs, and up to 20% iDCs could be transfected, but the 
cellular toxicity also ranged from 20 to 70% depending on the lipid for immunolipoplex 
formation [27]. 
The efficacy in human chondrocytes was acceptable, but can most likely be vastly improved. 
Using FuGENE6 (other lipid-based reagents, such as TransFast and LipofectAmine, failed to 
transfect chondrocytes) the transfection efficiency could be augmented from 9 up to about 
40% after treatment with hyaluronidase in order to make the extracellular matrix more 
permeable to the transfection agent [30-34]. Therefore, future studies will test whether this is 
also true for biodegradable PEI - polyplexes. 
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DCs are expensive to maintain and not available in a high quanities, thus, HT-29 cells were 
used as a model to test whether the uptake is one of the limiting steps in the transfection of 
‘hard-to-transfect’ cells. HT-29 cells were chosen because the transfection efficiency and 
cytotoxicity were similar to DCs and CLSM pictures indicated similar cell shape and uptake 
of polyplexes. Quantification of intracellular plasmid DNA in HT-29 cells revealed up to 21-
fold lower levels than CHO-K1 cells that were used as positive control. For the first time, it 
was demonstrated that the uptake using polymers for gene delivery may be one of the limiting 
steps in ‘hard-to-transfect’ cells. Moreover, the plasmid DNA taken up by HT-29 cells was 
less efficient, because the ratio of the uptake (CHO-K1/HT-29) was lower than the ratio of 
the transfection efficiency (CHO-K1/HT-29). This is due to the fact that endo-lysosomal 
escape and nuclear entry are further limiting steps in non-viral gene transfer.  
Concluding, for further improvement of non-viral gene delivery systems, much more effort 
should be made to transfer nucleic acids into ‘hard-to-transfect’ cells. It is our opinion that 
solving the problem will require the design of “intelligent” polyplexes. A first step would be 
to enhance their cellular uptake by attaching appropriate signalling sequences, such as the 
TAT peptide, to their surface [35,36]. TAT peptides derived from the HIV-1 TAT protein 
have been shown to facilitate intracellular delivery of proteins and small colloidal particles 
and also relatively large drug carriers, such as 200-nm liposomes [37]. 
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For non-viral gene delivery, the carriers for DNA transfer into cells must be vastly improved. 
The branched cationic polymer polyethylenimine has been described as an efficient gene 
carrier. However, polyethylenimine was demonstrated to mediate substantial cytotoxicity. 
Therefore, this study aimed at investigating per-N-methylated polyethylenimine, which is 
thought to have a much lower cytotoxicity due to its lower charge density. Results from a gel 
retardation assay and laser light scattering indicated that per-N-methylated polyethylenimine 
condenses DNA into small and compact nanoparticles with a mean diameter < 150 nm. 
Furthermore, polyplexes of polyethylenimine and per-N-methylated polyethylenimine with 
DNA had a positive zeta potential and the polymers protected DNA from nuclease-mediated 
digestion. The transfection efficiency of polyethylenimine and per-N-methylated 
polyethylenimine was tested in CHO-K1 cells. Using green fluorescent protein as reporter 
gene and flow cytometry analysis, we demonstrated that per-N-methylated polyethylenimine 
has a lower cytotoxicity, but also a significantly lower transfection efficiency. Using 
propidium iodide staining, we could additionally distinguish between viable and dead cells. 
At NP≥12, per-N-methylated polyethylenimine showed a much higher cell viability and the 
ratio of viable and transfected cells to dead and transfected cells was about 1.5 to 1.7 fold 
higher than for polyethylenimine. The results of cell viability from flow cytometry analysis 
were confirmed by the MTS assay. Using luciferase reporter gene for transfection 
experiments, the gene expression of per-N-methylated polyethylenimine was lower at NP 6, 
12 and 18 as compared to polyethylenimine, but at NP 24 it yielded similar levels. 
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In recent years, gene therapy research has become a scientific discipline with great potential 
for the treatment of genetic and acquired diseases, including cystic fibrosis and some 
cardiovascular disorders [1,2]. The basic principle of gene therapy is to deliver genetic 
material (DNA or RNA) to cells either to stimulate the production of lacking gene products or 
to turn off certain genes encoding undesirable proteins [3]. 
So far, viral vectors based on adenoviruses and retroviruses have been the most popular 
vehicles for gene transport. They have several great advantages, such as the ability to transfect 
cells of specific tissues and to enter cells easily and are also able to prompt the transcription 
machinery to produce the desired gene products. However, the safety concerns with such viral 
vectors are significant, as they can trigger immunogenic responses and insertional 
mutagenesis. In one gene therapy clinical trial, a patient died due to a severe immune response 
to the virus [4]. In another trial with modified retroviruses as shuttles for genes, one person 
developed cancer caused by the insertion of foreign DNA into his genome [5]. Therefore, 
non-viral delivery systems, even if they have lower transfection efficiencies, should be 
considered to circumvent these risks. 
One non-viral gene delivery strategy involves the use of cationic polymers that can assemble 
with negatively charged DNA into nanoparticles. Polyethylenimine (PEI) is one of the most 
promising polycations currently available for non-viral gene delivery in vivo and in vitro. PEI 
complexes with negatively charged DNA via an electrostatic interaction into polyplexes with 
a mean diameter less than 150 nm [6]. The positive net charge of the complexes, arising due 
to an excess of polymer, allows them to bind to polyanionic components of the cell 
membrane, which leads to endocytosis of the nanoparticles [7]. Due to the fact that PEI is 
only partially protonated at physiological pH, the accumulation of polyplexes in endosomes 
and the subsequent degradation in endolysosomes can be avoided. The ´proton sponge 
mechanism´ hypothesis [8] suggests that PEI will buffer the internal pH in early and late 
endosomes [9]. The protonation most likely triggers a passive chloride influx, which causes 
osmotic swelling with subsequent endosome rupture, releasing the polyplexes into the 
cytoplasm. After nuclear entry of the DNA-polymer nanoparticles, the final step in this 
process is the transcription of the delivered gene and production of the desired gene product. 
Transcription efficiencies of branched PEI with a molecular weight of 25 kDa have been 
reported to be 10 to 20% [10]. 
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Despite its excellent properties, however, PEI is not the ideal transfection agent. Due to its 
high cytotoxicity, host cell viability is strongly reduced. Both membrane permeabilization, a 
consequence of the high charge density, and the complexation of cellular DNA to excess 
polymer contribute to this cytotoxicity [10,11]. Therefore, it would be desirable to develop 
alternative polymers with both lower cytotoxicity and comparable transfection efficiency. 
One approach to decrease the cytotoxicity of PEI is to reduce its cationic charge density. 
Aliphatic amines entail increasing basicity, or charge density, as follows: primary < tertiary < 
secondary amines (10, 30 and 20). Branched PEI (Figure 1, top) with a molecular weight of 25 
kDa consists of 10, 20 and 30 amines [12]. In order to alter the charge density, we synthesized 
per-N-methylated polyethylenimine (mPEI, Figure 1, bottom) [13], a polycationic polymer in 
which all 10 and 20 amino groups of PEI are converted to 30 amino groups. 
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Figure 1: Structure of PEI (left) and mPEI (right). 
Testing mPEI´s ability to build nanoparticles for gene delivery, we investigated its DNA 
complexation capacity and transfection in vitro. Our main goal was to compare the 
cytotoxicity of PEI and its methylated form mPEI. Further, we examined the transfection 
efficiency of both non-viral gene carriers with special interest in the host cell viability 
following transfection. 
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Materials 
Branched PEI (MW = 25 kDa) was used as obtained from Sigma-Aldrich (Taufkirchen, 
Germany). mPEI was prepared by complete reductive methylation of branched PEI 
(Eschweiler-Clark reaction) [13]. Spectra/Por Biotech Membranes with a molecular weight 
cutoff (MWCO) of 8.000 Da were from Kleinfeld Labortechnik (Gehrden, Germany). 
Nutrient Mixture F-12 [Ham] (Ham´s F-12), DNase I, ethidium bromide (EtBr), propidium 
iodide, ampicillin and kanamycin were all purchased from Sigma-Aldrich (Taufkirchen, 
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Germany). pGL3-Enhancer vector, Luciferase Assay System, E. coli JM109 and CellTiter 
96® AQueous One Solution Cell Proliferation Assay were commercially obtained from 
Promega (Mannheim, Germany). pEGFP-N1 was from Clontech (Heidelberg, Germany). For 
transfection and cytotoxicity experiments, CHO-K1 cells (ATCC No. CCL-61) were used. 
Qiagen Plasmid Maxi Kit was from Qiagen (Hilden, Germany). Fetal bovine serum (FBS) 
was supplied by Biochrom KG seromed (Berlin, Germany). Agarose, PBS and LB broth 
medium were purchased from Invitrogen GmbH (Karlsruhe, Germany). Serva Blue G 250 
was from Serva Electrophoresis GmbH (Heidelberg, Germany). 0.2 µm membrane filters 
were obtained from Corning GmbH (Wiesbaden, Germany). All other solvents and chemicals 
were purchased in analytical grade from Sigma-Aldrich (Taufkirchen, Germany). 
Cell culture 
CHO-K1 cells were grown in 75 ml culture flasks containing 10 ml Ham´s F-12 
supplemented with 10% FBS in a 5% CO2 atmosphere at 37°C as adherent culture to 90% 
confluency before seeding. Culture medium (Ham´s F-12 supplemented with FBS) was 
changed every 3 days and cells were passaged roughly once a week. 
Non-viral carriers 
PEI was used without further purification, while mPEI was dialyzed against ddH2O using 
Spectra/Por Biotech Membranes with a MWCO of 8 kDa. Both polymer stock solutions 
were prepared with 150 mM NaCl at a concentration, such that 1 µl would contain as much 
nitrogens as 2 µg plasmid DNA would have phosphates (NP ratio = 1, where NP indicates the 
ratio of the number of nitrogens in polymer to the number of phosphates in DNA). The pH of 
PEI and mPEI solution was adjusted to 7 and then the solutions were filtered through a 0.2 
µm filter. 
Amplification and purification of plasmid DNA 
Plasmids encoding firefly luciferase (pGL3-enhancer vector) and GFP (pEGFP-N1) were 
used as reporter genes in this study. The plasmids were transformed into E. coli JM109 
bacterial strain. The transformed cells were expanded in LB broth medium supplemented with 
either ampicillin for pGL3-enhancer vector or kanamycin for pEGFP-N1. Plasmids were 
isolated by using a Qiagen Plasmid Maxi Kit according to the supplier´s protocol. The 
concentration and purity of the DNA were measured by UV absorption at 260 and 280 nm. 
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Gel retardation assay 
For evaluating the polymers´ complexation capacity, polyplexes were prepared at various NP 
ratios ranging from 0 to 5 in 150 mM NaCl by adding polymer solution to 1 µg reporter 
plasmid and incubated for 20 minutes at room temperature. The samples were loaded onto a 
0.8% agarose gel in Tris-borate buffer and run at 80 V for 1.5 h. DNA was visualized with 
EtBr staining on a UV transilluminator. 
Size and zeta potential measurements 
The effective hydrodynamic diameter, polydispersity indices and zeta potential of DNA-
polymer complexes were determined by using a Malvern ZetaSizer (Model 3000 HSA, 
Malvern Instruments GmbH, Germany). Samples were prepared at various NP ratios as 
follows: 10 µg plasmid DNA and the appropriate amount of polymer were each diluted in 250 
µl of 50 mM NaCl / 3.3% glucose or 150 mM NaCl and mixed by vortexing. The complexes 
were allowed to form for 20 minutes at room temperature. After the polyplex solution was 
diluted to a final volume of 2 ml with ddH2O, laser light scattering analyses were performed 
at 25°C with an incident laser beam of 633 nm at a scattering angle of 90°. The zeta potential 
of the polyplex solution was determined by measuring the electrophoretic mobility. The 
polyplex building and measurements were reproduced in triplicate. 
DNase I digestion 
The reaction compound consisted of either naked DNA or polyplexes at a NP ratio of 10, 
digestion buffer pH 8 (20 mM MgSO4) and DNase I solution. After 3 minutes at room 
temperature the digestion was halted by the addition of stop solution (0.2 M EDTA, 0.7 N 
NaOH) [14]. The integrity of the plasmid was examined by loading the samples on a 1% 
alkaline agarose gel containing EtBr. The gels were run at 60 V for 1 hour. 
Transfection experiments 
For gene transfer studies CHO-K1 cells were grown in 24-well plates at an initial density of 
40.000 cells per well. 20 hours after plating, the culture medium was replaced with 900 µl of 
serum-free medium. Polyplexes were prepared by mixing 50 µl of DNA (0.4 µg/µl pEGFP-
N1 or pGL3-enhancer vector) and 50 µl of polymer solution. Plasmid DNA and polymer were 
each diluted in 150 mM NaCl unless otherwise indicated. The solutions containing the 
polyplexes were incubated for 20 minutes at room temperature and then added to the cells. 
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After 4 hours, the transfection medium (serum-free medium containing polyplexes that were 
not taken up by cells) was replaced with 1 ml of culture medium. 
48 hours later, cells transfected with pEGFP-N1 were prepared for FACS (fluorescence 
activated cell sorting) analysis. Floating cells were collected and combined with trypsinized, 
adherent cells. The pooled cells were washed twice with 1 ml PBS, resuspended in 500 µl 
PBS and propidium iodide was added at a concentration of 1 µg/ml. Measurements were 
taken on a FACSCalibur (Becton Dickinson, Germany) using CellQuest Pro software (Becton 
Dickinson, Germany) and WinMDI 2.8 (1993-2000 Joseph Trotter). GFP positive cells 
were detected using a 530/30 nm bandpass filter, whereas the propidium iodide emission was 
measured with a 670 nm longpass filter. Logarithmic amplification of GFP and propidium 
iodide emission in green and red fluorescence was obtained with 20.000 cells counted for 
each sample. Two-parameter dot plots of GFP versus propidium iodide were used to analyse 
the measurements (Figure 2). The GFP positive region was drawn starting above cell 
autofluorescence, where GFP positive cells were < 0.2%. Dot plots were thereby divided in 
four quadrants: For evaluating transfected and viable cells, respectively transfection 
efficiency, cells in the upper left (UL) quadrant were determined. Transfected and dead cells 
were assesed counting events in the upper right quadrant (UR), viable cells were determined 
by the number of propidium iodide negative cells in the upper left and lower left quadrants 
(UL, LL). 
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Figure 2: FACS analysis: FL3-H assessed at 670 nm represents viability, FL1-H indicates 
GFP fluorescence intensity at 530 nm. Transfected and viable cells appear in the upper left 
(UL) quadrant, whereas transfected and dead cells appear in the upper right (UR) quadrant. 
Viable cells are determined by the number of propidium iodide negative cells in the upper left 
(UL) and lower left (LL) quadrants. Dead and non-transfected cells are shown in the lower 
right (LR) quadrant. 
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Cells transfected with pGL3-enhancer vector were lysed and analysed for luciferase activity 
by photon counting (Lumat LB 9507, Berthold, Germany) by using the Luciferase Assay 
System kit according to the supplier´s protocol. Total protein content was determined by 
Bradford assay [15]. Results were expressed as relative light units (RLU) per mg of protein. 
Cell viability 
Cell viability was evaluated using the CellTiter 96® AQueous One Solution Cell Proliferation 
Assay. Cells were seeded into 96-well plates at a density of 7.000 cells per well. 20 hours 
after seeding, polymer or prepared polyplexes (the amount of plasmid DNA was adjusted to 
the concentration of transfection experiments) diluted in 100 µl of serum-free medium were 
added to the cells, followed by incubation for 4 hours. The medium was then removed and 
replaced with culture medium. Cells were further incubated for 24 hours. Thereafter, 20 µl of 
Cell Titer 96® AQueous One Solution containing the tetrazolium compound MTS [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium-inner 
salt] was added into each well [16,17]. After 3 hours at 37°C in a humified 5% CO2 
atmosphere the amount of soluble formazan produced by cellular reduction of MTS was 
quantified by recording the absorption at 490 nm (Microplate Reader, ICN-Flow, Bartolomey 
Labortechnik, Germany). The relative cell viability was calculated according the following 
equation:  
Cell viability [%] = (OD490 sample / OD490 control) x 100. 
OD490 sample represents the wells treated with polymer or polyplexes and OD490 control is the 
measurement from wells treated with culture medium only. 
Statistics 
Statistical significance was assessed by one-way analysis of variance (ANOVA) followed by 
Tukey´s post-hoc test. Significance level was set as indicated. 
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Gel retardation assay 
The capacity of PEI and mPEI to form complexes with plasmid DNA was examined in a gel 
retardation assay with EtBr as a probe. This assay is a first indicator for the appropriate 
nanoparticle composition and the NP ratio at which polyplex building occurs. The interaction 
of the cationic polymer and negatively charged DNA was determined by retardation of the 
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electrophoretic mobility of DNA and finally at a polymer excess by displacement of the 
intercalated dye EtBr from the double helix accompanied by a quenching of EtBr fluorescene. 
Figure 3 illustrates a typical result of a gel retardation assay for PEI (top) and mPEI (bottom). 
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Figure 3: Plasmid DNA complexation capacity of PEI (top) and mPEI (bottom) at different 
NP ratios examined in a gel retardation assay. For each sample, 1 µg DNA was used and 
illuminated by ethidium bromide staining. 
Uncomplexed DNA (denoted by NP 0 in Figure 3) migrated normally into the gel, while 
increasing amounts of polycationic PEI and mPEI retarded movement of the DNA through the 
gel as a consequence of partial neutralization. Figure 3 also shows that PEI-DNA 
nanoparticles are neutral at NP 2 – 2.5, as DNA did not migrate in the electric field, whereas 
nanoparticles with mPEI are neutralized at NP 2.5. Further increase of polymer concentration 
reduced the intensity of EtBr fluorescence reflecting the formation of compact nanoparticles. 
When PEI was used as the complexing polycation, no DNA was visible at NP 3.5; polyplexes 
of mPEI and plasmid DNA completely quenched EtBr fluorescence first at NP 5. These 
results indicate that both polymers allow a sufficient plasmid DNA complexation and that 
mPEI due to its lower charge density, respectively less nitrogens protonated at pH 7, forms 
compact nanoparticles at higher NP ratios (NP ≥ 5) than PEI (NP ≥ 3.5). 
Size and zeta potential measurements 
The hydrodynamic diameter of nanoparticles to be ingested by cells via endocytotic vesicles 
should be smaller than 150 nm [18]. Therefore, it was important to verify, whether the 
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reduction of cationic charge density by methylation of PEI still allowed for the formation of 
small nanoparticles. 
The mean diameter of the polyplexes was dependent on the polymer, NP ratio and the ionic 
strength of the medium. When PEI was used as a nanoparticle forming agent, polyplexes built 
in 50 mM NaCl / 3.3% glucose were smaller than 150 nm in mean diameter at NP ratios 
ranging from NP 6 to 20 (Figure 4). Increasing amounts of PEI (NP ≥ 10) additionally 
reduced the size of the polyplexes from 150 to 100 nm. Generally, as Figure 4 shows, mPEI 
forms larger nanoparticles, especially at a NP ratio of 6, although at higher NP ratios (NP ≥ 
8), mPEI can condense plasmid DNA into polyplexes with a mean diameter ranging from 120 
– 140 nm. Laser light scattering analysis also measures a polydispersity index (PI) ranging 
from 0 up to 1.0 for determining the homogeneity of the size distribution. A PI of 0 denotes a 
completely monomodal size distribution, an inhomogenous sample with a wide distribution of 
nanoparticles is indicated by a PI of 1.0. With the exception of NP 6, PIs of polyplexes 
formed with mPEI have a lower value than the ones with PEI suggesting a narrower size 
distribution. 
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Figure 4: Effective size and polydispersity (PI) of DNA–polymer complexes formed with PEI 
(  size,  PI) or mPEI (
 
size,  PI) and 10 µg plasmid DNA at various NP ratios in 50 mM 
NaCl / 3.3% glucose. Values are means ± SD of three independent experiments. 
Investigating the influence of increasing the ionic strength of the complex formation medium, 
nanoparticles were produced in the same way with 150 mM NaCl instead of 50 mM NaCl / 
3.3% glucose. At low NP ratios (6, 8 and 10), polyplexes with PEI and mPEI formed in 150 
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mM NaCl were about 50 – 100 nm larger than those formed in 50 mM NaCl / 3.3% glucose, 
whereas at NP ≥ 12, the higher ionic strength only increased the mean diameter about 10 – 20 
nm (data not shown). Hypothetically, nanoparticles built in 50 mM NaCl / 3.3% glucose are 
more compact and smaller, because there are fewer free ions in solution that can interact in 
complex formation. Both types of polyplexes were subjected to transfection experiments (see 
3.4). 
Collectively, the data show that polyplexes formed with PEI and mPEI fulfill the requirement 
of building nanoparticles smaller than 150 nm. PEI, as compared with mPEI, forms smaller 
polyplexes, but in contrast the PIs of polyplexes with mPEI are lower. Despite less protonated 
nitrogens participating in polyplex building, mPEI allows formation of small nanoparticles. 
In order to induce a successful association with the negatively charged plasma membrane and 
to avoid aggregation, the surface charge of polyplexes, or the zeta potential, should be 
positive. 
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Figure 5: Zeta potential of DNA-polymer complexes formed with PEI ( ) or mPEI ( ) and 
10 µg plasmid DNA at various NP ratios in 50 mM NaCl / 3.3% glucose. Values are means ± 
SD of three independent experiments. Zeta potential of PEI-polyplexes is significantly 
different from mPEI-polyplexes at NP 2 (α < 0.01). 
Figure 5 shows that polyplexes of PEI are neutral at NP 2, while mPEI forms neutral 
polyplexes at NP 3. Hence, results of the zeta potential measurement confirmed the gel 
retardation assay: due to its lower basicity, mPEI is first capable of building polyplexes at 
higher NP ratios. With an increasing amount of polymer, the zeta potential yielded up to 30 – 
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40 mV. At NP ratios > 8, the values for the zeta potential of PEI-plasmid DNA plateaued; the 
surface charge of mPEI-DNA polyplexes slightly decreased, but the differences between the 
two were not considerable. Zeta potential of PEI-polyplexes is only significantly different 
from mPEI-polyplexes at NP 2 (α < 0.01). To summarize, the zeta potential of PEI and mPEI 
polyplexes should not result in different interactions with cells. 
DNase I digestion 
In non-viral gene delivery, the cationic polymers not only act as a gene carrier, but they also 
protect plasmid DNA from degradation [14,19]. To evaluate the accessibility of the plasmid 
DNA to nuclease-mediated hydrolysis, complexes were exposed to DNase I [20]. Digestion 
was stopped by addition of an alkaline buffer that also separated the polymer-DNA 
nanoparticles as a consequence of deprotonation of the polymer. 
Both naked DNA and DNA-polymer complexes were subjected to digestion reaction to 
compare stability with and without polymer. For negative control, polyplexes and DNA were 
used and treated in the same procedure as samples but without any enzyme units (Figure 6, 
lanes denoted with 1). As expected, DNA remained intact. Applying 5 enzyme units (Figure 
6, lanes indicated by 2), naked DNA was digested completely, whereas DNA protected with 
PEI was intact. Under the same conditions, DNA complexed with mPEI was slightly 
degraded, as indicated by a dimmer EtBr fluorescence. Serial dilution of the enzyme was 
made. With 2.5 enzyme units (Figure 6, lane 3), naked DNA was still completely degraded, 
but DNA protected with PEI and mPEI remained intact in the same quality. Figure 6, lane 5 
illustrates the samples digested with 0.005 enzyme units. At this enzyme concentration, naked 
DNA survived the digestion reaction. 
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Figure 6: DNase I digestion of plasmid DNA (D) and plasmid DNA-polymer complexes 
illuminated by ethidium bromide staining, P indicates polyplexes formed with PEI, M 
indicates polyplexes formed with mPEI. The numbers denote enzyme units (U) as follows: 1 = 
0 U, 2 = 5 U, 3 = 2.5 U, 4 = 1.25 U, 5 = 0.005 U. 
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Both PEI and mPEI are able to protect DNA from nucleases-mediated digestion, but PEI-
polyplexes have a better stability to higher DNase I concentrations. Whether this difference 
has an effect on polyplex stability in cells is difficult to assess, due to the fact that the 
physiological concentration of nucleases is not known. 
Transfection experiments 
The in vitro transfection ability of the non-viral gene carriers PEI and mPEI was compared in 
CHO-K1 cells with both pEGFP-N1 encoding green fluorescent protein (GFP) and pGL3-
Enhancer vector encoding firefly luciferase. For transfection experiments, NP ratios ≥ 6 were 
selected due to the fact that small polyplexes with a positive zeta potential are formed and 
because ratios ranging from 4.5 to 135 have been reported [8] previously. 
The measurement of the efficiency of pEGFP-N1 delivery utilized a versatile and quantitative 
flow cytometry method that simultaneously elucidates the cellular state of transfected and 
non-transfected cells. This method combines two color fluorescence analysis of GFP and 
propidium iodide in one experiment. The DNA intercalator propidium iodide was used to 
assess plasma membrane integrity and has been established in flow cytometry for the staining 
of dead cells. 
CHO-K1 cells were transfected with polymer-plasmid DNA nanoparticles formed at NP ratios 
of 6, 12, 18 and 24. Figure 7 illustrates that the transfection efficiency, i.e. the percentage of 
viable and transfected cells, of PEI yielded up from 9% (NP 6) to 18% at NP 12, followed by 
a decrease to 9% at NP 24 due to its high cytotoxicity. In contrast, mPEI showed minimal 
transfection ability at a NP ratio of 6. With an increasing amount of polymer, the transfection 
efficiency yielded up to 2.5 - 3% (NP 18). A further increase of mPEI (NP 24) did not 
augment the transfected and viable cells. Transfection efficiencies of the non-viral carrier PEI 
were significantly (α < 0.01) higher than efficiencies of mPEI. 
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Figure 7: Transfection efficiency of the non-viral carriers PEI ( ) and mPEI ( ) with 2 µg 
pEGFP-N1 as reporter gene. Values represent the GFP positive and viable cells as means ± 
SD of one representative experiment (n=3). Transfection efficiencies of PEI are significantly 
different from mPEI, denoted by  (α < 0.01). 
Having a closer look to the cellular state of the transfected cells, the ratio of viable and 
transfected cells (UL quadrant) to dead and transfected cells (UR quadrant) was determined. 
For PEI and mPEI at NP 6 a ratio of 6.8 and 6.5 (Tab. 1) was obtained. 
Table 1: Ratio of viable and transfected cells (UL quadrant) to dead and transfected cells (UR 
quadrant) of the non-viral carriers PEI and mPEI assessed by flow cytometry technique with 
GFP as reporter gene and propidium iodide staining. Values are indicated as means ± SD of 
one representative experiment (n=3). 
Ratio of viable and transfected cells to dead and transfected cells 
NP 
PEI mPEI 
6 6.8 ± 0.8 6.5 ±0.8 
12 4.1 ± 1.4 6.2 ± 0.3 
18 2.7 ± 0.1 4.3 ± 0.6 
24 2.3 ± 0.7 3.9 ± 0.4 
 
With increasing amounts of polymer, the ratio of viable and transfected cells to dead and 
transfected cells decreased due to the cytotoxicity, whereas values for mPEI were 1.5 to 1.7 
fold higher than for PEI. Higher ratios, i.e. more transfected and viable cells, for mPEI were 
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obtained as consequence of its lower cytotoxicity (see 3.5). The transfection efficiency of the 
smaller-sized polyplexes formed in reduced ionic strength medium (50 mM NaCl / 3.3% 
glucose) was also evaluated in CHO-K1 cells. mPEI showed a slight increase in transfection 
efficiency at NP 6, 12 (significantly different from polyplexes in 150 mM NaCl, α < 0.05) 
and 18 of ca. 0.5 – 1.0% (data not shown) accompanied by a loss in cell viability. Polyplexes 
produced in 50 mM NaCl / 3.3% glucose with PEI achieved a larger number of transfected 
cells at NP 6 (ca. 2% higher than in 150 mM NaCl), but at higher NP ratios a decrease in 
transfection efficiency was observed (data not shown). As mentioned before, nanoparticles 
formed in 50 mM NaCl / 3.3% glucose could be more stable due to less free ions that can 
interact in complex formation. This stability could be responsible for higher transfection 
efficiencies. Interestingly, higher transfection efficiencies of the smaller nanoparticles resulted 
in an increased cytotoxicity with both polymers (see 3.5). 
In conclusion, using pEGFP-N1 as a reporter gene, the non-viral carrier PEI shows a 
significantly higher transfection efficiency than mPEI at NP 6, 12, 18 and 24. 
Luciferase reporter gene expression (Figure 8) confirmed the trends seen with the cationic 
carrier PEI when using GFP as a reporter gene: the number of RLU / mg of protein could be 
augmented from NP 6 to NP 12 and then decreased. With mPEI, the gene expression could be 
increased from NP 6 to NP 24. 
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Figure 8: Luciferase reporter gene expression of the cationic carriers PEI ( ) and mPEI ( ) 
expressed as relative light units (RLU) / mg of protein. Values are means ± SD of one 
representative experiment (n=4). Gene expression of PEI at NP 12 is significantly different 
from mPEI, denoted by  (α < 0.01). 
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In contrast to the transfection efficiency with pEGFP-N1 as reporter gene, as Figure 8 
illustrates, gene expression with PEI and mPEI had nearly the same extent at NP 24. At NP 12 
RLU / mg of protein of PEI-DNA complexes were significantly different from mPEI 
nanoparticles. These results should be considered with regard to the fact that only adherent, 
respectively viable cells, were analysed. 
To summarize, evaluating transfection efficiency flow cytometry can be considered as more 
presice method. 
Cell viability 
Cell viability of CHO-K1 cells after treatment with DNA-polymer nanoparticles or free 
polymer was measured by the MTS assay. Free and complexed polymer were tested for 
tagging of which component contributes more to cytotoxicity. 
The cytotoxicities of polyplexes formed with PEI and mPEI are presented in Figure 9. It is 
shown that neither type of polyplex displayed significant cytotoxicity at NP 6. Higher NP 
ratios of mPEI-complexes did not influence cell viability, whereas cytotoxicity increased with 
PEI proportion in polyplexes. The number of viable cells after treatment with DNA-PEI 
nanoparticles decreased to 70% at NP 24. The relative viability of cells transfected with PEI 
compared with mPEI was significantly lower (α < 0.01) at NP 12, 18 and 24. 
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Figure 9: Relative Viability of CHO-K1 cells after treatment with DNA-PEI ( ) or –mPEI 
( ) complexes at various NP ratios determined with the MTS assay. Values are means ± SD 
of one representative experiment (n=4). Relative viability of cells transfected with PEI is 
significantly different from mPEI at NP 12, 18 and 24, denoted by  (α < 0.01). 
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With propidium iodide staining, we had the tool to determine the number of viable cells at the 
time point of flow cytometry analysis (UL and LL quadrants) and were also able to compare 
these results with data from the cell viability assay. Regarding polyplexes built in 150 mM 
NaCl, DNA-PEI nanoparticles reduced the fraction of viable cells from 90% at NP 6 to 60% 
(NP 24). In contrast, the values of viable cells after treatment with mPEI-plasmid DNA 
nanoparticles were without exception higher than after incubation with PEI nanoparticles 
(Figure 10). The number of viable cells was determined to be over 90% at NP 6 and decreased 
to about 80% at NP 24. 
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Figure 10: Viable, i.e. propidium iodide negative cell population, 48 hours post transfection 
with PEI ( ) and mPEI ( ), as assessed by flow cytometry. Propidium iodide staining is 
immediate in dead cells due to the loss of their membrane integrity, while live cells remain 
unstained. Viability of cells transfected with PEI is significantly different from mPEI at NP 
12, 18 and 24, as denoted by  (α < 0.01). 
To summarize, the number of viable cells transfected with PEI was significantly (α < 0.01) 
lower than transfected with mPEI at NP ratios of 12, 18 and 24. In comparison to polyplexes 
formed in 150 mM NaCl analysis of cells transfected with nanoparticles formed in 50 mM 
NaCl / 3.3% glucose showed a tremendous increase in cytotoxicity (data not shown). In 
contrast to FACS analysis, the results for the cell viability of the MTS assay were about 10% 
higher. The reason is that both methods have a different principle: in FACS analysis, changes 
in cell granularity and perforation of cell membranes are considered, whereas the MTS assay 
evaluates the metabolic activity. The membrane of a cell can be lysed or there can be changes 
+  !"	"
*)
in granularity and the cell will still be metabolically active. Despite of these differences, both 
methods demonstrate the same trend for cell viability. 
Figure 11 illustrates the value for cytotoxicity of free polymer in culture medium. Free mPEI 
had less toxic effects on CHO-K1 cells than PEI. 
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Figure 11: Relative viability as function of free PEI ( ) and mPEI ( ) in culture medium. 
Values are means ± SD of one representative experiment (n=4). 
Comparing free polymer and the same amount of polymer complexed with DNA, polymer 
solution displays higher values for cytotoxicity. These results are probably due to the fact that 
polyplex-building reduces the free function of polymer, i.e. polymer that can permeabilize cell 
membranes or complex cellular DNA. 
Our hypothesis that mPEI is less toxic due to its lower charge density could be verified by 
these results. 
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In this study we investigated the complexation capacity and transfection efficiency, with 
special regard to cell viability and cytotoxicity, of the cationic polymers PEI and mPEI. 
Despite the reduction of the cationic charge density of PEI by methylation, and thus the 
presence of fewer protonated nitrogens to participate in complex formation, mPEI allowed for 
the building of small and compact polyplexes for non-viral gene delivery. 
The results of the in vitro transfection experiments comparing the two cationic polymers were 
evaluated with special regard to cell viability. To summarize our results, PEI had a higher 
transfection efficiency than mPEI, but at NP 12, 18 and 24 the ratio of viable and transfected 
cells to dead and transfected cells was higher for mPEI. It can be concluded, that a higher 
transfection efficiency is accompanied by an increase in cytotoxicity. Transfection 
experiments with luciferase yielded better results for mPEI, but unfortunately this method of 
analysis provides no information about the cellular state. 
mPEI displayed a lower cytotoxicity than PEI because of fewer nitrogens protonated at 
physiological pH that can permeabilize cell membranes. Our hypothesis of reducing the 
cyotoxicity by methylation of PEI could be confirmed. 
The reason for mPEI´s lower transfection efficiency is unclear. Because the polyplex size is 
comparable to DNA-PEI nanoparticles, one possibility could be that mPEI is not able to 
buffer the pH in endosomes following by the escape of the polyplexes in cytoplasm. 
For future experiments, there are different approaches possible to improve the properties of 
non-viral vectors for gene delivery. A better understanding in polyplex building, a process 
that has been poorly investigated so far, could help in the designing of novel polymers. The 
development of a biodegradable PEI may be one way to both maintain the transfection 
efficiency and also reduce the cytotoxicity. Polyamines, such as tetra-amine spermine and 
triamine spermidine, are naturally found in cells, thus, short fragments of PEI should display 
less cytotoxicity. 
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With recent advances in molecular biology and the sequencing of the human genome, nucleic 
acids are expected to engage a pivotal position in the development of novel therapeutic 
concepts. The basic principle of nucleic acid delivery is to influence cellular functions either 
to stimulate or turn off the production of certain proteins. Furthermore, nucleic acid delivery 
is also increasingly utilized in basic research in order to gain a more complete comprehension 
of distinct cellular functions. So far, there are two common approaches towards nucleic acid 
delivery: the transfer of the genetic information using viral vectors or non-viral methods, such 
as wrapping of DNA to synthetic gene vehicles and physical principles [1-5]. Although viral 
vectors are very effective and are capable of many of the required tasks for efficient gene 
transfer, their broad use is limited by severe safety risks [6,7]. Therefore, non-viral delivery 
systems such as lipids, polymers or gene gun and electroporation are gaining growing 
attention. This work focused on the use of polymers as vehicles for nucleic acid delivery. 
Several important design criteria and characteristics towards effective polymer-based systems 
have been identified so far and, among various polymers, polyethylenimine (PEI) has become 
a gold standard for nucleic acid delivery [8]. The processing of DNA with the polymer to 
particles, the so-called polyplexes, their engulfment into cells and intracellular fate are being 
intensively investigated. Furthermore, the efficacy of polyplexes is being improved by 
exploiting particular cellular mechanisms and signal sequences are attached to polyplexes in 
order to steer them to certain intracellular organelles, especially the nucleus (Chapter 1). The 
relatively high transfection efficiency of branched PEI (BPEI) -based delivery systems is 
seriously afflicted by the cytotoxicity of the polymer. In contrast, the linear form (LPEI) has a 
particularly high gene expression accompanied by a lower cytotoxicity, but nevertheless the 
transfection efficiency of LPEI 22 kDa (ExGen®) cannot be enhanced beyond a certain limit 
due to cytotoxicity. 
Towards the development of optimal non-viral transfer systems and before polymer-based 
delivery systems may come into clinics, fundamental questions concerning their efficacy, 
cytotoxicity and interaction with the environment have to be resolved. Therefore, the ultimate 
goal of this thesis was to identify strategies towards effective PEI-based delivery systems 
with low cytotoxicity for in vitro use. 
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The first objective was to overcome the frequent restriction that high transfection efficiency is 
limited by the cytotoxicity of the non-viral carrier. Therefore, we explored the potential of 
utilizing LPEIs with a molecular weight (MW) ranging from 1.0 to 9.5 kDa to overcome this 
limitation (Chapter 2). This study showed that the transfection efficiency of LPEI - 
polyplexes in CHO-K1 cells as a model cell line could be altered by varying the MW and the 
amount of polymer available for polyplex formation. It was striking that the transfection 
efficiency with certain low MW LPEI derivatives was much higher compared to the 
commercially available LPEI 22 kDa within the same test system: in addition, the maximal 
transfection efficiency of about 44%, obtained with LPEI 5.6 kDa at NP 18, was accompanied 
by minimal cytotoxicity. By using LPEI 5.0 kDa and smaller in polyplexes, the transfection 
efficiency could be increased without affecting the cell viability. Furthermore, we could show 
that a MW greater than 1.0 kDa is necessary for gene expression. As observed by confocal 
laser scanning microscopy (CLSM) and demonstrated by the addition of lysosomotropic 
agents, LPEI - polyplexes have an impressive endo-lysosomal escape capacity. Additionally, 
LPEIs may also help the plasmid DNA to overcome the nuclear membrane, thereby 
enhancing the gene transfer. This study envisioned the decoupling of transfection efficiency 
from cytotoxicity and demonstrated that LPEIs with low MW are more efficient and 
significantly less toxic than their high MW counterparts in CHO-K1 cells in vitro. 
 
A follow-up study focused on the uptake and intracellular stability of various LPEI - 
polyplexes and plasmid DNA in order to investigate differences relevant for their efficacy. 
Furthermore, the influence of the ionic strength of the polyplex formation medium and 
presence of serum during the transfection process on the transfection efficiency was evaluated 
(Chapter 3). Generating the LPEI - polyplexes in 150 mM sodium chloride or 5% glucose 
produces either very large (>1 µm) or small (about 200 – 300 nm) polyplexes, respectively 
[9,10]. But once in contact with culture medium, the differences seemed to equalize. This 
means that the size of the resulting polyplexes is not susceptible to varying ionic strength in 
culture medium during the fabrication procedure. However, the transfection efficiency of 
LPEI 9.0 kDa, but not of derivatives with lower MW, was significantly influenced by the 
ionic strength: the fabrication of polyplexes in 5% glucose following transfection in serum-
free culture conditions remarkably enhanced the transfection efficiency compared to other 
conditions tested. The reason for this phenomenon is unclear and has to be further elucidated, 
most likely the polyplex assembly may favor the superiority of these polyplexes. 
The overall amount of polyplexes taken up by cells was slightly higher when polyplexes were 
built with LPEIs of 5.0 and 9.0 compared to 2.0 kDa, but independent of the polyplex 
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formation medium and the culture conditions during the transfection process. However, the 
higher number of intracellular polyplexes using LPEI 5.0 or 9.0 kDa as carrier systems did 
not entail a higher amount of plasmid DNA intracellularly available for transfection. 
Furthermore, we did not determine a correlation between the disintegration of polyplexes 
inside cells, the stability of plasmid DNA and the transfection efficiency. This means that we 
have a very robust system for LPEI-based nucleic acid delivery that is widely independent of 
external influences and suitable for routine transfection experiments. The high transfection 
efficiency of certain LPEI - polyplexes probably arises due to a balance of endo-lysosomal 
escape capacity, nuclear transport and cytotoxicity. 
 
The application of fluorescence imaging technology has demonstrated the capability for real-
time measurements in the field of non-viral gene delivery in order to investigate the 
interaction of polyplexes with their environment. However, due to the resolution limit of a 
light microscope, it remains possible that fluorescently labeled molecules observed are 
colocalized without being associated. Techniques such as fluorescence resonance energy 
transfer (FRET) provide the opportunity for a better resolution in the distance range of 1-10 
nm [11,12]. Hence, we evaluated whether FRET is a valuable tool to determine the 
intracellular disintegration of double labeled LPEI - polyplexes in CHO-K1 cells by CLSM 
(Chapter 4). In microscopy, allowing for the evaluation of the distribution of FRET events 
whithin a single cell, two approaches have been tested towards quantitative FRET analysis, 
sensitized emmision measurement and acceptor photobleaching. Results from the acceptor 
photobleach method were not accurate due to movements of or in the sample during the 
imaging and bleaching process. Sensitized emission measurement using the method according 
to Xia et al. [13] worked quite well for the determination of interaction between LPEI and 
plasmid DNA. The results confirmed images recorded by conventional CLSM: A fraction of 
the intracellular polyplexes disintegrated, but at certain areas the contact between polymer 
and DNA was still very close. Furthermore, FRET occuring between a donor and an acceptor 
molecule of double labeled LPEI - polyplexes was also measured by flow cytometry. The 
advantage of the flow cytometry-based method is the analysis of a whole cell population. As 
indicated by a decrease in the donor quenching, the stability of intracellular polyplexes built 
with LPEI 5.0 kDa seemed to be enhanced with increasing NP ratio. In summary, the 
interaction of polymer and plasmid DNA in living cells have to be carefully addressed by 
FRET-based techniques because of movements of or in the sample during the imaging 
process. We suggest that FRET is a valuable tool in order to gain a deeper insight into LPEI-
mediated gene transfer. 
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If polyplexes are applied once in vivo, the long-term fate of the polymeric carrier has to be 
considered in an organism. Therefore, high MW polymers that have superior properties to 
complex DNA and a stabilizing effect on polyplexes, but which can be easily degraded by the 
host, might help to overcome this obstacle. We hypothesized that a bioreversible crosslinking 
of low MW LPEIs would raise the polymer’s efficacy due to the higher MW and hence 
transfection efficiency, while the biodegradable linkages would undergo intracellular 
breakdown and hence minimize toxicity. In detail, various biodegradable PEIs, namely LR-
PEIs, were investigated concerning their transfection efficiency and cytotoxicity (Chapter 5). 
The biodegradable polymers had a different degree of branching and a slightly increasing 
MW with increasing linker/polymer proportion. LPEI 2.1 kDa was chosen as starting material 
for crosslinking because its polyplexes showed a minimal transfection efficiency and no 
cytotoxicty in a cell culture model (Chapter 2). We expected that crosslinking would lead to a 
transfection efficiency comparable to a LPEI derivative of the higher MW, but cytotxicity as 
low as for LPEI 2.1 kDa. Our results proved the hypothesis: the most effective LR-PEI was 
capable of gene delivery in 27-fold more cells than the non-degradable starting material and 
moreover, the maximum transfection efficiency achieved in CHO-K1 cells had a value of 
about 73%, which is much higher than that of the LPEI derivative of similar MW. These 
biodegradable PEIs can be counted among the most effective polymer-based gene delivery 
vehicles, because the efficacy was nearly 3-fold higher than with BPEI 25 kDa and LPEI 22 
kDa, to which newly synthesized polymers are usually compared. LR-PEI-mediated gene 
delivery was dependent on intracellular reduction and could be modulated by manipulation of 
the number of stabilizing bonds. CLSM revealed a longer colocalization of biodegradable 
PEI- polyplexes with acidic organelles compared to LPEI - polyplexes. In summary, we 
identified biodegradable PEI-based polyplexes that are superior to existing polymer-based 
gene delivery systems. 
 
After biodegradable PEI-based polyplexes had successfully been applied for the transfection 
of various cell lines in vitro, the next step was to evaluate their gene transfer ability in human 
primary cells and in a ‘hard-to-transfect’ cell line (Chapter 6). Primary cells should be more 
representative of the in vivo situation than transformed cell lines and would better predict 
limitations to gene transfer in vivo. We chose two different test systems, denritic cells (DCs) 
and chondrocytes. In contrast to cell lines that are permananetly dividing, DCs are terminally 
differentiated and non-dividing, while human chondrocytes still have the ability for 
proliferation, but their mitogenic activity is limited. In DCs the transfection efficiency was 
nearly negligible and also accompanied by a remarkable toxicity. According to confocal 
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images, the uptake of polyplexes seemed to be one of the limiting steps in the transfection 
process. Human chondrocytes were more susceptible to PEI-based transfection, but the 
efficacy was much lower compared to the cell lines tested in Chapter 5. In HT-29 cells, a 
‘hard-to-transfect’ cell line, the gene transfer was as low as in DCs, the uptake besides other 
reasons such as nuclear entry, has been demonstrated to be a limiting step in the transfection 
process. 
 
Last mentioned, we showed that the PEI backbone is a necessary prerequisite for efficient 
polymer-based gene delivery. The investigation of per-N-methylated PEI relvealed that the 
polymer is still capable of condensing plasmid DNA into polyplexes, but the resulting 
polyplexes lost their functionality in most instances (Chapter 7). This may be due to the fact 
that per-N-methylated PEI lost its most prominent feature: the high cationic charge density, 
which is postulated to be significantly responsible for efficient gene delivery [8]. 
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In conclusion, this thesis successfully demonstrated strategies towards very efficient PEI-
based nucleic acid delivery systems with low cytotoxicity. By comprehensively evaluating 
modifications in the structure of existing PEI derivatives it was possible to overcome the 
frequent restriction that a high transfection efficiency is accompanied by high cytotoxicty. To 
this end, we introduced LPEIs with low MW and biodegradable PEIs that are far more 
efficient and substantially less toxic in cell lines in vitro than other polymer-based systems 
reported in literature. Furthermore, these polymer-based systems are easy to handle and the 
transfection procedure is reproducible and independent of external influences. 
Polyplexes are challenged by numerous biological barriers on their way to the nucleus. We 
strove to gain more insight into the knowledge of interaction of polyplexes with these 
obstacles. 
The PEI-based systems presented here could be an excellent basis for future studies directed 
at the transfection of primary cells in vitro. A key step will be the development of PEI-based 
polyplexes with tailored structure-composition-properties that react to specific changes of 
their environment to enhance the cellular and nuclear entry. 
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1H-NMR proton nuclear magnetic resonance 
ANOVA analysis of variance 
APC antigen presenting cell 
As4.1 cell line from the murine kidney 
ATP adenosine triphosphate 
bp base pair 
BPEI branched PEI 
CD cluster of differentiation 
CHO-K1 chinese hamster ovarian cell line 
CLSM confocal laser scanning microscopy 
CMV cytomegalovirus 
CO2 carbon dioxide 
COS-7 monkey kidney cell line 
Da Dalton 
DC dendritic cell 
DMEM Dulbecco s` modified eagle s` medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DNase  deoxyribonuclease 
DTS DNA nuclear targeting sequences 
DTT dithiotreitol 
E the energy transfer efficiency of a FRET pair 
EDTA ethylendiaminetetraacetic acid 
EGFP enhanced green fluorescent protein 
ET the energy transfer efficiency of a FRET pair expressed by donor 
quenching 
EtBr ethidium bromide 
ETp the energy transfer parameter of a FRET pair 
FACS fluorescence activated cell sorting 
FBS fetal bovine serum 
Fc FRET corrected 
FCS fluorescence correlation spectroscopy 
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FISH fluorescent in situ hybridzation 
FM4-64 N-(3-triethylammoniumpropyl)-4-(6-(4-
(diethylamino)phenyl)hexatrienyl)pyridinium dibromide 
Fn FRET net 
FRET fluorescence resonance energy transfer 
GFP green fluorescent protein 
Glc glucose 
GM-CSF granulocyte-macrophage colony stimulating factor 
GSH MEE glutathione monoethyl ester 
Ham´s F-12 Nutrient Mixture F-12 
HeLa human cervical carcinoma cell line 
His-PLL histidylated PLL 
HIV human immunodeficiency virus 
HT-29 human colorectal adenocarcinoma cell line 
iDC immature DC 
IL-4 interleukine-4 
J the overlap integral 

2
  the orientationof the transition moments of the donor and acceptor 
molecules of a FRET pair 
kDa kilo Dalton 
kT , kF,  kD various rate constants describing decay events of the donor 
molecules of a FRET pair 
LL quadrant lower left quadrant 
LPEI linear PEI 
LR-LPEI biodegradable PEI 
LR quadrant lower right quadrant 
mDC mature DC 
MHC major histocompatibility complex 
mPEI per-N-methylated PEI 
MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium-inner salt] 
MW molecular weight 
MWCO molecular weight cut off 
n the refractive index 
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NF normalized FRET 
NLS nuclear localization signal 
NPC nuclear pore complex 
NP ratio the ratio of nitrogens in polymer to phosphates in DNA 
PAM polyamidoamine 
PBMC peripheral blood monocytotic cell 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
pDEAEMA poly(diethylaminoethyl methylacrylate) 
PEI poly(ethylenimine) 
pEGFP-N1 plasmid encoding EGFP 
pGL3-enhancer vector plasmid encoding firefly luciferase 
PI polydispersity index 
PLL poly(L-lysine) 
PNA peptide nucleic acid 
PTDs protein transduction domains 
R the distance between the FRET dye pair 
R0 the characteristic separation distance of every FRET dye pair 
defining where the probability of energy transfer is 50%. 
RLU relative light units 
RNA ribonucleic acid 
rpm rotations per minute 
ROI region of interest 
SDS dodium dodecyl sulfate 
SF serum free 
SV40 simian virus 40 
 the lifetime of a fluorophore 
TAMRA tetramethylrhodamine 
Tris buffer tris(hydroxymethyl)aminomethane buffer 
UL quadrant upper left quadrant 
UR quadrant upper right quadrant 
UV ultraviolett light or irradiation 
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